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We study the problem of estimating treatment effects when the outcome of primary interest (e.g., long-term health
status) is only seldom observed but abundant surrogate observations (e.g., short-term health outcomes) are available.
To investigate the role of surrogates in this setting, we derive the semiparametric efficiency lower bounds of average
treatment effect (ATE) both with and without presence of surrogates, as well as several intermediary settings. These
bounds characterize the best-possible precision of ATE estimation in each case, and their difference quantifies the
efficiency gains from optimally leveraging the surrogates in terms of key problem characteristics when only limited
outcome data are available. We show these results apply in two important regimes: when the number of surrogate
observations is comparable to primary-outcome observations and when the former dominates the latter. Importantly,
we take a missing-data approach that circumvents strong surrogate conditions which are commonly assumed in
previous literature but almost always fail in practice. To show how to leverage the efficiency gains of surrogate
observations, we propose ATE estimators and inferential methods based on flexible machine learning methods to
estimate nuisance parameters that appear in the influence functions. We show our estimators enjoy efficiency and
robustness guarantees under weak conditions.
1 Introduction
In many causal inference applications, it may be expensive, inconvenient or infeasible to measure the outcome of
primary interest. Nevertheless, some auxiliary variables that are faster or easier to measure may be available. In
clinical trials for AIDS, the primary outcome is often mortality, which may take years of follow-up to fully reveal.
But clinically relevant biomarkers like viral loads or CD4 counts can be measured quite rapidly [Fleming et al., 1994].
In comparative effectiveness research for long-term impact of therapies, e.g., long-term quality of life measures, many
patients may drop-out so their responses are missing. But short-term outcomes, e.g., responses shortly after the
therapy, may be well recorded [Post et al., 2010]. In program evaluation for addiction prevention projects, accurately
measuring the primary outcome, e.g., smoking behavior, may require costly chemical analysis of saliva samples for
the presence of cotinine, and thus are available for only a limited number of participants. Yet self-report data are
relatively inexpensive to collect [Pepe, 1992]. We refer to these easy-to-obtain auxiliary variables as surrogates, which
are often informative about the primary outcome of interest.
There has been considerable interest in using surrogate as a replacement for the missing primary outcome to reduce
data collection cost in causal inference. For example, U.S. Food and Drug Administration (FDA) launched the
Accelerated Approval Program to allow for early approval of drugs based on a clinically relevant surrogate, aiming to
speed up the clinical trials for drug approval [FDA, 2016]. This program is spurred by the urgent need to determine
the efficacy of new drugs quickly and economically. As is stated by National Center for Advancing Translational
Scicences (NCATS) of National Institutes of Health, many thousand diseases known to affect humans do not have
any approved treatment yet; meanwhile, a novel drug can “take 10 to 15 years and more than $2 billion to develop”
[NCATS, 2019]. Thus accelerating the drug approval is of extraordinary value to both pharmaceutical companies,
and also patients, especially those with unmet medical needs. Using surrogates that can be measured more easily
provides a promising way towards this goal.
∗Alphabetical order.
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However, one major challenge is that surrogates may not be perfectly indicative of the primary outcome, so a misuse
may lead to severe or even disastrous consequences. For example, three drugs (encainide, flecainide, and moricizine)
were approved by FDA based on early success of supressing ventricular arrhythmia (surrogate), but in later follow-up
trials the drugs clearly increased rather than decreased mortality (primary outcome) [Fleming and DeMets, 1996,
Echt et al., 1991]. It was estimated that the use of these drugs resulted in an estimated 50,000 excess deaths in United
States [Moore, 1997]. To resolve these problems, a wide variety of criteria have been proposed to ensure that it is
adequate to base causal inference solely on the surrogate without observing the primary outcome at all. However,
using these criteria to search a valid surrogate to replace the primary outcome is still extremely challenging, since all
criteria impose stringent assumptions that are generally violated in practice (see Related Literature in Section 1.3
and Appendix B). For example, the “statistical surrogate” condition [e.g., Prentice, 1989, Athey et al., 2019] requires
the primary outcome to be conditionally independent with the treatment given surrogates, i.e., surrogates can fully
explain away the dependence between the outcome and treatment. This condition can be easily invalidated even in
perfect randomized trials once there is any unmeasured confounder between surrogates (usually unmanipulable) and
the primary outcome (see Appendix B). Thus this surrogate condition, and similarly many other criteria, are very
unlikely to hold in practice.
In this paper, we view surrogates as supplements instead of replacements for the primary outcome. We consider
combining surrogates with the primary outcome, and investigate how this proposal can improve the efficiency of
treatment effect estimation. Such combination is possible because in practice often paired observations of both the
primary outcome and surrogates are available for at least some units (e.g., patients who were recruited early or have
higher risk). By incorporating a limited number of primary-outcome observations, we can avoid the aforementioned
probelms resulted from relying on surrogates alone, and circumvent stringent surrogate conditions. Instead, we only
assume standard causal inference assumptions and a typical missing data assumption that the primary outcome is
missing at random (MAR), i.e., whether the primary outcome is observed or not only depends on other observed
variables (e.g., pre-treatment covariates, treatment, surrogates). This condition guarantees that the distribution of
the subsample with primary-outcome observations (labelled data) is comparable with the distribution of the remaining
sample without primary-outcome observations (unlabelled data) after adjusting for the observed variables. Similar
missingness conditions are also commonly assumed in previous literature that combine different datasets [e.g., Athey
et al., 2019, Cheng et al., 2018, Zhang and Bradic, 2019]. Under only these standard assumptions, and in particular
no overly restrictive surrogate conditions, we aim to investigate the role of surrogates in estimating treatment effects
when the primary-outcome observations are limited.
We study possible benefits of leveraging surrogates from the perspective of estimation efficiency. Built on the
theory of semiparametric efficiency (see Section 1.2 for a review), we derive the efficiency lower bound of estimating
the average treatment effect (ATE) on the primary outcome (Theorem 2.1). This lower bound characterizes the
fundmental statistical limit in estimating ATE under our assumptions, in that it is the best possible precision
of ATE estimation that can be asymptotically achieved by any “reasonable” estimator (see Section 1.2 for more
interpretations). By comparing the efficiency lower bounds both with and without presence of surrogates, and bounds
in several intermediary settings (Theorem 2.2 and corollary 2.2.1), we quantify the efficiency gains from surrogates,
namely, the benefit of surrogates in terms of allowing us to estimate treatment effects up to the same precision with
fewer observations of the primary outcome. We find that surrogate observations can improve estimation efficiency only
when the primary outcome is not completely observed, i.e., it is missing at least for some units. Using surrogates is
particularly advantageous when (i) the primary outcome is missing for a large number of units, and (ii) the surrogates
are very predictive of the primary outcome, in that they can account for large variations of the primary outcome
that cannot be explained by the pre-treatment covariates. These theoretical results provide insightful guidelines for
understanding when surrogates can yield significant benefits. Moreover, we show that essentially the same efficiency
lower bound (under appropriate reformulation) reigns across two different regimes: when size of the unlabelled data
is comparable to the size of the labelled data (Theorem 2.1), and when the former is much larger than the latter
(Theorems 4.1 and 4.2). In the second regime, the commonly assumed overlap condition (Assumption 2 condition (5))
fails and the efficiency analysis under MAR setting becomes more challenging. Chakrabortty et al. [2018] remarked
that the literature “under such settings is virtually nonexistent”. Our results attempt to fill in the literature gap for
this very practical setting with enormous cheap unlabelled data available.
We further propose an ATE estimator that can optimally exploit the efficiency gains from surrogates and asymp-
totically achieve the efficiency lower bound. The proposed estimator involves some nuisance parameters that are of
no intrinsic interest but need to be estimated first. By employing the cross-fitting technique [Chernozhukov et al.,
2018], we can allow for any flexible machine learning estimators for the nuisance parameters as long as they satisfy
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some generic convergence rate conditions. We show that the proposed estimator converges to the true ATE value,
even if only some but not all nuisance parameters are consistently estimated (Theorem 3.1). If all nuisance parame-
ters are indeed consistently estimated under generic rate conditions, then the proposed estimator is asymptotically
normal centered at the true ATE value and its asymptotic variance attains the efficiency lower bound (Theorems 3.2
and 4.2). This means that, asymptotically speaking, our proposed estimator estimates ATE as precisely as possi-
ble. Furthermore, we construct asymptotically valid confidence intervals based on a simple plug-in estimator for
the asymptotic variance of our ATE estimator (Theorem 3.3). In summary, we propose an ATE estimator that can
leverage the power of flexible machine learning estimators for nuisance estimation, is robust to nuisance estimation
errors, achieves full estimation efficiency, and enjoys easy-to-use inferential method.
Our paper is organized as follows. In Section 1.1, we set up the problem of treatment effect estimation with surrogates
when the primary outcome is not fully observed, and introduce the notations. We briefly review the semiparametric
efficiency theory in Section 1.2 to formalize the concept of estimation efficiency, and then summarize related literature
in Section 1.3. In Section 2, we derive the efficiency lower bound for ATE estimation in our setting, and compare
it with bounds in other benchmark settings to characterize the efficiency gains from surrogates. We then construct
an asymptotically efficient estimator and prove its asymptotic properties in Section 3. In Section 4, we extend the
efficiency and estimation results to the setting where size of unlabelled data is much larger than size of the labelled
data. We point out the efficiency and estimation results in this setting are reformulations of those in Section 2 and
Section 3. We conclude our main content in Section 5. In Appendices A to C, we provide supplementary discussions
about the connection of our paper to previous literature, review the statistical surrogate condition in details, and
further expand the results in Section 4 respectively. All proofs are delegated to Appendix D.
1.1 Problem Setup
Let T ∈ {0, 1} denote a treatment indicator variable (e.g., T = 1 means being treated with a therapy of interest,
and T = 0 means control), X ∈ X ⊆ Rdx denote covariates measured prior to treatment (e.g., patients’ demographic
characteristics), and Y ∈ R denotes the outcome variable of primary interest (e.g., patients’ health outcome).
Following the Neyman-Rubin potential outcome framework [Neyman, 1923, Rubin, 2005], we assume the existence
of two potential outcomes Y (1), Y (0) corresponding to the outcomes that would have been realized with and without
the treatment respectively. We assume that the actual outcome is the potential outcome corresponding to the actual
treatment, i.e., Y = Y (T ), which encapsulates the non-interference and consistency assumptions in causal inference
[Imbens and Rubin, 2015]. Our goal is to estimate the average treatment effect (ATE):
δ∗ = ξ∗1 − ξ∗0 = E[Y (1)]− E[Y (0)]. (1)
If we could observe (T,X, Y ) for all units, then under standard causal assumptions, ATE can be estimated by many
existing methods such as stratification [e.g., Rosenbaum and Rubin, 1984, Lunceford and Davidian, 2004], weighting
[e.g., Robins et al., 1994, Hirano and Imbens, 2001], matching [e.g., Rosenbaum, 1989, Abadie and Imbens, 2006],
etc. See Imbens and Rubin [2015] for more comprehensive reviews.
In this paper, we consider a more challenging setting where the primary outcome Y cannot be observed for all units,
due to long follow-up, drop-out, budget constraints, etc. Instead, we can observe for all units some surrogates S ∈
S ⊆ Rds (e.g., intermediate outcomes) that may be quite informative about the primary outcome Y (e.g., a long-term
outcome). Since surrogates are measured after the treatment assignment, they may also be affected by the treatment.
Thus we hypothesize the existence of two potential surrogates S(1), S(0) analogously, and assume S = S(T ). We use
R ∈ {0, 1} to denote the indicator of the primary outcome Y being observed. In summary, we can observe a labelled
subset {(Xi, Ti, Si, Yi, Ri = 1) : i ∈ Il}, and an unlabelled subset {(Xi, Ti, Si, Yi = NA, Ri = 0) : i ∈ Iu}, where NA
stands for missing value, and Il and Iu are the index sets for labelled data and unlabelled data respectively. We
denote Nl = |Il|, Nu = |Iu| as the corresponding sample sizes for these two datasets, and N = Nl +Nu as the total
sample size. We represent the ith data point as Wi = (Xi, Ti, Si, Yi, Ri), and assume that each data point (in both
labelled subset and unlabelled subset) is an independent and identically distributed (i.i.d) draw from a population
(X,T, S(0), S(1), Y (0), Y (1), R) with distribution characterized by probability measure P.
We assume that both the treatment assignment T and the labeling indicator R are unconfounded given the observables
[Imbens and Rubin, 2015].
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Assumption 1 (Unconfoundedness). For t = 0, 1,
(Y (t), S(t)) ⊥ T | X (2)
R ⊥ Y (t) | (X,T = t, S(t)) (3)
Here condition (2) states that X include all confounders that can affect either the primary outcome and treatment
simultaneously, or the surrogate and treatment simultaneously. This is a standard assumption in causal inference
involving post-treatment variables [e.g., Rosenbaum, 1984, Imai et al., 2011]. It is satisfied by design in clinical trials
where the treatment T is assigned totally at random. Condition (3) requires the primary outcome to be missing at
random (MAR), i.e., the indicator R depends on only observed variables, including pre-treatment covariates X, the
treatment T and surrogates S. This condition guarantees that the distribution of the primary outcome on the labelled
data and unlabelled data are comparable after accounting for the observed variables, so that we can use the labelled
data to infer information about the missing primary outcome in the unlabelled data. This condition is considerably
weaker than the missing completely at random (MCAR) condition typically assumed in previous semi-supervised
inference literature [e.g., Cheng et al., 2018, Zhang and Bradic, 2019], since MCAR does not allow the missingness
of the primary outcome to depend on any other variable. Condition (3) may be satisfied by design in a two-phase
sampling scheme [e.g., Wang et al., 2009, Cochran, 2007]: in the first phase, relatively cheap measurements of T,X, S
are available for all units, and in the second phase, expensive measurements of the primary outcome Y are collected
for a validation subsample selected according to variables measured in the first phase. For example, we may want to
oversample units who self-report no-smoking behavior for further chemical analysis, if we suspect more misreporting
in this subpopulation.
We introduce some important quantities for ATE estimation: the regression functions of the primary outcome on
the labelled dataset, µ˜∗(t, x, s) = E[Y | T = t, R = 1, X = x, S = s] and µ∗(t, x) = E[Y | T = t, R = 1, X = x], and
the propensity scores for treatment and labeling respectively, e∗(x) = P(T = 1 | X = x) and r∗(t, x, s) = P(R = 1 |
T = t,X = x, S = s), for any x ∈ X and s ∈ S. Although these quantities are useful for ATE estimation, they are of
no intrinsic interest, so we refer to them as nuisance parameters and concatenate them in η∗ = (e∗, r∗, µ˜∗, µ∗). We
further assume the following strict overlap assumption for the two propensity scores.
Assumption 2 (Strict Overlap). There exist a constant  ∈ (0, 1/2) such that the following holds almost surely:
 ≤ e∗(X) ≤ 1−  (4)
 ≤ r∗(t,X, S(t)) ≤ 1, for t = 0, 1 (5)
This assumption states that units with any given values of the conditioning variables above have at least probability
of  to receive each treatment option, and get the primary outcome measured. This strict overlap assumption is
common in causal inference and missing data literature [e.g., Imbens and Rubin, 2015, Little and Rubin, 2019].
Obviously, condition (5) implies that  ≤ P(R = 1) ≤ 1, so with high probability the size of the unlabelled data is
comparable to the size of the labelled data, i.e., Nu  Nl. In Section 4, we will relax this condition and consider
the setting where enormous cheap unlabelled data are available so that its size is much larger than the size of the
labelled data, i.e., Nu  Nl.
In this paper, we focus on efficient estimation of ATE (i.e., δ∗ in eq. (1)) when the primary outcome Y is missing
for many units while surrogates S can be fully observed. Notably, we only assume Assumptions 1 and 2 (and some
straightforward variants) that are very typical in causal inference and missing data literature. In particular, we do
not assume any strong surrogate condition, e.g., the “statistical surrogate” condition Y ⊥ T | S,X,R = 1, that may
impose unrealistic restrictions (see Section 1.3 and Appendix B).
Notation. We use O, o,Op, op to denote the nonstochastic and stochastic asymptotic orders repsectively. For non-
stochastic positive sequences aN and bN , aN = O(bN ) if lim supN→∞ aN/bN <∞, and aN = o(bN ) if limN→∞ aN/bN =
0. For random variable sequence ZN , we denote ZN = Op(aN ) if for any positive constant ε, there exists a finite
positive constant M such that P(|ZN/aN | > M) < ε, and we denote ZN = op(aN ) if for any positive constant ε,
P(|ZN/aN | > ε) → 0 as N → ∞. We also use the notation  and , for asymptotic orders (both stochastic
and nonstochastic). For example, for nonstochastic asymptotic order, aN  bN if aN = O(bN ) and bN = O(aN ),
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aN  bN if bN/aN = o(1), and aN  bN if aN/bN = o(1). For an appropriately measurable and integrable function
f , we use ‖f‖, ‖f‖p, ‖f‖∞ to denote the L2, Lp and L∞ norms with respective to measure P: ‖f‖ =
{
E
[
f2(W )
]}1/2
,
‖f‖p = {E [|f(W )|p]}1/p, and ‖f‖∞ = inf{c ≥ 0 : P(|f(W )| ≤ c) = 1}, where E is the expectation defined with
respect to P. Throughout this paper, we use ∗-superscripts to denote unknown population quantities like δ∗, and
use hat or tilde mark to denote estimators, e.g., δˆ and δ˜.
1.2 Review of semiparametric efficiency theory
In this part, we briefly review the theory of semiparametric efficiency theory. For a more general and complete
presentation, we refer the readers to Bickel et al. [1993], Kosorok [2007], Tsiatis [2007], Van der Vaart [2000]. Suppose
that we observe i.i.d samples W1, . . . ,WN from an unknown distribution P. We assume a model M for the unknown
P, i.e., a class of distributions potentially generating the observed data that also contains the true distribution P.
This model encapsulates all assumptions we impose on the data generating process. The theory of semiparametric
efficiency studies the general problem of efficiently estimating a finite-dimensional parameter θ(P) under a given
model M. To reduce risk of model misspecification, we focus on a semiparametric model M that is very flexible
and cannot be parameterized by any finite-dimensional vector in Euclidean space. Semiparametric efficiency theory
provides a principled approach to study the best possible asymptotic performance of any “reasonable” estimator
for θ(P) under this model, and find an estimator that can achieve such optimal performance asymptotically. In the
following part, we consider a scale parameter θ(P) for simplicity, although all results can be readily generalized to
vector-valued parameters.
For a target parameter θ(P) that is smooth in the underlying distribution P [See Van der Vaart, 2000, Thm. 25.20 for
precise conditions], there exists a square-integrable function ψ(W ; θ(P),M), called the efficient influence function,
such that V = E
[
ψ2(W ; θ(P),M)] is the efficiency lower bound that bounds below the asymptotic variance of
any regular estimator for θ(P) under model M. Roughly speaking, regular estimators are those whose asymptotic
distributions are not affected by vanishing local perturbations to the underlying data distribution P. This type of
regularity is common and is often considered desirable, as otherwise the estimator may behave erratically under
undetectable changes to the data generating process [See Van der Vaart, 2000, Sec. 8.1 for details]. Furthermore, the
normal distribution N (0, V ) is actually the “best” asymptotic distribution: the asymptotic distribution of any regular
estimator is that of a N (0, V ) random variable plus an independent noise term [Van der Vaart, 2000, Thm. 25.20],
and the limiting risk of any regular estimator with respect to any bowl-shaped loss function (e.g., the asymptotic
mean squared error) is no less than the corresponding risk under normal distribution N (0, V ) [Van der Vaart, 2000,
Thm. 25.21]. Thus a regular estimator with asymptotic distribution N (0, V ) is called asymptotically efficient.
The efficiency lower bound is a property of the model M, the true distribution P, and the target parameter θ(P)
regardless of estimation methods, which characterizes the amount of information provided byM in terms of estimat-
ing θ(P). By comparing efficiency lower bounds for the same target parameter under different models for the same
true distribution, we can quantify the information gains with respect to the target parameter due to extra modeling
assumptions. For example, parameter estimation under a fully parametric model Mpara satisfying P ∈ Mpara ⊂M
is easier than estimation under the corresponding semiparametric model M, so the efficiency lower bound under
Mpara is also smaller than that under M. The difference of the efficiency lower bounds under these two models
quantifies the efficiency gains from additional parametric assumptions in Mpara. In fact, the efficiency lower bound
for a parametric model Mpara is exactly the famous Crame´r-Rao bound [e.g., Van der Vaart, 2000, Ex. 25.15].
Moreover, under proper regularity conditions, the efficiency lower bound for a semiparametric modelM is the supre-
mum of Crame´r-Rao bounds under all possible smooth parametric submodels Mpara ⊆ M, i.e., smooth parametric
models that obey the semiparametric assumptions and also contain the true distribution P. In Theorem 2.2, we will
take a similar efficiency comparison approach to measure the efficiency gains from optimally leveraging surrogates
in estimating ATE.
Besides revealing fundmental statistical limits in parameter estimation with a given model, efficiency analysis often
also sheds lights on how to construct efficient estimators that achieve the optimal asymptotic performance. Under
the same smoothness condition on θ(P), any efficient regular estimator θˆ must satisfy
√
N(θˆ − θ(P)) = 1√
N
N∑
i=1
ψ(Wi; θ(P),M) + op(1),
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that is, θˆ is asymptotically linear for which the contribution of the each data point is measured by the efficient
influence function ψ(Wi; θ(P),M) [Van der Vaart, 2000, Lemma 25.23]. This suggests a general estimation strategy: if
ψ′(W ;M) = ψ(W ; θ(P),M)+θ(P) does not depend on the unknown parameter θ(P), and it can be well approximated
by ψˆ′, then we can use θˆ = 1N
∑N
i=1 ψˆ
′(Wi;M). If done appropriately, this estimator can attain the efficiency lower
bound asymptotically. In Section 3, we will apply this strategy to construct an efficient estimator for ATE in presence
of surrogates.
1.3 Related Literature
Causal inference with surrogates. Many different criteria have been proposed to guarantee the treatment effect
on a surrogate to reliably predict the overall effect on the primary outcome. The statistical surrogate criterion pro-
posed by Prentice [1989] was the first criterion, which requires the primary outcome to be conditionally independent
with the treatment given the surrogate. However, Frangakis and Rubin [2002] pointed out that this criterion and
related methods [e.g., Freedman et al., 1992, Lin et al., 1997, Buyse and Molenberghs, 1998, Buyse et al., 2000] ignore
the fact that surrogates can be affected by the treatment, so their parameters of interest may not have valid causal
interpretation. Thus they proposed a principal surrogate criterion based on the principal stratification framework.
This new criterion satisfies the property of causal necessity, which requires that a non-zero treatment effect on the
primary outcome can occur only if a non-zero treatment effect on the surrogate occurs. Lauritzen et al. [2004]
further proposed a slightly stronger variant called strong surrogate criterion in the language of graphical models,
which assumes the surrogate to fully mediate the effect of treatment on the primary outcome. Nevertheless, Chen
et al. [2007] showed that all of these critria suffer from the surrogate paradox : even if the surrogate positively affects
the primary outcome, a positive treatment effect on the surrogate may still be associated with a negative treatment
effect on the primary outcome. To avoid this paradox, the consistent surrogate criterion and several variants were
proposed by Chen et al. [2007], Ju and Geng [2010], Ma et al. [2017], Yin et al. [2019]. However, almost all of these
criteria involve quantities that cannot be identified from the observed data, so they are unverifiable in practice. See
VanderWeele [2013] for a comprehensive review of these criteria, and Appendix B for a detailed dicussion about the
statistical surrogate condition.
Overall, all surrogate criteria above ambitiously aim to use a surrogate to replace the primary outcome, which
necessarily impose stringent assumptions that are often unverfiable, and generally violated in reality. However, in
practice, we often observe primary outcome in addition to the surrogates at least for some units. In this case,
Fleming et al. [1994] pointed out that using surrogates may improve estimation efficiency even without strong
surrogate conditions, and suggest using the surrogates to strengthen rather than replace the primary outcome.
Cheng et al. [2018] took the same standpoint and investigated efficient ATE estimation when combining a small
number of primary-outcome observations with many observations of the surrogates without any strong surrogate
condition above. However, they only focused on the setting when the unlabelled dataset is much larger than the
labelled dataset, i.e., Nu  Nl, and they assumed that the primary outcome is MCAR, while our paper studies
both Nu  Nl and Nu  Nl, and considers a more general MAR setting. Anderer et al. [2019] studied combining
surrogates and delayed primary outcome in Bayesian clinical trial design, yet their estimation method based on
bivariate Gaussian model with Gaussian prior may be very susceptible to model misspecification bias. In contrast,
our method allows for very flexible machine learning estimators with strong statistical guarantee. Athey et al.
[2019] also aims to combine surrogates with the primary outcome, but they study a more challenging setting where
the surrogates are always observed but primary outcome and treatment are observed in two separate datasets. To
fuse these two datasets, they have to assume the statistical surrogate condition that however may be unrealistic in
practice. See Appendix A for detailed discussions about the connection of our results to these literature.
Semi-supervised inference. Our paper is related to the growing body of literature on parameter estimation and
inference in the semi-supervised setting where a small labelled dataset is enriched with a large unlabelled dataset. A
string of research investigate how to the use unlabelled data to aid the estimation of a wide variety of parameters,
including linear regression coefficients [Azriel et al., 2016, Chakrabortty et al., 2018], population mean and average
treatment effect [Zhang et al., 2019, Zhang and Bradic, 2019], performance measures of a given classification rule
like receiver operating characteristic (ROC) curve [Gronsbell and Cai, 2018], etc. These papers typically propose
estimators for a finite dimensional target parameter and study their asymptotic performance, which supplement
extensive literature on semi-supervised learning of prediction rules [see Zhu and Goldberg, 2009, for a comprehensive
review]. However, all of these literature implicitly or explicitly assume that the labels are MCAR. Our paper relaxes
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this assumption by allowing the labeling process to depend on pre-treatment covariates, treatment and even the
surrogates, which is more realistic if the labeling process is not completely controlled by design. Moreover, our paper
incorporates surrogates as source of extra efficiency.
Measurement error problem with validation sample. We can also view our problem as a measurement
error problem: abundant mismeasurements of the primary outcome (i.e., the surrogate observations) are available,
while accurate measurements are observed only on a small validation sample (i.e., the labelled dataset). In similar
data settings, a variety of methods have been proposed to leverage surrogate variables to improve the efficiency of
estimating regression coefficients [e.g., Pepe et al., 1994, Pepe, 1992, Reilly and Pepe, 1995, Engel and Walstra, 1991,
Carroll and Wand, 1991, Chen and Chen, 2000] or solutions to estimation equations [e.g., Chen et al., 2008a, 2003,
2005, 2008b], when either the outcome or covariates of interest are mismeasured. In particular, some of these works
[e.g., Pepe, 1992, Chen et al., 2005] employ semiparametric methods that do not impose restrictive assumptions on the
measurement errors, and use the validation sample to nonparametrically estimate the relationship between surrogate
variables and the primary variable. Our paper follows the same principle, but we allow for arbitrary machine learning
nuisance estimators under only generic rate conditions. Some literature also cast this type of problem as a missing
data problem where the variables of primary interest are missing for all units not in the validation sample, and they
study the semiparametric efficiency lower bound and efficient estimator for parameters in regression problems [e.g.,
Robins and Rotnitzky, 1995, Robins et al., 1994, Yu and Nan, 2006, Chen and Breslow, 2004]. Our paper builds
on the missing data framework to study the efficiency of estimating treatment effects in presence of surrogates.
Moreover, in contrast to the missing data literature that commonly assume the proportion of complete observations
to be bounded away from 0, our paper allows the complete-case proportion to vanish to 0 in order to model the
setting with enormous unlabelled surrogate data.
2 Efficiency Analysis
We first derive the efficiency lower bound for ATE estimation in the following theorem.
Theorem 2.1. Under Assumptions 1 and 2, the efficiency lower bound for δ∗ is V ∗ = E[ψ2(W ; δ∗, η∗)] where
ψ(W ; δ∗, η∗) = µ∗(1, X)− µ∗(0, X) + TR
e∗(X)r∗(1, X, S)
(Y − µ˜∗(1, X, S))− (1− T )R
(1− e∗(X))r∗(0, X, S) (Y − µ˜
∗(0, X, S))
+
T
e∗(X)
(µ˜∗(1, X, S)− µ∗(1, X))− 1− T
1− e∗(X) (µ˜
∗(0, X, S)− µ∗(0, X))− δ∗. (6)
The efficiency lower bound remains the same no matter whether the propensity scores e∗ and r∗ are known or not.
Theorem 2.1 reveals the fundamental statistical limit in estimating δ∗ with surrogates under Assumptions 1 and 2:
for any regular estimator δˆ, the variance of the limiting distribution of
√
N(δˆ − δ∗) must be no smaller than V ∗. In
other words, V ∗ is the best possible precision we can aim to achieve asymptotically among all regular estimators.
Moreover, further knowing the propensity scores does not decrease the efficiency lower bound. This means that
the knowledge of propensity scores is ancillary to ATE estimation, which echos analogous results in causal inference
without surrogates [Hahn, 1998]. Notably, the efficiency lower bound here corresponds to the model that only assumes
Assumptions 1 and 2, but no any other strong surrogate condition. In Appendix A.3, we further study the setting
where the strong statistical surrogate condition Y ⊥ T | S,X,R = 1 is indeed true. We find that without assuming
the statistical surrogate condition even if it indeed holds, our efficiency lower bound in Theorem 2.1 automatically
recovers the correct bound, so that additionally assuming the statistical surrogate condition does not provide any
asymptotic efficiency benefit. Therefore, our efficiency result in Theorem 2.1 is not only robust to the often violation
of the strong statistical surrogate condition, but also still correct even if this condition happens to be true.
To quantify the benefit of surrogates in estimating ATE, we compare the efficiency lower bounds in following different
settings.
Setting I: no surrogate (Table 1a). We observe (X,T, Y ) for R = 1 and observe (X,T ) for R = 0;
Setting II: surrogate only on labelled data (Table 1b). We observe (X,T, S, Y ) forR = 1 and observe (X,T )
for R = 0;
7
X T S Y R
X X ? X
1...
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(a) Setting I
X T S Y R
X X X X
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...
...
X X X X
X X ? ?
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...
X X ? ?
(b) Setting II
X T S Y R
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X X X X
X X X ?
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...
X X X ?
(c) Setting III
X T S Y R
X X X X
1
...
...
...
...
X X X X
X X X X
...
...
...
...
X X X X
(d) Setting IV
Table 1: Illustrations for the observed data in Setting I to Setting IV. Here “X” stands for an observed value, and
“?” stands for a missing value.
Setting III: surrogate on all data (Table 1c). We observe (X,T, S, Y ) for R = 1 and observe (X,T, S) for
R = 0;
Setting IV: fully labelled data (Table 1d). We observe (X,T, S, Y ) for all units.
Obviously, increasingly more information is observed from setting I to setting IV. Setting I corresponds to one
extreme where no surrogates are observed at all, and setting IV corresponds to the other extreme where all variables
are completely observed. The intermediate setting II observes surrogates only for units whose primary outcome
is already observed, and setting III corresponds to our problem setup in Section 1.1, where surrogates are always
observed. Since surrogates S are not observed for some units in setting I and II, we need to further assume that
whether the primary outcome is observed or not, i.e., indicator variable R, does not rely on potential surrogates
(S(0), S(1)), so that ATE is identifiable in all settings (See Lemma D.2 for details). Otherwise the four settings
above cannot be compared on the same basis.
Assumption 3. For t = 0, 1, R ⊥ S(t) | T,X.
Under Assumption 3, the labeling propensity score has a simpler form: r∗(t, x, s) = P(R = 1 | T = t,X = x, S = s)
now reduces to r∗(t, x) := P(R = 1 | T = t,X = x) for any s ∈ S, x ∈ X , t = 0, 1. In the following theorem, we derive
efficiency lower bounds for ATE in the four settings.
Theorem 2.2. Under Assumptions 1 to 3, the efficiency lower bounds for δ∗ in setting j is V ∗j = E[ψ2j (W ; δ∗, η∗)]
for j = I, . . . , IV , where
ψI(W ; δ
∗, η∗) = ψII(W ; δ∗, η∗) = µ∗(1, X)− µ∗(0, X)
+
TR
e∗(X)r∗(1, X)
(Y − µ∗(1, X))− (1− T )R
(1− e∗(X))r∗(0, X) (Y − µ
∗(0, X))− δ∗,
ψIII(W ; δ
∗, η∗) = µ∗(1, X)− µ∗(0, X) + TR
e∗(X)r∗(1, X)
(Y − µ˜∗(1, X, S))− (1− T )R
(1− e∗(X))r∗(0, X) (Y − µ˜
∗(0, X, S))
+
T
e∗(X)
(µ˜∗(1, X, S)− µ∗(1, X))− 1− T
1− e∗(X) (µ˜
∗(0, X, S)− µ∗(0, X))− δ∗,
ψIV (W ; δ
∗, η∗) = µ∗(1, X)− µ∗(0, X) + T
e∗(X)
(Y − µ∗(1, X))− 1− T
(1− e∗(X)) (Y − µ
∗(0, X))− δ∗.
These efficiency lower bounds remain the same no matter whether the propensity scores e∗ and r∗ are known or not.
In Theorem 2.2, the efficiency lower bound for setting III directly follows from Theorem 2.1, while all other bounds
need to be derived separately. We note that even though we have access to surrogates for at least a subset of units
in in setting II and IV, their efficiency lower bounds do not depend on surrogates S. This means that surrogates
cannot improve the efficiency of ATE estimation if surrogates are observed only when the primary outcome is
already observed. In other words, surrogates can be beneficial for ATE estimation only when there exist some units
whose primary outcome is missing but surrogates are observed. Indeed, for units whose primary outcome is already
observed, surrogates can provide no extra information for ATE beyond the observed primary outcome, especially
considering that we do not restrict the relationship between surrogates and the primary outcome at all (e.g., no
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parametric modeling assumptions). In contrast, for units whose primary outcome is missing, the observed surrogates
do provide extra information, because under Assumptions 1 to 3, we can learn the relationship between surrogates
and the primary outcome based on the labelled data and extrapolate it to the unlabelled data to impute the missing
primary outcome. Similar phenomenon was also observed in Fleming et al. [1994], who remarked that it is the fact
that the primary outcome cannot be perfectly observed that opens up the possibility of efficiency improvement from
surrogates.
Corollary 2.2.1. The efficiency gain from observing the surrogates on all units is measured by
V ∗I − V ∗III = E
{
1
e∗(X)
1− r∗(1, X)
r∗(1, X)
Var{µ˜∗(1, X, S(1)) | X}+ 1
1− e∗(X)
1− r∗(0, X)
r∗(0, X)
Var{µ˜∗(0, X, S(0)) | X}
}
.
The information loss due to not observing the primary outcome on the unlabelled data is measured by
V ∗III − V ∗IV = E
{
1
e∗(X)
1− r∗(1, X)
r∗(1, X)
Var{Y (1) | X,S(1)}+ 1
1− e∗(X)
1− r∗(0, X)
r∗(0, X)
Var{Y (0) | X,S(0)}
}
.
Corollary 2.2.1 further quantifies the efficiency gain from optimally leveraging surrogates, and the efficiency gap to
the ideal setting where the primary outcome is fully observed. It shows that the efficiency benefits of surrogates
crucially depend on two factors: the predictivity of the surrogates with respect to the primary outcome, and the
extent of missingness of the primary outcome.
Predictivity of the surrogates. The efficiency gain due to surrogates (i.e., V ∗I − V ∗III) positively depends on the terms
Var [µ˜∗(t,X, S(t)) | X] for t = 0, 1 i.e., the variations of the primary outcome that can be explained by surrogates
modulo pre-treatment covariates. Similarly, the efficiency loss compared to the ideal setting (i.e., V ∗III − V ∗IV )
positively depends on Var [Y (t) | X,S(t)] for t = 0, 1, i.e., the residual variations of the primary outcome that cannot
be explained by either the surrogates or the pre-treatment covariates. This means that the more predictive the
surrogates are, the more efficiency improvement can be achieved by leveraging the surrogates (i.e., larger V ∗I −V ∗III),
and the closer the efficiency bound is to the ideal limit with fully observed primary outcome (i.e., smaller V ∗III−V ∗IV ).
In the extreme, if surrogates S can perfectly predict Y , i.e., there exists a deterministic function that maps S to Y ,
then observing surrogates is equivalent to observing the primary outcome, and thus V ∗III = V
∗
IV .
Missingness of the primary outcome. Both quantities in Corollary 2.2.1 decrease with the labeling propensity scores
r∗(1, X) and r∗(0, X). This means that when the primary outcome is less missing (i.e., overall higher labeling
propensity scores), the efficiency gains from additionally observing surrogates or the primary outcome both decrease.
Indeed, if the primary outcome is already observed for most of the units, then the room for extra efficiency gain from
surrogates is small.
The efficiency analysis above provides important guidelines on when leveraging surrogates can improve the efficiency.
It shows that surrogates are particularly beneficial for ATE estimation when (1) surrogates can account for huge
variations of the primary outcome that cannot be explained by the pre-treatment covariates, and (2) the primary
outcome for a large number of units is missing.
3 Treatment effect estimator
In Section 2, we characterize the efficiency lower bound for estimating ATE. We may wonder whether the lower
bound can be achieved by any estimator. We could easily find one such estimator if the nuisance parameters
η∗ = (e∗, r∗, µ˜∗, µ∗) were known: the efficient influence function in eq. (6) motivates the following estimator:
δˆ0 =
1
N
N∑
i=1
ψ(Wi; δ
∗, η∗) + δ∗. (7)
It is easy to verify that δˆ0 is a valid estimator in that it does not depend on the unknown δ
∗, and
√
N(δˆ0 − δ∗) d→
N (0, V ∗) according to Central Limit Theorem.
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However, in practice, we usually do not know the nuisance parameters, so estimator δˆ0 is infeasible. Instead we
may construct some nuisance parameter estimators ηˆ = (eˆ, rˆ, µˆ, ˆ˜µ) first, and plug them into eq. (7). In particular,
we prefer flexible machine learning estimators that do not put restrictive modeling assumptions (e.g., parametric
assumptions) on the nuisance parameters to avoid misspecification error. For example, estimating eˆ, rˆ amounts
to learning conditional probabilities from binary classification data, and estimating µˆ, ˆ˜µ is essentially learning two
regression functions, for which many successful machine learning methods exist, e.g., random forest [Breiman, 2001],
gradient boosting [Friedman, 2001, Chen and Guestrin, 2016], and neural network [Goodfellow et al., 2016, Farrell
et al., 2018], etc. However, nonparametric machine learning estimators for the nuisance parameters generally converge
at slow rates (i.e., slower than O(N−1/2)), and they may have considerble bias (e.g., regularization bias) or overfitting
error. To prevent these nuisance estimators from undermining the resulting ATE estimator, we apply the cross-
fitting technique that has been widely used for bias reduction in many semiparametric estimation problems [e.g.,
Chernozhukov et al., 2018, Newey and Robins, 2018].
Definition 1 (Estimator). Let K be a fixed positive interger that does not change with sample size N . We take
K-fold random partitions {Ilk}Kk=1 and {Iuk }Kk=1 of the labelled and unlabelled index set Il and Iu respecitvely. The
resulting {Ik = Ilk ∪Iuk }Kk=1 constitutes a K-fold random partition of the whole index set {1, . . . , N}. For simplicity1,
we assume that both Nl and Nu can be evenly divided by K, and nl = Nl/K, nu = Nu/K, n = nl + nu are sample
sizes of the labelled data, unlabelled data, and all data in each fold respectively. For each k = 1, . . . ,K, we define
Ick = {1, . . . , N} \ Ik, and use all but the kth fold data2 to train machine learning estimators for the nuisance
parameters, i.e., ηˆk = ηˆ({Wi}i∈Ick). The final ATE estimator is
δˆ =
1
K
K∑
k=1
Eˆn,k [ψ(W ; δ∗, ηˆk) + δ∗]
=
1
K
K∑
k=1
Eˆn,k
{
µˆk(1, X)− µˆk(0, X) + TR
eˆk(X)rˆk(1, X, S)
(Y − ˆ˜µk(1, X, S))− (1− T )R
(1− eˆk(X))rˆk(0, X, S) (Y −
ˆ˜µk(0, X, S))
+
T
eˆk(X)
(ˆ˜µk(1, X, S)− µˆk(1, X))− 1− T
1− eˆk(X) (
ˆ˜µk(0, X, S)− µˆk(0, X))
}
, (8)
where Eˆn,k is an empirical average operator for all data in the kth fold, e.g., Eˆn,kµˆk(1, X) = 1n
∑
i∈Ik µˆk(1, Xi).
In estimator δˆ, we apply each nuisance estimator ηˆk only to data in the kth fold Ik, i.e., data that are not used to
train ηˆk. This cross-fitting technique prevents ηˆk from overfitting to the data where it is evaluated. In the follow-
ing assumption, we further specify the convergence rates of these working estimators for the nuisance parameters.
Notably, we allow the nuisance estimators to be misspecified in that they may not converge to the truth, i.e., their
limiting values η0 may not equal η
∗.
Assumption 4 (Nuisance Estimator Convergence Rate). For k = 1, . . . ,K, the nuisance estimators ηˆk = (eˆk, rˆk, µˆk, ˆ˜µk)
converge to their limit η0 = (e0, r0, µ0, µ˜0) in mean sqaured error at the following rates:
‖eˆk − e0‖2 = Op(ρN,e), ‖rˆk − r0‖2 = Op(ρN,r), ‖µˆk − µ0‖2 = Op(ρN,µ), ‖ ˆ˜µk − µ˜0‖2 = Op(ρN,µ˜).
Furthermore, the propensity score estimators and their asymptotic limits are almost surely bounded: eˆk(X), e0(X) ∈
[, 1− ] and rˆk(X), r0(X) ∈ [, 1] with probability 1.
We further assume the following regularity conditions on moments of surrogates and the primary outcome.
Assumption 5 (Moment Condition). There exist positive constants C > 0 and q > 2 such that
‖Var{Y | X,S, T}‖∞ ≤ C, ‖Var{Y | X,T}‖∞ ≤ C,
‖Var{µ˜∗(T,X, S) | T,X}‖∞ ≤ C, ‖Y (1)‖q ∨ ‖Y (0)‖q ≤ C
1We do not require each fold to have equal sample size. For example, for each unit, we can draw a number uniformly at random from
{1, . . . ,K} and put that unit into the fold corresponding to this number.
2Concretely, we use {Wi}i∈Ic
k
, i.e., all data not in the kth fold to construct (eˆk, rˆk), and, {Wi}i∈Il\Il
k
, i.e., labelled data not in the
kth fold to construct µˆk, ˆ˜µk.
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Theorem 3.1 (Double Robustness). Given Assumptions 1, 2, 4 and 5, if we further assume that ρN,e, ρN,r, ρN,µ, ρN,µ˜ =
o(1),
(µ˜0 − µ˜∗)(r0 − r∗) = 0, (µ0 − µ∗)(e0 − e∗) = 0,
and the asymptotic bias of the outcome regressions are almost surely bounded by the positive constant C, i.e., ‖µ˜0 −
µ˜∗‖∞ ≤ C and ‖µ0 − µ∗‖∞ ≤ C, then
δˆ
p→ δ∗ as N →∞.
Theorem 3.1 states that the proposed estimator converges to the true ATE, as long as all nuisance estimators
converge, and at least one of the converging limits, but not both, in each pair of (µ˜0, r0) and (µ0, e0) is equal to
the corresponding true value. Thus the consistency of our estimator does not require all nuisance parameters to be
correctly estimated, nor the knowledge of which one is correctly estimated. This means that our estimator is robust
to misspecification errors of estimating some nuisance parameters, as long as the rest are consistently estimated.
This property is called “double robustness” in causal inference literature [e.g., Scharfstein et al., 1999, Kang et al.,
2007].
Theorem 3.2 (Asymptotic Normality). Under assumptions in Theorem 3.1, if we further assume ρN,rρN,µ˜ =
o(N−1/2), ρN,eρN,µ˜ = o(N−1/2), ρN,eρN,µ = o(N−1/2), and all nuisance components are correctly specified so that
µ˜0 − µ˜∗ = r0 − r∗ = µ0 − µ∗ = e0 − e∗ = 0, then as N →∞,
√
N(δˆ − δ∗) d→ N (0, V ∗), (9)
where V ∗ is the efficiency lower bound in Theorem 2.1.
Theorem 3.2 further shows that if all nuisance estimators converge to the truth at sufficiently fast rate, then the
proposed estimator δˆ converges at rate O(N−1/2), and it is asymptotically normal with the efficiency lower bound
V ∗ as its limiting variance. Therefore, our estimator achieves the optimal asymptotic performance. Importantly,
the estimation errors of machine learning nuisance estimators do not undermine the asymptotic property of the final
ATE estimator: the proposed estimator δˆ is asymptotically equivalent to the infeasible estimator δˆ0 in eq. (7) that
plugs in the true values of nuisance parameters. This is possible because we construct the ATE estimator based
on the efficient influence function ψ(W ; δ∗, η∗) in Theorem 2.1 with the cross-fitting technique, and ψ(W ; δ∗, η∗)
can be verified to satisfy the Neyman Orthogonality condition [see Chernozhukov et al., 2018, Def. 2.1 for precise
definition]. Informally, this orthogonality condition states that ψ(W ; δ∗, η∗) is insensitive to small local perturbations
in the nuisance parameters η∗, which guarantees that plugging in estimated nuisance parameters rather than the
true values has only negligible impact.
Notably, we do not restrict the nuisance estimators to Donsker or bounded entropy classes [Van der Vaart, 2000],
which flexible machine learning methods usually violate. Instead, we only require rate condition on the nuisance
estimators, which are satisfied for example if all nuisance estimators converge to the true values at op(N
−1/4)
rate. This rate requirement can be achieved by many machine learning estimators under appropriate structural
assumptions [Chernozhukov et al., 2018]. Moreover, we allow estimators converging at faster rate to compensate
for those converging at slower rate. For example, if we have strong domain knowledge about the labeling process
and treatment assignment process (e.g., in a randomized experiment with two-phase sampling design) so that we
can estimate the labeling propensity score r∗ and treatment propensity score e∗ at very fast rate, then we can allow
regression estimator µˆ, ˆ˜µ to converge at relatively slow rate.
Theorem 3.3 (Variance Estimation and Confidence Interval). Under the assumptions in theorem 3.2,
Vˆ =
1
K
K∑
k=1
Eˆn,k[ψ2(W ; δˆ, ηˆk)]
p→ V ∗ as N →∞.
Consequently, the following (1− α)× 100% confidence interval
CI = (δˆ − Φ−1(1− α/2)(Vˆ /N)1/2, δˆ + Φ−1(1− α/2)(Vˆ /N)1/2) (10)
with Φ as the cumulative density function of standard normal distribution satisfies that
P(δ∗ ∈ CI)→ 1− α as N →∞.
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Theorem 3.3 shows that under the same conditions, a consistent estimator for the efficiency lower bound can be
obtained by forming the sample analogue of E[ψ2(W ; δ∗, η∗)] with cross-fitting nuisance estimators and the proposed
estimator δˆ. The resulting confidence interval in (10) asymptotically achieves correct coverage probability. Also,
since the proposed estimator δˆ asymptotically achieves the smallest possible variance, the confidence interval in (10)
tends to be shorter than confidence intervals based on other less efficient estimators.
4 Extension: unlabelled data size  labelled data size
In this section, we consider the setting where the size of unlabelled data is much larger than the size of the labelled
data, i.e., Nu  Nl. This could happen frequently in modern big data era when massive unlabelled data (e.g.,
electronic medical records [Cheng et al., 2018]) may be quite cheap to acquire. Despite its great practical relevance,
this setting cannot be directly accommodated by the efficiency and estimation theory in Sections 2 and 3. This is
because previous results all hinge on the overlap condition (5) in Assumption 2 that requires the labeling propensity
score r∗ to be bounded away from 0, so that its reciprocal 1/r∗ appearing in the efficient influence function ψ (eq. (6))
is well-defined. However, this condition also requires that the marginal probability P(R = 1) >  and thus Nu  Nl
with high probability, which cannot model the current setting with Nu  Nl and P(R = 1) = 0. In fact, in the
current setting, we can show that r∗(T,X, S) = 0 almost surely (Lemma D.3), so previous efficiency lower bounds
based on 1/r∗ are invalid. Despite these drastic differences, we will show that essentially the same efficiency results
and estimation strategy actually still apply in the current setting, as long as we change the perspective accordingly.
We change the efficiency considerations mainly in two aspects. First, we characterize the efficiency lower bound in
terms of the density ratio
λ∗(X) :=
f∗(X)
f∗(X | R = 1) =
f∗(X | R = 1)
f∗(X | R = 1) P(R = 1)︸ ︷︷ ︸
=0
+
f∗(X | R = 0)
f∗(X | R = 1) P(R = 0)︸ ︷︷ ︸
=1
=
f∗(X | R = 0)
f∗(X | R = 1) , (11)
where f∗(· | R = ·) and f∗(·) are the conditional and unconditional density functions of X corresponding to the
target distribution P with respect to an appropriate dominating measure (e.g., Lebesgue measure). This density ratio
λ∗ is well-defined and bounded almost surely as long as the distribution of X on the labelled data and that on the
unlabelled data sufficiently overlap, regardless of whether Nl  Nu or Nl  Nu. In contrast, previous formulation
based on inverse labeling propensity score 1/r∗ is valid only when Nl  Nu, and we will show that in this case, the
density ratio formulation is actually equally valid. Second, we will focus on ATE estimators whose convergence rates
scale with the sample size of labelled data, as opposed to the total sample size. Again, these two viewpoints are
equally valid in previous sections where Nl  N with high probability. However, in the current setting, the size of
the labelled data becomes the bottleneck for estimation convergence rates, since the primary outcome observed in
the labelled data is the primary information source for ATE, but its sample size is now much smaller than the total
sample size.
Inspired by Cheng et al. [2018], we study the efficiency of ATE estimation from the perspective of labelled data. In
the current setting, the sample sizes of labelled data, unlabelled data, and combined data satisfy that Nl/Nu → 0
and Nu/N → 1. So from the perspective of the labelled dataset, the size of the unlabelled dataset is infinitely
larger and thus its distribution, i.e., the distribution of (X,T, S) given R = 0, is virtually known. Moreover, in the
asymptotic limit, the labelled dataset is negligiable, and the combined dataset is virtually identical to the unlabelled
dataset. This means that the unconditional distribution of (X,T, S) for the combined data is virtually the same as
the conditional distribution of (X,T, S) given R = 0 for the unlabelled data (e.g., see eq. (11) for the distribution of
X), thus it can also be viewed as known from the perspective of labelled data. The efficiency lower bound from this
perspective is formalized in the following theorem.
Theorem 4.1. Suppose we only observe the labelled data, i.e., i.i.d samples from the conditional distribution of
(X,T, S, Y ) given R = 1. In addition, we assume that the unconditional distribution of (X,T, S) is known. Besides
assuming that ‖λ∗(X)‖∞ ≤ C for the positive constant C, Assumption 1 and Assumption 2 condition (4), we also
assume two simplifying conditions3: Assumption 3 and R ⊥ T | X. Then the efficiency lower bound is V˜ ∗ =
3We can analogously derive the efficiency lower bound without these two conditions. However, without these simplifying conditions,
finding an efficient ATE estimator that can asymptotically achieve the corresponding efficiency lower bound is much more challenging.
See Appendix C for details.
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E[ψ˜2(W ; δ∗, η˜∗) | R = 1], where the new nuisance parameters are η˜∗ = (e∗, λ∗, µ˜∗, µ∗), and
ψ˜(W ; δ∗, η˜∗) =
Tλ∗(X)
e∗(X)
(Y − µ˜∗(1, X, S))− (1− T )λ
∗(X)
1− e∗(X) (Y − µ˜
∗(0, X, S)). (12)
In Theorem 4.1, Assumption 1 condition (2), Assumption 3 and R ⊥ T | X together imply that R ⊥ (Y (t), S(t), T ) |
X for t = 0, 1. In other words, the primary outcome is still missing at random, whose missingness depends on only
pre-treatment covariates X. In Appendix Theorem C.2, we further relax the two simplifying conditions, and provide
the efficiency lower bound when R can depend on treatment T and surrogates S as well. Our results thus strictly
generalize the efficiency lower bound in Cheng et al. [2018] that assumes the more restrictive missing completely
at random condition, i.e., R is independent with any other random variable. This generalization is possible mainly
because we formulate the efficiency lower bound in terms of the density ratio, as opposed to inverse labeling propensity
score formulation that is more commonly used but ill-defined in the current setting. Although the assumption of
exactly knowing the distribution of (X,T, S) in Theorem 4.1 seems rather ideal, we will confirm in Theorem 4.2 that
this indeed characterizes the role of unlabelled data (in asymptotic sense) from the perspective of labelled data.
The discussions above are all based on the target distribution P satisfying P(R = 1) = 0, which cannot directly
characterize the labelled data that play a crucial role in finite sample estimation. Indeed, the unconditional dis-
tribution of (X,T, S, Y ) under P degenerates into its conditional distribution given R = 0 (e.g., see eq. (11) for
the distribution of X), which corresponds to only the unlabelled data. To deal with this, we allow the marginal
probability of R = 1, which we denote as rN , to depend on the total sample size N , and assume that rN > 0 for
any finite N , rN → P(R = 1) and the expected size of labelled data N l = rNN → ∞ as N → ∞. This specifica-
tion aptly models the regime of interest: even when P(R = 1) = 0, the labelled data are always available in finite
sample, and asymptotically its absolute size grows to infinity despite that its relative size vanishes as N →∞. The
specified rN in turn induces a finite-sample probability distribution PN 4: for any event E measurable with respect
to (X,T, S(0), S(1), Y (0), Y (1), R), PN (E) = P(E | R = 1)rN + P(E | R = 0)rN , i.e., PN varies with N only through
the marginal probability rN . We can view rN as PN (R = 1), which converges to P(R = 1) as N → ∞. Thus the
target distribution P is exactly the limit of the finite-sample distribution PN . Given this distribution, we consider
the observed data as a triangular array {Wi,N = (Xi,N , Ti,N , Si,N , Yi,N , Ri,N ) : i = 1, . . . , N} consisting of i.i.d
draws from the distribution PN . This setup with N -dependent distribution and observations is very general: it can
accommodate both the current setting by letting rN → 0, and the setting in previous sections (see Section 1.1) by
letting limN→∞ rN > 0.
We now follow our estimation strategy in Definition 1 to construct an analogous ATE estimator that can attain the
efficiency lower bound in Theorem 4.1.
Definition 2 (Revised Estimator). We take the K-fold random partitions in Definition 1, and analogously construct
nuisance estimators ˆ˜ηk = (eˆk, λˆk, ˆ˜µk, µˆk) for k = 1, . . . ,K. The resulting ATE estimator is
δ˜ =
1
K
K∑
k=1
EˆNn,k
{
µˆk(1, X)− µˆk(0, X) + T
eˆk(X)
(ˆ˜µk(1, X, S)− µˆk(1, X))− 1− T
1− eˆk(X) (
ˆ˜µk(0, X, S)− µˆk(0, X))
+
Rλˆk(X)
rˆN
T
eˆk(X)
(Y − ˆ˜µk(1, X, S))− Rλˆk(X)
rˆN
1− T
1− eˆk(X) (Y −
ˆ˜µk(0, X, S))
}
, (13)
where rˆN = Nl/N > 0 estimates rN , and EˆNn,k is the empirical average operator for data in the kth fold (in triangular
array), e.g., EˆNn,kµˆk(1, X) =
1
n
∑
i∈Ik µˆk(1, Xi,N ).
This estimator δ˜ is almost the same as the previous estimator δˆ in Definition 1, except that δ˜ is based on nuisance
estimators for the density ratio λ∗, while δˆ is based on nuisance estimators for the labeling propensity score r∗.
In Theorem 4.2, we will show that these two estimators are asymptotically equivalent if the overlap condition (5)
holds. But when the overlap condition indeed holds, we prefer estimator δˆ that only requires estimating the labeling
propensity score r∗, i.e., the conditional probability function in a classification task with the labeling indicator R as
response, which is arguably easier than estimating the density ratio λ∗ in δ˜. However, in this section where Nl  Nu,
estimating labeling propensity score may be very unstable given the extremely imbalanced response data. Thus, we
4Note that PN is not the empirical measure defined in terms of the point mass of Nobservations. Instead, it is a population measure
that generates the N observations, although it can vary across different N through the missingness propensity rN .
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consider directly estimating the density ratio λ∗ that appears in the efficiency lower bound in Theorem 4.1, e.g., by
existing estimators reviewed in Sugiyama and Kawanabe [2012], Sugiyama et al. [2012].
In the following theorem, we show the asymptotic normality and efficiency of estimator δ˜ under conditions analogous
to those in Theorem 3.2. Notably, we consider a generic limiting marginal probability P(R = 1) that can be either 0
(i.e., the setting in this section) or strictly positive (i.e., the setting in Section 3).
Theorem 4.2. Suppose that assumptions in Theorem 4.1 hold, rN > 0 for any finite N , rN → P(R = 1), N l =
rNN → ∞, r2NN → ∞ as N → ∞, and mild moment regularity conditions given in Appendix Assumption 6. We
assume that for 1 ≤ k ≤ K, the convergence rates of nuisance estimators eˆk, λˆk, ˆ˜µk, µˆk are Op(ρN,e), Op(ρN l,λ),
Op(ρN l,µ), and Op(ρN l,µ˜) respectively (see Assumption 7 in Appendix for precise definitions), ‖λˆk(X)‖∞ ≤ C, and
eˆk(X) ∈ [ε, 1 − ε] almost surely. We further assume that ρN,e, ρN l,µ, ρN l,λ, ρN l,µ˜ are all o(1), and they satisfy that
ρN l,λρN l,µ˜ = o(N
−1/2
l ), ρN,eρN l,µ˜ = o(N
−1/2
l ), ρN,eρN l,µ = o(N
−1/2
l ). Then estimator δ˜ given in Definition 2
satisfies that
N
1/2
l (δ˜ − δ∗) d→ N (0, V˜ ), as N →∞, (14)
where
V˜ = E[ψ˜2(W ; δ∗, η˜∗) | R = 1] + P(R = 1)E [µ∗(1, X)− µ∗(0, X)− δ∗]2
+ P(R = 1)E
[
T
e∗(X)
(µ˜∗(1, X, S)− µ∗(1, X))− 1− T
1− e∗(X) (µ˜
∗(0, X, S)− µ∗(0, X))
]2
. (15)
If the overlap condition (5) holds so that P(R = 1) > 0, and we further assume the conditions in Theorem 3.2, then
estimator δˆ in Definition 1 is asymptotically equivalent to estimator δ˜, i.e.,
N
1/2
l (δˆ − δ∗) = N
1/2
l (δ˜ − δ∗) + op(1) d→ N (0, V˜ ), as N →∞. (16)
If P(R = 1) = 0, then V˜ is equal to the efficiency lower bound V˜ ∗ given in Theorem 4.1.
Theorem 4.2 shows that if the overlap condition (5) holds and nuisance estimators are accurate enough, estimators
δ˜ and δˆ are asymptotically equivalent, and they are both asymptotically efficient. Their asymptotic variance V˜ can
be viewed as an equivalent reformulation of the efficient lower bound V ∗ in Theorem 2.1 from the perspective of the
labelled data. In particular, in contrast to the scaling factor of N1/2 and the inverse labeling propensity score 1/r∗
in V ∗, V˜ is formulated in terms of the scaling factor N
1/2
l and the density ratio λ
∗ appearing in ψ˜(W ; δ∗, η˜∗). This
new formulation is not only valid under the overlap condition, but also particularly suitable for the current setting
where P(R = 1) = 0. In the current setting, although the estimated marginal labeling probability rˆN in δ˜ (eq. (13))
converges to 0, the scaling factor N
1/2
l effectively stablizes the asymptotic variance of δ˜ and ensures meaningful
asymptotic distribution (see eq. (14)). In contrast, the scaling factor N1/2 will be too large and leads to exploding
asymptotic variance. Moreover, the density ratio formulation circumvents the inverse labeling propensity score 1/r∗
that is ill-defined in the current setting.
Theorem 4.2 also demonstrates that our previous efficiency and estimation results still apply to the current setting:
when P(R = 1) = 0, V˜ exactly equals the efficicieny lower bound in Theorem 4.1. This means that the current
setting can be viewed as a special limiting case of the previous setting in Sections 2 and 3. More concretely, when we
have access to increasingly more unlabelled data and move from the regime of Nl  Nu to the regime of Nl  Nu,
Theorem 4.1 suggests that from the perspective of labelled data, we virtually know the unconditional distribution of
(T,X, S), so variances due to these variables disappear, and only variance due the the variations of Y not explained
by (T,X, S), i.e., the first term in the right hand side of eq. (15), remains. These efficiency and estimation results
thus reveal the whole spectrum of efficiency in estimating ATE with surrogates, and feature a smooth transition
from the regime Nl  Nu to the regime Nl  Nu. In Appendix Theorem C.1, we further extend Theorem 2.2 and
Corollary 2.2.1 to the current setting, and we again confirm that more predictive surrogates result in bigger efficiency
gains.
All results above depend on the density ratio λ∗, which might be challenging to estimate in practice, especially if
the pre-treatment covariates are high dimensional. One straightforward setting where we can avoid this possibly
daunting estimation task is when the primary outcome is MCAR. This is exactly the setting studied in Cheng et al.
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[2018], Zhang and Bradic [2019]. In this special setting, R is independent with all other variables, so λ∗(X) =
f∗(X)/f∗(X | R = 1) = 1 does not need to be estimated, and the estimator δ˜ in Definition 2 reduces to
δ˜′ =
1
K
K∑
k=1
En,k
{
µˆk(1, X)− µˆk(0, X) + T
eˆk(X)
(ˆ˜µk(1, X, S)− µˆk(1, X))− 1− T
1− eˆk(X) (
ˆ˜µk(0, X, S)− µˆk(0, X))
+
TR
eˆk(X)rˆN
(Y − ˆ˜µk(1, X, S))− (1− T )R
(1− eˆk(X))rˆN (Y −
ˆ˜µk(0, X, S))
}
. (17)
This estimator δ˜′ is exactly identical to the estimator δˆ in Definition 1 under MCAR assumption. In Appendix A,
we further discuss how this estimator connects to those in Cheng et al. [2018], Zhang and Bradic [2019], and how
our result generalizes those in previous literature.
5 Conclusion
We study the estimation of average treatment effect with only limited number of observations of the primary outcome
but abundant observations of surrogates. Particularly, we avoid stringent surrogate conditions that are almost always
violated in practice, and only assume standard causal inference and missing data assumptions.
We investigate the role of surrogates by comparing the efficiency lower bounds of ATE with and without presence
of surrogates, and also bounds in some intermediary cases. We find that efficiency gains from optimally leveraging
surrogates crucially depend on how well surrogates can predict the primary outcome and also the propensity of the
primary outcome being measured. These results provide valuable insights on when leveraging surrogates can be
beneficial. We also show that the efficiency results are valid in two regimes: when the size of surrogate observations
is comparable to the size of primary-outcome observations (i.e., Nu  Nl), and when the former is much larger than
the other (i.e., Nu  Nl). The second regime violates the overlap condition commonly assumed in the literature, and
was thus rarely investigated in the past, even though it is highly relevant in modern big data era. Our analysis shows
that the second regime can be viewed as a limiting case of the first regime, which reveals the intimate connection
between these two regimes.
Moreover, we propose ATE estimators that can employ any flexible machine learning method for nuisance parameter
estimation. We provide strong statistical guarantee for the proposed estimators by showing that they are robust
to nuisance estimation bias, and they asymptotically achieve the semiparametric efficiency lower bounds under
high-level rate conditions for the machine learning nuisance estimators. We further develop consistent estimators
for the efficiency lower bounds and construct asymptotically valid confidence intervals for ATE. In summary, our
methods provide a principled approach to optimally leverage surrogate observations when only a limited number of
primary-outcome observations are available.
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Table 2: Illustrations for the observed data in our paper and Cheng et al. [2018], Zhang and Bradic [2019], Athey
et al. [2019] respectively. Here “X” stands for an observed value, and “?” stands for a missing value.
A Connections to previous literature
A.1 Connection to Cheng et al. [2018]
Cheng et al. [2018] consider the same data configuration as our paper (Table 2a), but they assume that the primary
outcome is missing completely at random.
Recall that our estimator under MCAR setting (see eq. (17)) reduces to
δ˜′ =
1
K
K∑
k=1
Eˆn,k
{
µˆk(1, X)− µˆk(0, X) + T
eˆk(X)
(ˆ˜µk(1, X, S)− µˆk(1, X))− 1− T
1− eˆk(X) (
ˆ˜µk(0, X, S)− µˆk(0, X))
+
TR
eˆk(X)rˆN
(Y − ˆ˜µk(1, X, S))− (1− T )R
(1− eˆk(X))rˆN (Y −
ˆ˜µk(0, X, S))
}
.
This estimator and the estimator in Cheng et al. [2018] both asymptotically achieve the efficiency lower bound in
Theorem 4.1 with λ∗(X) = 1. However, the estimator in Cheng et al. [2018] is valid only under MCAR setting,
while our estimator can be straightforwardly extended to MAR setting, if augmented with a density ratio estimator
(Definition 2). Moreover, the estimator in Cheng et al. [2018] imposes parametric assumptions on the nuisance pa-
rameters and relies on computationally intensive resampling methods to construct confidence intervals. In contrast,
our estimator can leverage the power of any flexible machine learning nuisance estimator under generic rate condi-
tions, and its confidence interval can be easily constructed using a straightforward plug-in estimator for standard
errors (Theorem 3.3). Furthermore, Cheng et al. [2018] only studies the setting of Nl  Nu, while our analysis
accommodates both Nl  Nu and Nl  Nu, and reveals the the whole spectrum of efficiency limits across two
regimes.
A.2 Connection to Zhang and Bradic [2019]
Zhang and Bradic [2019] mainly study the efficiency improvement from unlabelled data, and they do not incorporate
surrogates in their analysis (Table 2b, or equivalently the setting I in Table 1a).
This setting can be viewed as a special case of our problem: we can view S as an empty set of random variables and
thus µ˜∗(T,X, s) = µ∗(T,X) for any s ∈ S. Consequently, our estimator in eq. (17) corresponding MCAR primary
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outcome reduces to the following form:
Our estimator: δˆour =
1
N
N∑
i=1
[
µˆk(i)(1, Xi)− µˆk(i)(0, Xi)
]
+
1
Nl
∑
i∈Il
[
Ti
eˆk(i)(Xi)
(Yi − µˆk(i)(1, Xi))− 1− Ti
(1− eˆk(i)(Xi)) (Yi − µˆk(i)(0, Xi))
]
, (18)
where k(i) is the fold that the ith observation belongs to. Note that δˆour can be equivalently motivated by the efficient
influence function ψI in Theorem 2.2 under the MCAR assumption, since for any function f ,
1
Nl
∑
i∈Il f(Wi) =
1
N
∑N
i=1 f(Wi)Ri/rˆN where rˆN = Nl/N estimates the labeling propensity score.
The estimator in eq. (18) appears very similar to the following ATE estimator proposed by Zhang and Bradic [2019]:
Zhang and Bradic [2019]: δˆZB =
1
Nu
∑
i∈Iu
[
µˆk(i)(1, Xi)− µˆk(i)(0, Xi)
]
+
1
Nl
∑
i∈Il
[
Ti
eˆk(i)(Xi)
(Yi − µˆk(i)(1, Xi))− 1− Ti
(1− eˆk(i)(Xi)) (Yi − µˆk(i)(0, Xi))
]
. (19)
Our estimator δˆour differs with the estimator in Zhang and Bradic [2019] mainly in two aspects: first, our estimator
δˆour allows for any flexible machine learning estimator as µˆk as long as they satisfy generic rate conditions, while
Zhang and Bradic [2019] only considers lasso regression; second, we use µˆ to impute the primary outcome for the
whole data (i.e., the first term in Equation (18)), while Zhang and Bradic [2019] imputed the primary outcome only
for the unlabelled data (i.e., the first term in eq. (19)).
With same nuisance estimators eˆ and µˆ and when Nl  Nu, it is easy to prove that estimators δˆour and δˆZB
are symptotically equivalent and they both asymptotically achieve the efficiency lower bound in Theorem 4.1 with
λ∗(X) = 1 and S being empty. Indeed, the unlabelled dataset is asymptotically almost the same as the whole
combined dataset, so not imputing on the labelled data has only negligible effect. However, if the size of the labelled
data is comparable to that of the unlabelled data, i.e., Nl  Nu, then the following proposition shows that our
estimator δˆour asymptotically achieves the full efficiency while the estimator δˆZB proposed by Zhang and Bradic
[2019] does not.
Proposition A.1. Suppose Assumption 1 condition (2), Assumption 2 (which implies Nl  Nu with high probability),
and Assumption 5 hold. We assume that Y is missing completely at random, i.e., R is independent of all other
variables. If for k = 1, . . . ,K, the convergence rates of nuisance estimators µˆk and eˆk are ‖µˆk − µ∗‖ = O(ρN,µ) and
‖eˆk − e∗‖ = O(ρN,e) with ρN,µ = o(1), ρN,e = o(1) and ρN,µρN,e = o(N−1/2), then as N →∞,
√
N(δˆour − δ∗) d→ N (0, Vour),
√
N(δˆZB − δ∗) d→ N (0, VZB),
where
Vour = E
{
[µ∗(1, X)− µ∗(0, X)− δ∗]2
}
+
1
P(R = 1)
E
{[
T − e∗(X)
e∗(X)(1− e∗(X)) (Y − µ
∗(T,X))
]2}
,
VZB =
1
1− P(R = 1)E
{
[µ∗(1, X)− µ∗(0, X)− δ∗]2
}
+
1
P(R = 1)
E
{[
T − e∗(X)
e∗(X)(1− e∗(X)) (Y − µ
∗(T,X))
]2}
.
Moreover, Vour equals the efficiency lower bound in this setting, while whenever P(R = 1) > 0,
VZB − Vour = P(R = 1)
1− P(R = 1)E
[
(µ∗(1, X)− µ∗(0, X)− δ∗)2
]
> 0.
Proposition A.1 shows that the efficiency gap between our estimator and the ATE estimator in Zhang and Bradic
[2019] depends on the P(R = 1)/(1−P(R = 1)), i.e., the (expected) relative size of the labelled data versus unlabelled
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data, and also E[(µ∗(1, X)− µ∗(0, X)− δ∗)2], i.e., the variance due to pre-treatment covariates X. This exactly
characterizes the extra efficiency gain from using our estimator compared to the ATE estimator in Zhang and Bradic
[2019]: our estimator additionally imputes µ∗ for the labelled data, and averages the variations of pre-treatment
covariates observed in the labelled data.
A.3 Connection to Athey et al. [2019]
In Athey et al. [2019], they assumed the assumption that Y ⊥ T | X,S,R = 1, namely the observed primary outcome
and the treatment on the labelled data are independent given the pre-treatment covariates and surrogates. This is
called statistical surrogate condition in the literature (see Section 1.3 and appendix B). This assumption is important
for ensuring identification of treatment effects in the setting considered by Athey et al. [2019]: the treatment and
primary outcome are observed on separate datasets, but surrogates are always observed (Table 2c). Their setting is
different from our setting where the treatment is also always observed (Table 2a). Although the statistical surrogate
condition seems inevitable in their setting to fuse the two separate datasets without any complete observation,
the causal assumptions underlying this statistical surrogate condition may be too strong to hold in practice. See
Appendix B for more details.
Nevertheless, we may still wonder what we would gain in our setting if the statistical surrogate condition happens to be
true. Indeed, if it is true, incorporating this condition may improve finite-sample estimation performance, especially
for small sample size. This is because estimators of µ˜∗(X,S) trained on pooled data with both treatment options
may be more precise than estimators of µ˜∗(1, X, S) and µ˜∗(0, X, S) trained on two separate datasets corresponding
to two different treatment options respectively. But of course, explicitly assuming this statistical surrogate condition
also raises the risk of misspecification errors considering that this condition is often violated in practice.
In the following theorem, we show that even when the statistical surrogate condition is indeed true, explicitly
assuming this condition does not result in any efficiency improvement.
Theorem A.1. Under assumptions in Theorem 2.1, if we do not assume the statistical surrogate condition Y ⊥ T |
X,S,R = 1 even though it is actually true, then the efficiency lower bound for estimating δ∗ is still E[ψ2(W ; δ∗, η∗)]
with ψ(W ; δ∗, η∗) reduced to the following form:
ψ(W ; δ∗, η∗) = µ∗(1, X)− µ∗(0, X) + TR
e∗(X)r∗(1, X, S)
(Y − µ˜∗(X,S))− (1− T )R
(1− e∗(X))r∗(0, X, S) (Y − µ˜
∗(X,S))
+
T
e∗(X)
(µ˜∗(X,S)− µ∗(1, X))− 1− T
1− e∗(X) (µ˜
∗(X,S)− µ∗(0, X))− δ∗,
where µ˜∗(X,S) := E[Y | R = 1, X, S] and it satisfies that µ˜∗(X,S) = µ˜∗(t,X, S) for t = 0, 1 under the statistical
surrogate condition.
If we explicitly assume the statistical surrogate condition, then the efficiency lower bound remains the same.
Theorem A.1 implies that previous efficiency lower bound in Theorem 2.1 automatically becomes the correct efficiency
lower bound if the statistical surrogate condition indeed holds, even if we do not expect this condition and fail
to explicitly assume it in our model. Under only assumptions in Theorem 3.2 (but not the statistical surrogate
condition), our nuisance estimators ˆ˜µ will correctly converge to the true µ˜∗ that satisfies the statistical surrogate
condition, if this condition is indeed true. Consequently, our estimator δˆ in Definition 1 also asymptotically achieves
the efficiency lower bound in Theorem A.1 accordingly. This means that without assuming the statistical surrogate
condition, our approach is not only guarding against the often (if not always) violation of this condition, but also
achieves the full asymptotic efficiency if this condition happens to be true.
Our result in Theorem A.1 is quite distinct from the efficiency result in Athey et al. [2019] Theorem 3, even though
both results consider the statistical surrogate condition. In Athey et al. [2019], their efficiency analysis deviates from
their main setting of not observing treatment and primary outcome simultaneously (Table 2c). Instead, they switch
to the ideal setting where we can always observe pre-treatment covariates, treatment, surrogates and the primary
outcome together (Table 2d or equivalently Setting IV in Table 1d). They compared the efficiency lower bound with
and without assuming the statistical surrogate condition when this condition is actually true, and they found that
explicitly assuming the surrogate condition can result in smaller efficiency lower bound. In contrast, we consider the
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Figure 1: Causal diagrams illustrating the statistical surrogate condition: (a) statistical surrogate condition holds;
(b) statistical surrogate condition can be violated in presence of unmeasured confounder U .
setting where we can only observe the primary outcome for a subset of units but we observe other variables for all
units (Table 2a), and find that additionally assuming the statistical surrogate condition does not bring about any
asymptotic efficiency gain. Since surrogates are most relevant when we cannot observe all primary outcomes, we
believe that our characterization of the role of surrogates in efficient estimation of treatment effect is more pertinent
to real applications.
B Statistical surrogate condition
In this section, we review the definition of statistical surrogate condition proposed by Prentice [1989]. Throughout
this section, we implicitly condition on pre-treatment variables X in all distributional statements. For example,
Y ⊥ T | S stands for Y ⊥ T | S,X.
Prentice [1989] suggested a valid surrogate S satisfy that a test of the null of no effect of the treatment T on surrogate
S should serve as a valid test of the null of no effect of treatment T on outcome Y . They formalized this by the
following “statistical surrogate” condition.
Definition 3 (Statistical Surrogate). S is said to be a surrogate for the effect of T on Y if (i) Y ⊥ T | S; (ii) S
and Y are correlated.
To justify this condition, Prentice [1989] considered a time-to-event primary outcome with surrogates sampled from
a stochastic process. For simplicity, we now adapt their argument to a single-time measurement case. Note that
under the statistical surrogate condition, we can easily show that
F (y | t) =
∫
F (y | t, s)dF (s | t) =
∫
F (y | s)dF (s | t),
where F (y | t), F (y | t, s), F (s | t) are conditional cumulative distribution functions for the corresponding random
variables. This equation shows that under the statistical surrogate condition, T is dependent with Y only if T is
dependent with S. See also Freedman et al. [1992] for a similar argument for binary outcome. However, this type of
argument is based purely on the statistical relationship rather causal relationship among the treatment, surrogate,
and the primary outcome. Thus, the causal implication of this argument is not immediately straightforward.
In the language of causal diagram [Pearl, 2009], the statistical surrogate condition is often characterized by Figure 1a
[VanderWeele, 2013, Athey et al., 2019]. In this diagram, T has no direct effect on Y , and S has an effect on Y .
As a result, T can have an effect on Y only if T has an effect on S. Also, no direct effect of T on Y implies that
T is independent of Y given S, namely the condition (i) in the definition of statistical surrogate. However, this
relationship may be invalidated by any unmeasured confounder between the surrogate and the primary outcome
(e.g., the variable U in Figure 1b): since S is a collider on the causal path T → S ← U → Y , conditioning on S can
induce spurious dependence between T and Y , even though there is no direct effect of T on Y [Elwert and Winship,
2014]. In other words, no direct effect of the treatment T on the primary outcome Y does not necessarily ensure
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conditional independence between the treatment T and primary outcome Y given surrogates S, if there exists any
unmeasured confounder between surrogates S and the primary outcome Y .
The following proposition, adapted from Proposition 3 in Athey et al. [2019], reiterates the implication of Figure 1a
in language of potential outcomes, and further elucidates the causal assumptions underlying the statistical surrogate
condtion. We denote Y (t, s) as the potential outcome that would have been realized if treatment T had been set to
t, and surrogate oucomes S had been set to s.
Proposition B.1. S satisfies condition (i) in Definition 3 if the following conditions hold:
(i) Y (t, s) = Y (t′, s) for any t, t′ ∈ {0, 1} and s ∈ S; ;
(ii) T ⊥ (Y (0, s), Y (1, s))s∈S ;
(iii) S(t) ⊥ {Y (t, s)}s∈S | T = t for any t ∈ {0, 1}.
Proof. See Appendix E.2 for details.
Proposition B.1 above shows that no direct effect of treatment on the primary outcome (condition (i)), and no
unmeasured confounding either between treatment and the primary outcome (condition (ii)) or between surrogates
and primary outcome (condition (iii)) together ensure statistical surrogate condition. Conditions (ii)(iii) are also
commonly assumed in mediation analysis that aims to decompose the total effect of treatment T into the direct effect
not through post-treatment variable S and the effect mediated by S [e.g., Imai et al., 2011]. Here condition (ii)
may be satisfied by design in randomized trials where the treatment assignment T is under perfect control. However,
surrogates S and their relationship to the primary outcome are generally not manipulatable, so (i) and (iii) are often
(if not always) violated even in perfect randomized trials.
The discussions above also reveal that it is perhaps misleading to follow the quite common practice of interpreting
statistical surrogates as variables that block all causal pathways between the treatment and primary outcome (i.e.,
no-direct-effect assumption characterized by condition (i) in Proposition B.1). Actually, the no-direct-effect condition
is neither sufficient nor necessary for the conditional independence between the treatment and the primary outcome
given surrogates (i.e., condition (i) in Definition 3), since there may exist unmeasured confounders between the
surrogates and the primary outcome (i.e., condition (iii) in Proposition B.1 is violated). For example, section 5.2 in
Frangakis and Rubin [2002] provide counter-examples to show that statistical surrogates may not satisfy no-direct-
effect condition and vice versa.
C More on the extension in Section 4
C.1 Assumptions
In this part, we give some supplementary assumptions for Theorem 4.2.
Assumption 6. There exist positive constants q > 2 and C such that for t = 0, 1,
{E [|Y − µ˜∗(T,X, S)|q | R = 1]}1/q ≤ C,
‖µ˜∗(t,X, S)− µ∗(t,X)‖q ≤ C, ‖µ∗(t,X)‖q ≤ C.
Moment conditions in Assumption 6 are mainly used in verifying the Lyapunov condition in Lindberg-Feller Central
Limit Theorem in the proof of Theorem 4.2.
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Assumption 7. Suppose that the nuisance estimators have the following convergence rates: for 1 ≤ k ≤ K, and
r = 0, 1,{
E
[
(eˆk(X)− e∗(X))2 | R = r
]}1/2
= Op(ρN,e),
{
E
[
(λˆk(X)− λ∗(X))2 | R = r
]}1/2
= Op(ρN l,λ),{
E
[
(µˆk(X)− µ∗(X))2 | R = r
]}1/2
= Op(ρN l,µ),
{
E
[
(ˆ˜µk(X)− µ˜∗(X))2 | R = r
]}1/2
= Op(ρN l,µ˜).
In Assumption 7, we specify the convergence rates of the nuisance estimators in mean squared error both on the
labelled data and on the unlabelled data. Since eˆk is trained on the whole data where the treatment variable is
always fully observed, its convergence rate ρN,e scales with the total sample size N . In contrast, the convergence
rates of µˆk and ˆ˜µk, i.e., ρN l,µ and ρN l,µ˜, scale with N l because they are trained only on the labelled data. The
convergence rate of λˆk is also constrained by the expected size of labelled data N l, because it involves estimating
the density of covariates on the labelled data, i.e., f∗(X | R = 1).
C.2 Efficiency Comparison
We now provide the efficiency lower bounds for other settings in Section 2 when Nl  Nu. Note that setting IV is the
ideal setting with fully labelled data, so it does not have natural counterpart in the regime of Nl  Nu. Therefore,
we only provide bounds for setting I and setting II.
Theorem C.1. Consider the following two settings:
I. we only observe the labelled data, i.e., i.i.d samples from the conditional distribution of (X,T, Y ) given R = 1,
and we know the unconditional distribution of (X,T );
II. we only observe the labelled data, i.e., i.i.d samples from the conditional distribution of (X,T, S, Y ) given R = 1,
and we know the unconditional distribution of (X,T );
We further assume Assumption 1 and Assumption 2 condition (4), Assumption 3, R ⊥ T | X, and that ‖λ∗(X)‖∞ ≤
C for the positive constant C. Then the efficiency lower bounds for two settings above are V˜ ∗j = E[ψ˜2j (W ; δ∗, η˜∗) |
R = 1] for j = I, II, where
ψ˜I(W ; δ
∗, η˜∗) = ψ˜II(W ; δ∗, η˜∗) =
Tλ∗(X)
e∗(X)
(Y − µ∗(1, X))− (1− T )λ
∗(X)
1− e∗(X) (Y − µ
∗(0, X)).
The efficiency gains from surrogates are quantified by
V˜ ∗I − V˜ ∗ = V˜ ∗II − V˜ ∗ = E
[
λ∗2(X)
e∗(X)
Var{µ˜∗(1, X, S(1)) | X}+ λ
∗2(X)
1− e∗(X) Var{µ˜
∗(0, X, S(0)) | X} | R = 1
]
.
Theorem C.1 shows that the efficiency gains from surrogates increase with the variations of the primary outcome
explained by the surrogates beyond the pre-treatment covariates, i.e., Var{µ˜∗(t,X, S(t)) | X} for t = 0, 1. This
means that surrogates that are more predictive of the primary outcome can result in larger efficiency improvement,
which is consistent with the finding in Corollary 2.2.1.
C.3 More general results
Compared to Theorem 2.1, the efficiency theory in Section 4 further assumes the Assumption 3 that R ⊥ S(t) | T,X
for t = 0, 1 and T ⊥ R | X. In this subsection, we relax these two conditions and present a more general efficiency
lower bound. We point out that finding efficient estimators without these two conditions is considerably more
challenging.
To streamline the presentation, we maintain the definition that λ∗(X) := f∗(X)/f∗(X | R = 1), and additionally
define λ∗t (S,X) := f
∗(S | X,T = t)/f∗(S | X,T = t, R = 1) for t = 0, 1, e∗(1, X) := P(T = 1 | R = 1, X).
24
Theorem C.2. Suppose we only observe i.i.d samples from the distribution of (X,T, S, Y ) given R = 1, and we
additionally know the unconditional distribution of (X,T, S) under P. We assume Assumption 1, Assumption 2
condition (4), and that λ∗(X), λ∗1(S,X), λ
∗
0(S,X) are all almost surely upper bounded by a positive constant C.
Then the efficiency lower bound is V˜
′∗ = E[ψ˜′2(W ; δ∗, η˜′∗) | R = 1], where the new nuisance parameters are η˜′∗ =
(e∗, λ∗, λ∗1, λ
∗
0, µ˜
∗, µ∗), and
ψ˜′(W ; δ∗, η˜
′∗) =
Tλ∗(X)λ∗1(S,X)
e∗(1, X)
(Y − µ˜∗(1, X, S))− (1− T )λ
∗(X)λ∗0(S,X)
1− e∗(1, X) (Y − µ˜
∗(0, X, S)).
If we further assume R ⊥ S(t) | (T,X) and R ⊥ T | X, then λ∗1(S,X) = λ∗0(S,X) = 1, and e∗(1, X) = e∗(0, X) =
e∗(X), so that the efficiency lower bound in Theorem C.2 recovers the bound in Theorem 4.1. However, once we do
not assume R ⊥ S(t) | (T,X), we need to consider the density ratio products λ∗1λ∗ and λ∗0λ∗ which themselves are not
density ratios. Thus we cannot estimate these products directly. To estimate the products, we need to estimate two
more density ratios λ∗1 and λ
∗
0 besides the density ratio λ
∗ first, which makes treatment effect estimation considerably
more challenging.
If we can construct nuisance estimators for all density ratios besides other nuisance parameters, then we may follow
our estimation strategy in Definition 2 and use the following estimator:
1
K
K∑
k=1
Eˆn,k
{
µˆk(1, X)− µˆk(0, X) + T
eˆk(X)
(ˆ˜µk(1, X, S)− µˆk(1, X))− 1− T
1− eˆk(X) (
ˆ˜µk(0, X, S)− µˆk(0, X)) (20)
+
R
rˆN
λˆk(X)λˆ1,k(X)T
eˆk(1, X)
(Y − ˆ˜µk(1, X, S))− R
rˆN
λˆk(X)λˆ0,k(X)(1− T )
1− eˆk(1, X) (Y −
ˆ˜µk(0, X, S))
}
. (21)
However, since we do not assume T ⊥ R | X either, we need to estimate both e∗(X) in eq. (20), and e∗(1, X) in
eq. (21). This mismatch of the treatment propensity scores in eq. (20) and eq. (21) disrupts the Neyman Orthogonality
structure [Chernozhukov et al., 2018] of our previous ATE estimators that enables strong asymptotic guarantee while
using machine learning nuisance estimators with slow convergence rates. As a result, we cannot directly follow the
proof of Theorem 4.2 to prove that the estimator above achieves efficiency lower bound in Theorem C.2 under only
high level rate conditions.
In summary, we can analogously derive the efficiency lower bound without Assumption 3 and the condition T ⊥ R | X
when Nl  Nu. However, in this case, constructing an ATE estimator that can asymptotically achieve the efficiency
lower bound is much more challenging. Therefore, we maintain Assumption 3 and the condition T ⊥ R | X
throughout Section 4 for simplicity.
C.4 MCAR setting
To further illustrate the efficiency improvement from the unlabelled data, we compare the efficiency lower bounds of
ATE under three different settings: only labelled data are available (Setting i), both labelled data and unlabelled data
are available and their sizes are comparable (Setting ii), and size of the unlabelled data is much larger than size of the
labelled data (Setting iii). We assume that the primary outcome is MCAR, i.e., R ⊥ (X,T, S(1), S(0), Y (1), Y (0)),
so that we can estimate ATE based on labelled data alone.
Setting i: only labelled data. We observe M i.i.d samples from the distribution of (X,T, S, Y ) given R = 1.
Setting ii: labelled data and unlabelled data of comparable size. We observe N i.i.d samples from the dis-
tribution of (X,T, S, Y,R) with Y = NA when R = 0. The total sample size N satisfies that NP(R = 1) = M ,
i.e., the expected size of labelled data is also M .
Setting iii: much more unlabelled data than labelled data. We observe M i.i.d samples from the distribu-
tion of (X,T, S, Y ) given R = 1, and we additionally know the marginal distribution of (X,T, S). According to
Theorem 4.1, this setting also asymptotically characterizes the regime where we have access to unlabelled data
whose size is much larger than the size of the labelled data, but we do not know the distribution of (X,T, S)
exactly (see Section 4).
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We now provide the efficiency lower bounds in these three settings to illustrate efficiency improvement from increas-
ingly more unlabelled data information. Notably, we follow Section 4 to formulate the efficiency lower bounds from
the perspective of the labelled data (see Section 4 for more interpretations).
Proposition C.1. Suppose Assumption 1, Assumption 2 condition (4), and R ⊥ (X,T, S(1), S(0), Y (1), Y (0)) hold
for setting i to setting iii. Then for j = i, ii, iii, the efficiency lower bound for ATE from the perspective of the
labelled data (see Section 4 for precise interpretations) in setting j is given by V ∗j , where
V ∗i = E
[
T
e∗(X)
(Y − µ∗(1, X))− (1− T )
1− e∗(X) (Y − µ
∗(0, X))
]2
+ E [µ∗(1, X)− µ∗(0, X)− δ∗]2 ,
V ∗ii = E
[
T
e∗(X)
(Y − µ˜∗(1, X, S))− (1− T )
1− e∗(X) (Y − µ˜
∗(0, X, S))
]2
+ P(R = 1)E [µ∗(1, X)− µ∗(0, X)− δ∗]2
+ P(R = 1)E
[
T
e∗(X)
(µ˜∗(1, X, S)− µ∗(1, X))− 1− T
1− e∗(X) (µ˜
∗(0, X, S)− µ∗(0, X))
]2
,
V ∗iii = E
[
T
e∗(X)
(Y − µ˜∗(1, X, S))− (1− T )
1− e∗(X) (Y − µ˜
∗(0, X, S))
]2
.
It follows that the efficiency gain from observing the unlabelled data in setting ii compared to setting i is
V ∗i − V ∗ii = (1− P(R = 1))E
[
1
e∗(X)
Var{µ˜∗(1, X, S(1)) | X}+ 1
1− e∗(X) Var{µ˜
∗(0, X, S(0)) | X}
]
+ (1− P(R = 1))E [µ∗(1, X)− µ∗(0, X)− δ∗]2 ,
and the further efficiency gain from knowing the marginal distribution of (X,T, S) in setting iii (or equivalently
observing unlabelled data whose size is much larger than M) is
V ∗ii − V ∗iii = P(R = 1)E
[
1
e∗(X)
Var{µ˜∗(1, X, S(1)) | X}+ 1
1− e∗(X) Var{µ˜
∗(0, X, S(0)) | X}
]
︸ ︷︷ ︸
VS
+ P(R = 1)E [µ∗(1, X)− µ∗(0, X)− δ∗]2︸ ︷︷ ︸
VX
.
Proposition C.1 shows that efficiency improvement from optimally leveraging extra unlabelled data depends on the
relative size of the unlabelled data (characterized by 1−P(R = 1)), and variations of surrogates S and pre-treatment
covariates X (characterized by VS and VX respectively). In the limit, if the size of the unlabelled data is much larger
than the size of the labelled data, so that from the perspective of labelled data we virtually know the unlabelled
data distribution, then only residual variations of Y not explained by X,S, i.e., V ∗iii remains in the efficiency lower
bound. This analysis supplements the efficiency comparisons in Theorems 2.2 and C.1.
D Proofs
Throughtout all proofs, we use EIk to denote the conditional expectation operator given data not from the kth fold,
i.e., EIk fˆ(W ) = E[fˆ(W ) | {Wi}i∈Ick ], where fˆ(W ) is any appropriate function measurable with respect to {Wi}Ni=1.
For example, fˆ can depend on nuisance estimators trained on data {Wi}i∈Ick . Thus when we condition on {Wi}i∈Ick
through EIk , those nuisance estimators can be viewed as fixed.
We will often show the stochastic asymptotic order of EIk fˆ(W ) conditionally on {Wi}i∈Ick . According to Lemma D.4,
the unconditional stochastic asymptotic order of EIk fˆ(W ) keeps the same. We will repeatedly apply this fact without
explicit reference to Lemma D.4 when bounding error terms involving cross-fitting nuisance estimators in proofs for
Theorems 3.1 to 3.3 and 4.2 and proposition A.1.
In all proofs for efficiency results (Theorems 2.1, 2.2, 4.1, A.1 and C.1), we focus on the efficient influence function
and efficiency lower bound for ξ∗1 = E[Y (1)]. Then we can analogously derive the efficient influence function and
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efficiency lower bound for ξ∗0 = E[Y (0)] and δ∗ = ξ∗1 − ξ∗0 . Similarly, in all proofs for asymptotic properties of ATE
estimators (Theorems 3.2 and 4.2 and proposition A.1), we focus estimators for ξ∗1 , and we can derive analogous
results for the estimators of ATE.
D.1 Supporting Lemmas
Lemma D.1. Under condition (2) in Assumption 1, the following holds:
E[µ˜∗(T,X, S) | T,X] = µ∗(T,X).
Proof. For t = 0, 1,
E[µ˜∗(T,X, S) | T = t,X] = E[E[Y (t) | R = 1, T = t,X, S(t)] | T = t,X]
= E[E[Y (t) | T = t,X, S(t)] | T = t,X]
= E[Y (t) | T = t,X] = µ∗(t,X)
= E[Y (t) | T = t,X,R = 1] = µ∗(t,X)
Lemma D.2. Under Assumption 1
E[Y (t)] = E
[
E
[
E[Y | T = t, R = 1, X, S] | X,T = t]], (22)
where the right hand side only depends on distributions of observed data in Setting III in Section 2.
Under Assumption 1 and Assumption 3,
E[Y (t)] = E
{
E
[
E
(
Y | T = t, R = 1, X, S) | R = 1, T = t,X]}, (23)
= E
[
E
(
Y | T = t, R = 1, X)] (24)
where eq. (23) only depends on distributions of observed data in Setting II in Section 2, and eq. (24) only depends on
distributions of observed data in Setting I in Section 2.
Proof. Note that under Assumption 1
E[Y (t)] = E
{
E
[
Y (t) | X]}
= E
{
E
[
E
(
Y (t) | X,S(t)) | X]}
= E
{
E
[
E
(
Y (t) | T = t,X, S(t)) | X]}
= E
{
E
[
E
(
Y (t) | T = t,X, S(t), R = 1) | X]}
= E
{
E
[
E
(
Y (t) | T = t,X, S(t), R = 1) | X,T = t]},
where the third equality holds because of Assumption 1 condition (2), the fourth equality holds because of Assump-
tion 1 condition (3), and the fourth condition holds because of Assumption 1 condition (2).
To prove eq. (22), we note that
E[Y (t)] = E
{
E
[
E
(
Y (t) | T = t,X, S(t), R = 1) | X,T = t]}
= E
{
E
[
E
(
Y | T = t,X, S,R = 1) | X,T = t]}.
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where the last display only depends on distributions of observed data in setting III in Section 2.
To prove eq. (23), we note that
E[Y (t)] = E
{
E
[
E
(
Y (t) | T = t,X, S(t), R = 1) | X,T = t]}
= E
{
E
[
E
(
Y (t) | T = t,X, S(t), R = 1) | X,T = t, R = 1]}
= E
{
E
[
E
(
Y | T = t, R = 1, X, S) | R = 1, T = t,X]}.
where the second equality holds because of Assumption 3. the last display only depends on distributions of observed
data in setting II in Section 2.
To prove eq. (24), we note that Assumption 1 and Assumption 3 together imply that (Y (t), S(t)) ⊥ (T,R) | X, so
E[Y (t)] = E
[
E
(
Y (t) | X)]
= E
[
E
(
Y (t) | T = t, R = 1, X)]
= E
[
E
(
Y | T = t, R = 1, X)],
where the last display only depends on distributions of observed data in setting I in Section 2.
Lemma D.3. If P(R = 1) = 0, then r∗(T,X, S) = P(R = 1 | T,X, S) = 0 almost surely.
Proof. Obviously E[r∗(T,X, S)] = P(R = 1) = 0.
DenoteA = {P(R = 1 | T,X, S) > 0} andAm = {P(R = 1 | T,X, S) ≥ 1m} form = 1, 2, . . . . OviouslyA = ∪∞m=1Am.
By Chebyshev inequality,
0 ≤ P(Am) ≤ mE[r∗(T,X, S)] = 0.
This implies that P(Am) = 0. By the countable subadditivity of probability measure, we thus have P(A) ≤∑∞
m=1 P(Am) = 0.
Lemma D.4 (Lemma 6.1 in Chernozhukov et al. [2018]). Let {Xm} and {Ym} be two sequences of random variables.
If |Xm| = Op(Am) conditionally on Ym, namely, that for any lm → ∞, P(|Xm| > lmAm | Ym) → 0, then |Xm| =
Op(Am) unconditionally as well. If |Xm| = op(Am) conditionally on Ym, namely, that for any ε > 0, P(|Xm| >
εAm | Ym)→ 0 as m→∞, then |Xm| = op(Am) unconditionally as well.
Lemma D.5 (Concentration of the sample size of labelled data). Suppose that the triangular array {Ri,N : i =
1, . . . , N} consists of N i.i.d samples drawn from a bernoulli distribution with mean rN = P(R = 1). Let N l = NrN ,
Nl =
∑N
i=1Ri, and rˆN =
Nl
N . If r
2
NN →∞ and rNN →∞, then
rN (
1
rˆN
− 1
rN
) =
rN
rˆN
− 1 = op(1).
Proof. By Hoeffding inequality, for any ε > 0,
P(−ε ≤ rˆN − rN ≤ ε) ≥ 1− 2 exp(−2Nε2).
Take ε =
(r2NN)
1/4
√
N
, then
P(− (r
2
NN)
1/4
√
N
≤ rˆN − rN ≤ (r
2
NN)
1/4
√
N
) ≥ 1− 2 exp(−2(r2NN)1/2)→ 1.
Since rNrˆN =
rN
rˆN−rN+rN is monotonically decreasing in rˆN − rN when rN + rˆN − rN > 0, and rN > r
1/2
N N
1/4/
√
N for
large enough N given NrN →∞, the inequality above implies that with high prob 1− 2 exp(−2(r2NN)1/2)→ 1,
1
1 + 1
N1/4r
1/2
N
=
rN
rN +
r
1/2
N N
1/4
N1/2
≤ rN
rˆN
≤ rN
rN − r
1/2
N N
1/4
N1/2
=
1
1− 1
N1/4r
1/2
N
.
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Moreover, r
1/2
N N
1/4 = r2NN
1/4 →∞, so both 1
1− 1
N1/4r
1/2
N
and 1
1+ 1
N1/4r
1/2
N
are both 1/(1 + o(1)) = 1 + o(1).
Therefore,
rN (
1
rˆN
− 1
rN
) =
rN
rˆN
− 1 = op(1)
Lemma D.6. For k = 1, . . . ,K, if ‖µˆk −µ0‖2 = Op(ρN,µ), ‖ ˆ˜µk − µ˜0‖2 = Op(ρN,µ˜), and ‖rˆ− r0‖2 = Op(ρN,r), then
‖µˆk(t,X)− µ0(t,X)‖2 = Op(ρN,µ),
‖ ˆ˜µk(t,X, S(t))− µ˜0(t,X, S(t))‖2 = Op(ρN,µ˜), ‖rˆk(t,X, S(t))− r0(t,X, S(t))‖2 = Op(ρN,r).
If ‖µ˜0− µ˜∗‖2, ‖µ0−µ∗‖2 are almost surely bounded, then ‖µ˜0(t,X, S(t))− µ˜∗(t,X, S(t))‖2, ‖µ0(t,X)−µ∗(t,X)‖2 for
t = 0, 1 are also almost surely bounded.
Moreover, if ‖Y (0)‖q ∨ ‖Y (1)‖q ≤ C for a constant q > 2, then ‖µ∗(t,X)‖q ≤ C, ‖µ˜∗(t,X, S)‖q ≤ C for t = 0, 1.
Proof. We note that
‖µˆk − µ0‖2 =
{
E[µˆk(T,X)− µ0(T,X)]2
}1/2
=
{
E
[
(µˆk(1, X)− µ0(1, X))2e∗(X) + (µˆk(0, X)− µ0(0, X))2(1− e∗(X))
]}1/2
≥ (2)1/2[‖µˆk(1, X)− µ0(1, X)‖2 ∨ ‖µˆk(0, X)− µ0(0, X)‖2].
Thus ‖µˆk − µ0‖2 = Op(ρN,µ) implies ‖µˆ(t,X) − µ0(t,X)‖2 = Op(ρN,µ) for t = 0, 1. Similarly, we can prove that
‖ ˆ˜µ(t,X, S(t))−µ˜0(t,X, S(t))‖2 = Op(ρN,µ˜) given ‖ ˆ˜µk−µ˜0‖2 = Op(ρN,µ˜), and ‖µ˜0(t,X, S(t))−µ˜∗(t,X, S(t))‖2, ‖µ0(t,X)−
µ∗(t,X)‖2 are almost surely bounded given that ‖µ˜0 − µ˜∗‖2, ‖µ0 − µ∗‖2 are almost surely bounded.
Moreover,
‖rˆ − r0‖22 = E
[(
rˆ(T,X, S)− r(T,X, S))2]
= E
[
E
[
E[
(
rˆ(T,X, S)− r(T,X, S))2 | X,T ] | X]]
= E
[
e∗(X)E
[(
rˆ(1, X, S(1))− r(1, X, S(1)))2 | X,T = 1]
+ (1− e∗(X))E[(rˆ(0, X, S(0))− r(0, X, S(0)))2 | X,T = 0]]
= E
[
e∗(X)(rˆ(1, X, S(1))− r(1, X, S(1)))2 + (1− e∗(X))(rˆ(0, X, S(0))− r(0, X, S(0)))2]
≥ 2(‖rˆ(1, X, S(1))− r0(1, X, S(1))‖22 ∨ ‖rˆ(0, X, S(0))− r0(0, X, S(0))‖22)
Therefore, ‖rˆ(1, X, S(1))− r0(1, X, S(1))‖2 = Op(ρN,r) and ‖rˆ(0, X, S(0))− r0(0, X, S(0))‖2 = Op(ρN,r).
For the last statement, note that
‖µ∗(1, X)‖q = E
[
Eq[Y (1) | X]]1/q Jensen’s inequality≤ ‖Y (1)‖q ≤ C.
Similarly we can prove that ‖µ∗(0, X)‖q, ‖µ˜∗(0, X, S)‖q ≤ ‖Y (0)‖q and ‖µ˜∗(1, X, S)‖q ≤ ‖Y (1)‖q. Thus ‖ψ(W ; δ∗, η∗)‖q =
O(1).
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D.2 Proofs for section 2
Proof for theorem 2.1. Suppose that distribution of X, conditional distributin of S | X,T , and conditional distribu-
tion of Y | R,S, T,X have true density functions f∗X , f∗S|X,T , f∗Y |R,S,T,X with respect to a certain dominating measure.
We consider the following model:
Mnp =
{
fX,T,S,R,Y (X,T, S,R, Y ) = fX(X)
[
e(X)T (1− e(X))1−T ]fS|X,T (S | X,T )
× [r(T,X, S)R(1− r(T,X, S))1−R]fRY |R=1,S,T,X(Y, S, T,X) :
fX , fS|X,T , and fY |R=1,S,T,Xare arbitrary density functions of the distributions indicated by the subscripts
respectively, and e(X), r(T,X, S) are arbitrary functions obeying e(X) ∈ [, 1− ], r(T,X, S) ∈ [, 1]
}
According to Lemma D.2, our estimand is
δ∗ = E[Y (1)]− E[Y (0)] = E
[
E
[
E[Y | R = 1, T = 1, X, S] | X,T = 1]]− E[E[E[Y | R = 1, T = 0, X, S] | X,T = 0]].
Thus onlyf∗X , f
∗
S|X,T , f
∗
Y |R=1,S,T,X contribute to the definition of the target parameter δ
∗. In contrast, the propensity
scores r∗ and e∗ do not, so whether the propensity scores they are known or not does not influence the efficiency lower
bound and efficient influence function for δ∗. This means that we can equivalently consider the following model that
fix the propensity scores at truth, since this model leads to the same efficiency lower bound and efficient influence
function for δ∗.
Mfix =
{
fX,T,S,R,Y (X,T, S,R, Y ) = fX(X)
[
e∗(X)T (1− e∗(X))1−T ]fS|X,T (S | X,T )
× [r∗(T,X, S)R(1− r∗(T,X, S))1−R]fRY |R=1,S,T,X(Y, S, T,X) : fX , fS|X,T , and fY |R=1,S,T,X
are arbitrary density functions of the distributions indicated by the subscripts respectively
}
In the following part, we focus onMfix to derive the efficient influence function. We will derive the efficient influence
function for ξ∗1 = E[Y (1)], and the efficient influence function for ξ∗0 = E[Y (0)] and δ∗ = ξ∗1 − ξ∗0 analogously.
Step I: find the tangent set. We consider smooth and regular parametric submodels indexed by parameter γ:
Mfix,sub =
{
fX,T,S,R,Y (X,T, S,R, Y ; γ) = fX(X; γ)
[
e∗(X)T (1− e∗(X))1−T ]fS|X,T (S | X,T ; γ)[r∗(X)R(1− r∗(X))1−R]
× fRY |R=1,S,T,X(Y,R, S, T,X; γ) : γ ∈ Γ,
∃γ∗ such that fX(X; γ∗) = f∗X(X), fS|X,T (S | X,T ; γ∗) = f∗S|X,T (S | X,T ),
fY |R=1,S,T,X(Y, S, T,X; γ∗) = f∗Y |R=1,S,T,X(Y, S, T,X)
}
.
The score vector of this parametric submodel is
S(Y,R, S, T,X; γ∗) = SX(X; γ∗) + SS|X,T (S,X, T ; γ∗) + SY |R=1,S,X,T (Y,R, S,X, T ; γ∗),
where
SX(X; γ
∗) =
∂ log fX(X; γ
∗)
∂γ
, SS|X,T (S,X, T ; γ∗) =
∂ log fS|X,T (S,X, T ; γ∗)
∂γ
,
SY |R=1,S,X,T (Y,R, S,X, T ; γ∗) =
∂ log fRY |R=1,S,T,X(Y, S, T,X; γ
∗)
∂γ
.
From the analysis of the score vectors for Mfix,sub, we can obtain that any score vector S(X,T, S,R, Y ) in the
tangent space for Mfix takes the form S(X,T, S,R, Y ) = SX(X) + SS|X,T (S,X, T ) + SY |R=1,S,X,T (Y,R, S,X, T )
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where SX(X), SS|X,T (S,X, T ), SY |R=1,S,X,T (Y,R, S,X, T ) are any elements from the following spaces respectively:
ΛX = {SX(X) ∈ H : E[SX(X)] = 0},
ΛS|X,T = {SS|X,T (S,X, T ) ∈ H : E[SS|X,T (S,X, T ) | X,T ] = 0},
ΛY |R=1,S,X,T = {SY |R=1,S,X,T (Y,R, S,X, T ) ∈ H : E[SY |R=1,S,X,T (Y,R, S,X, T ) | R = 1, S,X, T ] = 0}.
In other words, the tangent set corresponding to Mfix is Λ = ΛX ⊕ ΛS|X,T ⊕ ΛY |R,S,X,T .
According to the partitioning of Hilbert space [e.g., Tsiatis, 2007, Sec. 4.4], we know that the whole Hilbert
space H consisting of all square integerable functions of W = (Y,R, S, T,X) with zero mean can be decomposed as
H = ΛX ⊕ ΛT |X ⊕ ΛS|X,T ⊕ ΛR|S,T,X ⊕ ΛY |R=1,S,X,T . Therefore, the orthogonal complement to the tangent set is
Λ⊥ = ΛT |X ⊕ ΛR|S,X,T where
ΛT |X = {ST |X(T,X) ∈ H : E[ST |X(T,X) | X] = 0}
ΛR|S,T,X = {SR|S,T,X(R,S, T,X) ∈ H : E[SR|S,T,X(R,S, T,X) | S, T,X] = 0}.
Step II: derive a preliminary influence function using parametric submodels. In this part, I will prove
that the parameter ξ∗1 is path-differentiable relative to the tangent set Λ. We prove this by considering smooth and
regular parametric submodel classes consisting of models like Mfix,sub.
Given Eγ [Y (1)] = Eγ
[
Eγ
[
Eγ [Y | R = 1, T = 1, X, S] | X,T = 1
]]
,
∂Eγ [Y (1)]
∂γ
|γ=γ∗ = ∂
∂γ
Eγ
[
Eγ∗ [Y | T = 1, X]
]|γ=γ∗ + Eγ∗[ ∂
∂γ
Eγ
[
Eγ∗ [Y | T = 1, R = 1, X, S] | X,T = 1
]|γ=γ∗]
+ Eγ∗
[
Eγ∗
[ ∂
∂γ
Eγ [Y | T = 1, R = 1, X, S]|γ=γ∗ | X,T = 1
]]
. (25)
Now we deal with each term respectively.
∂
∂γ
Eγ
[
Eγ∗ [Y | T = 1, X]
]|γ=γ∗ = Eγ∗[µ∗(1, X)SX(X; γ∗)]
= Eγ∗
[
µ∗(1, X)(SX(X; γ∗) + SS|X,T (S | X,T ; γ∗) + SY |R=1,S,T,X(Y,R, S, T,X; γ∗))
]
(26)
where the second equality holds because
E[SS|X,T (S | X,T ; γ∗) | X] = E[E[SS|X,T (S | X,T ; γ∗) | X,T ] | X] = 0
E[SY |R=1,S,T,X(Y,R, S, T,X; γ∗)) | X] = E[E[SY |R=1,S,T,X(Y,R, S, T,X; γ∗)) | R,S, T,X] | X] = 0.
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Moreover,
Eγ∗
[
∂
∂γ
Eγ
[
Eγ∗ [Y | T = 1, R = 1, X, S] | X,T = 1
]|γ=γ∗]
= Eγ∗
[
Eγ∗
[
Eγ∗ [Y | T = 1, R = 1, X, S]SS|X,T=1(S,X, T = 1; γ∗) | X,T = 1
]|γ=γ∗]
= Eγ∗
[
Eγ∗
[
Eγ∗ [Y SS|X,T=1(S,X, T = 1; γ∗) | R = 1, T = 1, S,X] | X,T = 1
]]
= Eγ∗
[
Eγ∗
[
Eγ∗ [
TR
e∗(X)r∗(1, X, S)
Y SS|X,T (S,X, T ; γ∗) | S(1), X] | X,T = 1
]]
= Eγ∗
[
Eγ∗
[
Eγ∗ [
TR
e∗(X)r∗(1, X, S)
Y SS|X,T (S,X, T ; γ∗) | S(1), X] | X
]]
= E
[
TR
e∗(X)r∗(1, X, S)
Y SS|X,T (S,X, T ; γ∗)
]
= E
[
TR
e∗(X)r∗(1, X, S)
(Y − µ∗(T,X))SS|X,T (S,X, T ; γ∗)
]
= E
[
TR
e∗(X)r∗(1, X, S)
(Y − µ∗(T,X))(SS|X,T (S,X, T ; γ∗) + SX(X; γ∗))
]
. (27)
where the fourth equality holds because S(1) ⊥ T | X, the sixth equality holds because
E
[
TR
e∗(X)r∗(1, X, S)
µ∗(T,X)SS|X,T (S,X, T ; γ∗)
]
=E
[
µ∗(T,X)SS|X,T (S,X, T ; γ∗)
T
e∗(X)r∗(1, X, S)
E[R | T, S,X]
]
=E
[
µ∗(T,X)SS|X,T (S,X, T ; γ∗)
T
e∗(X)r∗(1, X, S)
P(R = 1 | T = 1, S(1), X)
]
=E
[
µ∗(T,X)E[SS|X,T (S,X, T ; γ∗) | T,X] T
e∗(X)
]
= 0.
and the last equality holds because
E
[
TR
e∗(X)r∗(1, X, S)
(Y − µ∗(T,X))SX(X; γ∗)
]
=E
[
T
e∗(X)r∗(1, X, S)
(Y − µ∗(T,X))SX(X; γ∗)E[R | Y (1), T = 1, X, S(1)]
]
=E
[
T
e∗(X)
(Y − µ∗(T,X))SX(X; γ∗)
]
=E
[
T
e∗(X)
E[Y − µ∗(T,X) | T,X]SX(X; γ∗)
]
= 0.
Similarly, we can obtain that
Eγ∗
[
Eγ∗
[ ∂
∂γ
Eγ [Y | T = 1, R = 1, X, S]|γ=γ∗ | X,T = 1
]]
=E
[
TR
e∗(X)r∗(1, X, S)
Y SY |R=1,S,T,X(Y,R, S, T,X; γ∗)
]
=E
[
TR
e∗(X)r∗(1, X, S)
(Y − µ∗(T,X))SY |R=1,S,T,X(Y,R, S, T,X; γ∗)
]
. (28)
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where the second equality holds because
E
[
TR
e∗(X)r∗(1, X, S)
µ∗(T,X)SY |R=1,S,T,X(Y,R, S, T,X; γ∗)
]
=E
[
T
e∗(X)r∗(1, X, S(1))
E[R | T = 1, X, S(1), Y (1)]µ∗(1, X)SY |R=1,S,T,X(Y (1), R = 1, S(1), T = 1, X; γ∗)
]
=E
[
T
e∗(X)
µ∗(1, X)SY |R=1,S,T,X(Y (1), R = 1, S(1), T = 1, X; γ∗)
]
=E
[
T
e∗(X)
µ∗(1, X)E[SY |R=1,S,T,X(Y (1), R = 1, S(1), T = 1, X; γ∗) | T,X, S(1)]
]
=E
[
T
e∗(X)
µ∗(1, X)E[SY |R=1,S,T,X(Y (1), R = 1, S(1), T = 1, X; γ∗) | X,S(1), T = 1, R = 1]
]
=E
[
T
e∗(X)
µ∗(T,X)E[SY |R=1,S,T,X(Y,R, S, T,X; γ∗) | X,S, T,R = 1]
]
= 0.
Plugging eqs. (26) to (28) back into eq. (29) gives that for any parametric submodel Mfix,sub,
∂Eγ [Y (1)]
∂γ
|γ=γ∗ = E
[
φ1(W ; ξ
∗
1 , η
∗)(SX(X; γ∗) + SS|X,T (S | X,T ; γ∗) + SY |R=1,S,T,X(Y,R, S, T,X; γ∗))
]
, (29)
where
φ1(W ; ξ
∗
1 , η
∗) = µ∗(1, X) +
TR
e∗(X)r∗(1, X, S)
(Y − µ∗(T,X))− ξ∗1
= µ∗(1, X) +
TR
e∗(X)r∗(1, X, S)
(Y − µ∗(1, X))− ξ∗1 .
Equation (29) implies that φ1(W ; ξ
∗
1 , η
∗) is an influence function for ξ∗1 .
Step III: derive the efficient influence function. For any element h(W ) ∈ H, the projection of h(W ) onto Λ⊥
is given by
Π[h(X,T, S,R, Y ) | Λ⊥] = Π[h(W ) | ΛT |X ] + Π[h(X,T, S,R, Y ) | ΛR|S,T,X ]
= E[h(W ) | T,X]− E[h(W ) | X] + E[h(W ) | R,S, T,X]− E[h(W ) | S, T,X].
The efficient influence function for ξ∗1 = E[Y (1)] is given by
ψ1(W ; ξ
∗
1 , η
∗) = φ1(W ; ξ∗1 , η
∗)−Π[φ1(W ; ξ∗1 , η∗) | Λ⊥]
= φ1(W ; ξ
∗
1 , η
∗)−
(
E[φ1(W ; ξ∗1 , η∗) | T,X]− E[φ1(W ; ξ∗1 , η∗) | X]
+ E[φ1(W ; ξ∗1 , η∗) | R,S, T,X]− E[φ1(W ; ξ∗1 , η∗) | S, T,X]
)
. (30)
Note that
E[φ1(W ; ξ∗1 , η∗) | T,X] = µ∗(1, X)− ξ∗1 +
T
e∗(X)
E[
R
r∗(1, X, S)
(Y − µ∗(1, X)) | T = 1, X]
= µ∗(1, X)− ξ∗1 +
T
e∗(X)
E[
Y (1)− µ∗(1, X)
r∗(1, X, S)
E[R | T = 1, X, S(1), Y (1)] | T = 1, X]
= µ∗(1, X)− ξ∗1 +
T
e∗(X)
E[Y (1)− µ∗(1, X) | T = 1, X]
= µ∗(1, X)− ξ∗1
E[φ1(W ; ξ∗1 , η∗) | X] = E[E[φ1(W ; ξ∗1 , η∗) | T,X] | X] = µ∗(1, X)− ξ∗1 ,
33
and
E[φ1(W ; ξ∗1 , η∗) | R,S, T,X] = µ∗(1, X) +
TR
e∗(X)r∗(1, X, S)
[
E[Y | R, T, S,X]− µ∗(1, X)]− ξ∗1
= µ∗(1, X) +
TR
e∗(X)r∗(1, X, S)
[
E[Y | R = 1, T = 1, S,X]− µ∗(1, X)]− ξ∗1
= µ∗(1, X) +
TR
e∗(X)r∗(1, X, S)
[
µ˜∗(1, X, S)− µ∗(1, X)]− ξ∗1
E[φ1(W ; ξ∗1 , η∗) | S, T,X] = E[E[φ1(W ; ξ∗1 , η∗) | R,S, T,X] | S, T,X]
= µ∗(1, X) +
TE[R | S, T = 1, X]
e∗(X)r∗(1, X, S)
[
µ˜∗(1, X, S)− µ∗(1, X)]− ξ∗1
= µ∗(1, X) +
T
e∗(X)
[
µ˜∗(1, X, S)− µ∗(1, X)]− ξ∗1
Therefore, eq. (30) implies that the efficient influence function for ξ∗1 = E[Y (1)] is given by
ψ1(W ; ξ
∗
1 , η
∗) = µ∗(1, X) +
TR
e∗(X)r∗(1, X, S)
(Y − µ˜∗(1, X, S)) + T
e∗(X)
(µ˜∗(1, X, S)− µ∗(1, X))− ξ∗1 .
Similarly, the efficient influence function for ξ∗0 = E[Y (0)] is
ψ0(W ; ξ
∗
1 , η
∗) = µ∗(0, X) +
(1− T )R
(1− e∗(X))r∗(0, X, S) (Y − µ˜
∗(0, X, S)) +
1− T
1− e∗(X) (µ˜
∗(0, X, S)− µ∗(0, X))− ξ∗0 .
Thus the efficient influence function for δ∗ = ξ∗1 − ξ∗0 is
ψ(W ; δ∗, η∗) = ψ1(W ; ξ∗1 , η
∗)− ψ0(W ; ξ∗1 , η∗)
= µ∗(1, X)− µ∗(0, X) + TR
e∗(X)r∗(1, X, S)
(Y − µ˜∗(1, X, S))− (1− T )R
(1− e∗(X))r∗(0, X, S) (Y − µ˜
∗(0, X, S))
+
T
e∗(X)
(µ˜∗(1, X, S)− µ∗(1, X))− 1− T
1− e∗(X) (µ˜
∗(0, X, S)− µ∗(0, X))− δ∗
Therefore, the efficiency lower bound is V ∗ = E[ψ2(W ; δ∗, η∗)].
Corollary D.0.1. The efficiency lower bound in Theorem 2.1 is
V ∗ = E[ψ2(W ; δ∗, η∗)] = Var
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
Y
}
− E
{(√
1− e∗(X)
e∗(X)
µ∗(1, X) +
√
e∗(X)
1− e∗(X)µ
∗(0, X)
)2}
− E
{
1
e∗(X)
1− r∗(1, X, S(1))
r∗(1, X, S(1))
µ˜∗2(1, X, S(1)) +
1
1− e∗(X)
1− r∗(0, X, S(0))
r∗(0, X, S(0))
µ˜∗2(0, X, S(0))
}
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Proof. By straightforward algebra, we can show that
V ∗ = Var[ψ(W ; ξ∗1 , η
∗)]
= Var
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
Y
}
+ Var{µ∗(1, X)− µ∗(0, X)}︸ ︷︷ ︸
V1
+ Var
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
µ˜∗(T,X, S)
}
︸ ︷︷ ︸
V2
+ Var
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
µ˜∗(T,X, S)
}
︸ ︷︷ ︸
V3
+ Var
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
µ∗(T,X)
}
︸ ︷︷ ︸
V4
+ 2 Cov
(
µ∗(1, X)− µ∗(0, X),
(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
(Y − µ˜∗(T,X, S)
)
︸ ︷︷ ︸
V5
+ 2 Cov
(
µ∗(1, X)− µ∗(0, X),
(
T
e∗(X)
− 1− T
1− e∗(X)
)
(µ˜∗(T,X, S)− µ∗(T,X))
)
︸ ︷︷ ︸
V6
+ 2 Cov
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
(µ˜∗(T,X, S)− µ∗(T,X)),
(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
(Y − µ˜∗(T,X, S)
}
︸ ︷︷ ︸
V7
− 2 Cov
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
Y,
(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
µ˜∗(T,X, S)
}
︸ ︷︷ ︸
V8
− 2 Cov
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
µ˜∗(T,X, S),
(
T
e∗(X)
− 1− T
1− e∗(X)
)
µ∗(T,X)
}
︸ ︷︷ ︸
V9
Now we compute these terms one by one. For V1:
Var{µ∗(1, X)− µ∗(0, X)} = E[(µ∗(1, X)− µ∗(0, X))2]− E2[µ∗(1, X)− µ∗(0, X)]
= E[(µ∗(1, X)− µ∗(0, X))2]− (ξ∗1 − ξ∗0)2
For V2 ∼ V4:
V2 = Var
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
µ˜∗(T,X, S)
}
= Var
{
TR
e∗(X)r∗(1, X, S(1))
µ˜∗(1, X, S(1))
}
+ Var
{
(1− T )R
(1− e∗(X))r∗(0, X, S(0)) µ˜
∗(0, X, S(0))
}
− 2 Cov
(
TR
e∗(X)r∗(1, X, S(1))
µ˜∗(1, X, S(1)),
(1− T )R
(1− e∗(X))r∗(0, X, S(0)) µ˜
∗(0, X, S(0))
)
= E
{
1
e∗(X)r∗(1, X, S(1))
µ˜∗2(1, X, S(1))
}
+ E
{
1
(1− e∗(X))r∗(0, X, S(0)) µ˜
∗2(0, X, S(0))
}
− (ξ∗1 − ξ∗0)2.
since
Var
{
TR
e∗(X)r∗(1, X, S(1))
µ˜∗(1, X, S(1))
}
= E
{
E[TR | X,S(1)]
(e∗(X)r∗(1, X, S(1)))2
µ˜∗2(1, X, S(1))
}
− E2
{
E[TR | X,S(1)]
e∗(X)r∗(1, X, S(1))
µ˜∗(1, X, S(1))
}
= E
{
1
e∗(X)r∗(1, X, S(1))
µ˜∗2(1, X, S(1))
}
− ξ∗21 ,
Var
{
(1− T )R
(1− e∗(X))r∗(0, X, S(0)) µ˜
∗(0, X, S(0))
}
= E
{
1
(1− e∗(X))r∗(0, X, S(0)) µ˜
∗2(0, X, S(0))
}
− ξ∗20 ,
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and
Cov
(
TR
e∗(X)r∗(1, X, S(1))
µ˜∗(1, X, S(1)),
(1− T )R
(1− e∗(X))r∗(0, X, S(0)) µ˜
∗(0, X, S(0))
)
= −E
[
TR
e∗(X)r∗(1, X, S(1))
µ˜∗(1, X, S(1))
]
E
[
(1− T )R
(1− e∗(X))r∗(0, X, S(0)) µ˜
∗(0, X, S(0))
]
= −ξ∗1ξ∗0 .
Similarly,
V3 = E
{
1
e∗(X)
µ˜∗2(1, X, S(1))
}
+ E
{
1
1− e∗(X) µ˜
∗2(0, X, S(0))
}
− (ξ∗1 − ξ∗0)2
V4 = E
{
1
e∗(X)
µ˜∗2(1, X)
}
+ E
{
1
1− e∗(X) µ˜
∗2(0, X)
}
− (ξ∗1 − ξ∗0)2.
For V5 ∼ V7:
V5 = Cov
(
µ∗(1, X)− µ∗(0, X),
(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
(Y − µ˜∗(T,X, S)
)
= E
{
(µ∗(1, X)− µ∗(0, X))
(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
(E[Y | R = 1, T,X, S]− µ˜∗(T,X, S)
}
− E
{
(µ∗(1, X)− µ∗(0, X))
}
E
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
(E[Y | R = 1, T,X, S]− µ˜∗(T,X, S)
}
= 0,
since E[Y | R = 1, T,X, S] = µ˜∗(T,X, S). Similarly V7 = 0. It is analogous to prove that V6 = 0 by noting that
E[µ˜∗(T,X, S) | X,T ] = µ∗(T,X) according to lemma D.1.
For V8 and V9:
V8 = E
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)2
Y µ˜∗(T,X, S)
}
− E
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
µ˜∗(T,X, S)
}
E
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
Y
}
= E
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)2
µ˜∗2(T,X, S)
}
− E2
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
µ˜∗(T,X, S)
}
= Var
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
µ˜∗(T,X, S)
}
= V2,
where the second equality holds because E[Y | R, T,X, S] = µ˜∗(T,X, S). Analogously, we can prove that V9 = V4 by
again noting that E[µ˜∗(T,X, S) | X,T ] = µ∗(T,X) according to lemma D.1.
Therefore,
V ∗ = Var
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
Y
}
+ V1 + V3 − V2 − V4
= Var
{(
TR
e∗(X)r∗(1, X, S)
− (1− T )R
(1− e∗(X))r∗(0, X, S)
)
Y
}
− E
{(√
1− e∗(X)
e∗(X)
µ∗(1, X) +
√
e∗(X)
1− e∗(X)µ
∗(0, X)
)2}
− E
{
1
e∗(X)
1− r∗(1, X, S(1))
r∗(1, X, S(1))
µ˜∗2(1, X, S(1)) +
1
1− e∗(X)
1− r∗(0, X, S(0))
r∗(0, X, S(0))
µ˜∗2(0, X, S(0))
}
,
since
V1 − V4 = −E
{
1− e∗(X)
e∗(X)
µ˜∗2(1, X) +
e∗(X)
1− e∗(X) µ˜
∗2(0, X) + 2µ˜∗(1, X)µ˜∗(0, X)
}
= −E
{(√
1− e∗(X)
e∗(X)
µ∗(1, X) +
√
e∗(X)
1− e∗(X)µ
∗(0, X)
)2}
,
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and
V3 − V2 = −E
{
1
e∗(X)
1− r∗(1, X, S(1))
r∗(1, X, S(1))
µ˜∗2(1, X, S(1)) +
1
1− e∗(X)
1− r∗(0, X, S(0))
r∗(0, X, S(0))
µ˜∗2(0, X, S(0))
}
.
Proof for theorem 2.2. We derive the efficient influence functions and efficiency bounds for different settings respec-
tively. In all parts, we focus on efficient influence function for ξ∗1 . The efficient influence function for ξ
∗
0 and δ
∗ can
be derived analogously.
Efficienct influence function in setting I. Efficient influence function and efficiency lower bound in this setting
are already well known [Hahn, 1998, Robins et al., 1994]. In this part, we provide a proof for completeness.
Analogous to the proof of theorem 2.1 , we can equivalently consider the nonparametric model classes with fixed
propensities:
Mfix,I =
{
fX,T,R,Y (X,T,R, Y ) = fX(X)
[
e∗(X)T (1− e∗(X))1−T ][r∗(T,X)R(1− r∗(T,X))1−R]fRY |R=1,T,X(Y,R, T,X) :
∀fX and fY |R=1,T,Xare arbitrary density functions
}
Similarly to the step I in proof of Theorem 2.1, the orthogonal complement to the associated tangent space of the
model Mfix,I is
Λ⊥I = {S(R, T,X) ∈ L2(P ) : E[S(R, T,X) | X] = 0} = ΛT,R|X .
Note that the model above is a submodel ofMfix in the proof of theorem 2.1, so any score vector forMfix,I is also
a score vector for Mfix. Since ψ1,I(W ; δ∗, η∗) = TRe∗(X)r∗(1,X) (Y − µ∗(1, X)) + µ∗(1, X) is an influence function for
E[Y (1)] under Mfix according to the proof of theorem 2.1, it is also an influence function under Mfix,I .
It is easy to verify that Π(ψ1,I(W ; δ
∗, η∗) | ΛT,R|X) = E[ψ1,I(W ; δ∗, η∗) | T,R,X] − E[ψ1,I(W ; δ∗, η∗) | X] = 0.
Therefore, ψ1,I(W ; δ
∗, η∗) is the efficient influence function for E[Y (1)] in setting I. It follows that ψI(W ; δ∗, η∗) =
µ∗(1, X)−µ∗(0, X)+ TRe∗(X)r∗(1,X) (Y −µ∗(1, X))− (1−T )R(1−e∗(X))r∗(0,X) (Y −µ∗(0, X))−δ∗ is the efficient influence function
for δ∗ = E[Y (1)]− E[Y (0)]. Therefore, V ∗1 = E{ψ2I (W ; δ∗, η∗)} is the efficiency lower bound in Setting I.
Efficienct influence function in setting II. Analogous to the proof of theorem 2.1 , we can equivalently consider
the nonparametric model classes with fixed propensities:
Mfix,II =
{
fX,T,S,R,Y (X,T, S,R, Y ) = fX(X)
[
e∗(X)T (1− e∗(X))1−T ][r∗(T,X)R(1− r∗(T,X))1−R]
× fRS|X,T,R(S | X,T,R = 1)fRY |R=1,S,T,X(Y, S, T,X) : fX , fS|X,T , and fY |R=1,S,T,Xare arbitrary density functions
}
The efficient influence function can be obtained analogously to the proof for setting I: since Mfix,II is again a
submodel of Mfix, ψ1,II(W ; δ∗, η∗) = TRe∗(X)r∗(1,X) (Y − µ∗(1, X)) + µ∗(1, X) is also an influence function under
Mfix,II , and the orthogonal complement to Mfix,II is the same as that to Mfix,I , i.e., Λ⊥I . Thus the efficient
influence function for ξ∗1 is the same as that in Setting I. It follows that the efficiency lower bound for δ
∗ is also the
same as that in Setting I.
Efficienct influence function in setting III. The conclusion straightforwardly follows from theorem 2.1.
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Efficienct influence function in setting IV. Analogous to the proof of theorem 2.1 , we can equivalently
consider the nonparametric model classes with fixed propensities:
Mfix,IV =
{
fX,T,S,Y (X,T, Y ) = fX(X)
[
e∗(X)T (1− e∗(X))1−T ]fS|T,X(S, T,X)fY |T,X,S(Y, T,X, S) :
fX , fS|T,X , and fY |T,X,S are arbitrary density functions
}
The orthogonal complement to the associated tangent space of the model above is
Λ⊥IV = {S(T,X) ∈ L2(P ) : E[S(T,X) | X] = 0} = ΛT |X .
We consider smooth and regular parametric submodels parameterized by γ analogous to Msub,fix when analyzing
the path-differentiability of ξ∗1 .
∂
∂γ
Eγ [Y (1)]|γ=γ∗ = ∂
∂γ
Eγ [Eγ [Y | T = 1, X]]|γ=γ∗
= E[µ∗(1, X)SX(X)] + E[E[Y SY |T=1,X(Y | T = 1, X) | T = 1, X]]
Note that
E[µ∗(1, X)SX(X)] = E[µ∗(1, X)(SX(X) + SS|T,X(S, T,X) + SY |T,X,S(Y, T,X, S))]
E[E[Y SY |T=1,X(Y | T = 1, X) | T = 1, X]] = E[E[ T
e∗(X)
Y SY |T,X(Y | T,X) | X]]
= E[E[
T
e∗(X)
(Y − µ∗(T,X))SY |T,X(Y | T,X) | X]]
= E[
T
e∗(X)
(Y − µ∗(T,X))SY |T,X(Y | T,X)]
= E[
T
e∗(X)
(Y − µ∗(T,X))(SY |T,X(Y | T,X) + SX(X) + SS|T,X(S, T,X))]
Thus
∂
∂γ
E[λ1(γ)]|γ=γ∗ = E
[(
T
e∗(X)
(Y − µ∗(1, X)) + µ∗(1, X)
)
(SY |T,X(Y | T,X) + SX(X) + SS|T,X(S, T,X))
]
This implies that Te∗(X) (Y −µ∗(1, X))+µ∗(1, X) is an influence function, which can be easily shown to be orthogonal
to Λ⊥IV . Thus it is also the efficient influence function for estimating ξ
∗
1 . It then follows that ψIV (W ; δ
∗, η∗) =
µ∗(1, X)−µ∗(0, X)+ Te∗(X) (Y −µ∗(1, X))− 1−T(1−e∗(X)) (Y −µ∗(0, X))−δ∗ is the efficient influnce function for estimating
δ∗ in setting IV. Thus E[ψ2IV (W ; δ∗, η∗)] is the efficiency lower bound for δ∗ in setting IV.
Corollary D.0.2. The efficiency lower bounds for setting I-IV in Section 2 are given as follows:
V ∗I = V
∗
II = Var
{(
TR
e∗(X)r∗(1, X)
− (1− T )R
(1− e∗(X))r∗(0, X)
)
Y
}
− E
{
P(R = 0 | X)
e∗(X)r∗(1, X)
µ∗2(1, X) +
P(R = 0 | X)
e∗(X)r∗(0, X)
µ∗2(0, X)
}
− E
{(√
1− e∗(X)
e∗(X)
r∗(0, X)
r∗(1, X)
µ∗(1, X) +
√
e∗(X)
1− e∗(X)
r∗(1, X)
r∗(0, X)
µ∗(0, X)
)2}
V ∗III = Var
{(
TR
e∗(X)r∗(1, X)
− (1− T )R
(1− e∗(X))r∗(0, X)
)
Y
}
− E
{(√
1− e∗(X)
e∗(X)
µ∗(1, X) +
√
e∗(X)
1− e∗(X)µ
∗(0, X)
)2}
− E
{
1
e∗(X)
1− r∗(1, X)
r∗(1, X)
µ˜∗2(1, X, S(1)) +
1
1− e∗(X)
1− r∗(0, X)
r∗(0, X)
µ˜∗2(0, X, S(0))
}
V ∗IV = Var
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
Y
}
− E
{(√
1− e∗(X)
e∗(X)
µ∗(1, X) +
√
e∗(X)
1− e∗(X)µ
∗(0, X)
)2}
.
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Proof. Efficiency bound in setting I. The semiparametric efficiency bound is given by Var{ψI(W ; δ∗, η∗)}:
V ∗I = Var{ψI(W ; δ∗, η∗)}
= Var
{(
TR
e∗(X)r∗(1, X)
− (1− T )R
(1− e∗(X))r∗(0, X)
)
Y
}
+ Var {µ∗(1, X)− µ∗(0, X)}︸ ︷︷ ︸
V10
+ Var
{(
TR
e∗(X)r∗(1, X)
− (1− T )R
(1− e∗(X))r∗(0, X)
)
µ∗(T,X)
}
︸ ︷︷ ︸
V11
− 2 Cov
{(
TR
e∗(X)r∗(1, X)
− (1− T )R
(1− e∗(X))r∗(0, X)
)
Y,
(
TR
e∗(X)r∗(1, X)
− (1− T )R
(1− e∗(X))r∗(0, X)
)
µ∗(T,X)
}
︸ ︷︷ ︸
V12
− 2 Cov
{
µ∗(1, X)− µ∗(0, X),
(
TR
e∗(X)r∗(1, X)
− (1− T )R
(1− e∗(X))r∗(0, X)
)
µ∗(T,X)
}
︸ ︷︷ ︸
V13
+ 2 Cov
{
µ∗(1, X)− µ∗(0, X),
(
TR
e∗(X)r∗(1, X)
− (1− T )R
(1− e∗(X))r∗(0, X)
)
Y
}
︸ ︷︷ ︸
V14
Similarly to Step IV in the proof of Corollary D.0.1, we can show that
V10 = E [µ∗(1, X)− µ∗(0, X)]2 − (ξ∗1 − ξ∗0)2
V11 = V12 = E
{
µ∗2(1, X)
e∗(X)r∗(1, X)
+
µ∗2(0, X)
e∗(X)r∗(0, X)
}
− (ξ∗1 − ξ∗0)2
V13 = V14.
Therefore,
V ∗I = Var{ψI(W ; δ∗, η∗)} = Var
{(
TR
e∗(X)r∗(1, X)
− (1− T )R
(1− e∗(X))r∗(0, X)
)
Y
}
+ V10 − V11
= Var
{(
TR
e∗(X)r∗(1, X)
− (1− T )R
(1− e∗(X))r∗(0, X)
)
Y
}
− E
{(√
1− e∗(X)
e∗(X)
r∗(0, X)
r∗(1, X)
µ∗(1, X) +
√
e∗(X)
1− e∗(X)
r∗(1, X)
r∗(0, X)
µ∗(0, X)
)2}
− E
{
P(R = 0 | X)
e∗(X)r∗(1, X)
µ∗2(1, X) +
P(R = 0 | X)
e∗(X)r∗(0, X)
µ∗2(0, X)
}
.
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The second equality above holds because
V10 − V11 = E [µ∗(1, X)− µ∗(0, X)]2 − E
{
µ∗2(1, X)
e∗(X)r∗(1, X)
+
µ∗2(0, X)
e∗(X)r∗(0, X)
}
= −E
{
1− P(T = 1, R = 1 | X)
P(T = 1, R = 1 | X) µ
∗2(1, X) +
1− P(T = 0, R = 1 | X)
P(T = 0, R = 1 | X) µ
∗2(0, X)
}
− 2E {µ∗(1, X)µ∗(0, X)}
= −E
{
P(R = 1 | X)− P(T = 1, R = 1 | X)
P(T = 1, R = 1 | X) µ
∗2(1, X) +
P(R = 1 | X)− P(T = 0, R = 1 | X)
P(T = 0, R = 1 | X) µ
∗2(0, X)
}
− E
{
P(R = 0 | X)
P(T = 1, R = 1 | X)µ
∗2(1, X) +
P(R = 0 | X)
P(T = 0, R = 1 | X)µ
∗2(0, X)
}
− 2E {µ∗(1, X)µ∗(0, X)}
= −E
{
(1− e∗(X))r∗(0, X)
e∗(X)r∗(1, X)
µ∗2(1, X) +
e∗(X)r∗(1, X)
(1− e∗(X))r∗(0, X)µ
∗2(0, X)
}
− 2E {µ∗(1, X)µ∗(0, X)}
− E
{
P(R = 0 | X)
e∗(X)r∗(1, X)
µ∗2(1, X) +
P(R = 0 | X)
(1− e∗(X))r∗(0, X)µ
∗2(0, X)
}
= −E
{(√
1− e∗(X)
e∗(X)
r∗(0, X)
r∗(1, X)
µ∗(1, X) +
√
e∗(X)
1− e∗(X)
r∗(1, X)
r∗(0, X)
µ∗(0, X)
)2}
− E
{
P(R = 0 | X)
e∗(X)r∗(1, X)
µ∗2(1, X) +
P(R = 0 | X)
e∗(X)r∗(0, X)
µ∗2(0, X)
}
.
Efficiency lower bound in setting II. From the proof of Theorem 2.2, we know that V ∗2 = V
∗
1 .
Efficiency lower bound in setting III. The conclusion follows directly from Corollary D.0.1 by noting that
r∗(t,X, S) = r∗(t,X).
Efficiency lower bound in setting IV. The efficiency lower bound is given by E{ψ2IV (W ; δ∗, η∗)}:
V ∗IV = E{ψ2IV (W ; δ∗, η∗)}
= Var
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
Y
}
+ Var {µ∗(1, X)− µ∗(0, X)}+ Var
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
µ∗(T,X)
}
+ 2 Cov
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
Y, µ∗(1, X)− µ∗(0, X)
}
− 2 Cov
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
µ∗(T,X), µ∗(1, X)− µ∗(0, X)
}
− 2 Cov
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
Y,
(
T
e∗(X)
− 1− T
1− e∗(X)
)
µ∗(T,X)
}
.
Analogously to step IV in the proof of Corollary D.0.1, we can show that
Var
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
µ∗(T,X)
}
= Cov
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
Y,
(
T
e∗(X)
− 1− T
1− e∗(X)
)
µ∗(T,X)
}
= E
{
1
e∗(X)
µ∗2(1, X) +
1
1− e∗(X)µ
∗2(0, X)
}
− (λ∗1 − λ∗0)2
Cov
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
Y, µ∗(1, X)− µ∗(0, X)
}
= Cov
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
µ∗(T,X), µ∗(1, X)− µ∗(0, X)
}
.
Thus
Var{ψIV (W ; δ∗, η∗)}
= Var
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
Y
}
− E
{
1
e∗(X)
µ∗2(1, X) +
1
1− e∗(X)µ
∗2(0, X)
}
+ E [µ∗(1, X)− µ∗(0, X)]2
= Var
{(
T
e∗(X)
− 1− T
1− e∗(X)
)
Y
}
− E
{(√
1− e∗(X)
e∗(X)
µ∗(1, X) +
√
e∗(X)
1− e∗(X)µ
∗(0, X)
)2}
.
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Proof for corollary 2.2.1. According to corollary D.0.2 and corollary D.0.1, we can verify that
V ∗I − V ∗III = V ∗II − V ∗III
= E
{(√
1− e∗(X)
e∗(X)
µ∗(1, X) +
√
e∗(X)
1− e∗(X)µ
∗(0, X)
)2}
− E
{
P(R = 0 | X)
e∗(X)r∗(1, X)
µ∗2(1, X) +
P(R = 0 | X)
e∗(X)r∗(0, X)
µ∗2(0, X)
}
− E
{(√
1− e∗(X)
e∗(X)
r∗(0, X)
r∗(1, X)
µ∗(1, X) +
√
e∗(X)
1− e∗(X)
r∗(1, X)
r∗(0, X)
µ∗(0, X)
)2}
+ E
{
1
e∗(X)
1− r∗(1, X)
r∗(1, X)
µ˜∗2(1, X, S(1)) +
1
1− e∗(X)
1− r∗(0, X)
r∗(0, X)
µ˜∗2(0, X, S(0))
}
= E
{
1− e∗(X)
e∗(X)
µ∗2(1, X) +
e∗(X)
1− e∗(X)µ
∗2(0, X)
}
+ 2E {µ∗(1, X)µ∗(0, X)}
− E
{
1− P(T = 1, R = 1 | X)
P(T = 1, R = 1 | X) µ
∗2(1, X) +
1− P(T = 0, R = 1 | X)
P(T = 0, R = 1 | X) µ
∗2(0, X)
}
− 2E {µ∗(1, X)µ∗(0, X)}
+ E
{
1
e∗(X)
1− r∗(1, X)
r∗(1, X)
µ˜∗2(1, X, S(1)) +
1
1− e∗(X)
1− r∗(0, X)
r∗(0, X)
µ˜∗2(0, X, S(0))
}
= E
{
1− e∗(X)
e∗(X)
µ∗2(1, X) +
e∗(X)
1− e∗(X)µ
∗2(0, X)
}
− E
{
1− e∗(X)r∗(1, X)
e∗(X)r∗(1, X)
µ∗2(1, X) +
1− (1− e∗(X))r∗(0, X)
(1− e∗(X))r∗(0, X) µ
∗2(0, X)
}
+ E
{
1
e∗(X)
1− r∗(1, X)
r∗(1, X)
µ˜∗2(1, X, S(1)) +
1
1− e∗(X)
1− r∗(0, X)
r∗(0, X)
µ˜∗2(0, X, S(0))
}
= E
{
1
e∗(X)
1− r∗(1, X)
r∗(1, X)
(µ˜∗2(1, X, S(1))− µ∗2(1, X)) + 1
1− e∗(X)
1− r∗(0, X)
r∗(0, X)
(µ˜∗2(0, X, S(0))− µ∗2(0, X))
}
Furthermore,
V ∗III − V ∗IV
= Var
{(
TR
e∗(X)r∗(1, X)
− (1− T )R
(1− e∗(X))r∗(0, X)
)
Y
}
−Var
{(
T
e∗(X)
− (1− T )
(1− e∗(X))
)
Y
}
− E
{
1
e∗(X)
1− r∗(1, X)
r∗(1, X)
µ˜∗2(1, X, S(1)) +
1
1− e∗(X)
1− r∗(0, X)
r∗(0, X)
µ˜∗2(0, X, S(0))
}
= E
{
1
e∗(X)r∗(1, X)
Y 2(1) +
1
e∗(X)r∗(0, X)
Y 2(0)
}
− (ξ∗1 − ξ∗0)2 − E
{
1
e∗(X)
Y 2(1) +
1
e∗(X)
Y 2(0)
}
+ (ξ∗1 − ξ∗0)2
− E
{
1
e∗(X)
1− r∗(1, X)
r∗(1, X)
µ˜∗2(1, X, S(1)) +
1
1− e∗(X)
1− r∗(0, X)
r∗(0, X)
µ˜∗2(0, X, S(0))
}
= E
{
1
e∗(X)
1− r∗(1, X)
r∗(1, X)
(Y 2(1)− µ˜∗2(1, X, S(1))) + 1
1− e∗(X)
1− r∗(0, X)
r∗(0, X)
(Y 2(0)− µ˜∗2(0, X, S(0)))
}
.
D.3 Proofs for section 3
Proof for theorem 3.1. We show the consistency for
ξˆ1 =
1
K
K∑
i=1
Eˆn,k
{
µˆk(1, X) +
TR
eˆk(X)rˆk(1, X, S)
(Y − ˆ˜µk(1, X, S)) + T
eˆk(X)
(ˆ˜µk(1, X, S)− µˆk(1, X))
}
.
It is straightforward to verify that
ξˆ1 − ξ∗1 =
1
N
N∑
i=1
{
Yi(1)− λ∗1 +
Ti(Ri − r0(1, Xi, Si))
e0(Xi)r0(1, Xi, Si)
(Y (1)− µ˜0(1, Xi, Si)) + Ti − e0(Xi)
e0(Xi)
(Yi(1)− µ0(1, Xi))
}
+R (31)
41
where the remainder R is given by the following
R = 1
K
K∑
k=1
{
Eˆn,k
T
eˆk(X)
(
R
rˆk(1, X, S)
− R
r0(1, X, S)
)(Yi − µ˜0(1, X, S))︸ ︷︷ ︸
Rk,1
+Eˆn,k
R
r0(X)
(
T
eˆk(X)
− T
e0(X)
)(Yi − µ˜0(1, X, S))︸ ︷︷ ︸
Rk,2
+ Eˆn,k
T
eˆk(X)
(
R
rˆk(1, X, S)
− R
r0(1, X, S)
)(µ˜0(1, X, S)− ˆ˜µ(1, X, S))︸ ︷︷ ︸
Rk,3
+Eˆn,k (
T
eˆk(X)
− T
e0(X)
)(ˆ˜µ(1, X, S)− µ˜0(1, X, S))︸ ︷︷ ︸
Rk,4
+ Eˆn,k
R
r0(X)
(
T
eˆk(X)
− T
e0(X)
)(µ˜0(1, X, S)− ˆ˜µ(1, X, S))︸ ︷︷ ︸
Rk,5
+Eˆn,k (
T
eˆk(X)
− T
e0(X)
)(µ0(1, X)− µˆ(1, X))︸ ︷︷ ︸
Rk,6
+ Eˆn,k (1− T
e0(X)
)(µˆ(1, X)− µ0(1, X))︸ ︷︷ ︸
Rk,7
+Eˆn,k
T
e0(X)
(1− R
r0(1, X, S)
)(ˆ˜µ(1, X, S)− µ˜0(1, X, S))︸ ︷︷ ︸
Rk,8
+ Eˆn,k (
T
eˆk(X)
− T
e0(X)
)(µ˜0(1, X, S)− µ0(1, X))︸ ︷︷ ︸
Rk,9
}
(32)
In the following part, we will bound Eˆn,kRk,j for a generic k ∈ {1, . . . ,K} and j = 1, . . . , 9. Then 1K
∑K
k=1 Eˆn,kRk,j
will have the same asymptotic order, since K is a fixed number that does not change with N . We will extensively use
the fact that for k = 1, . . . ,K and t = 0, 1, ‖µˆk(t,X) − µ0(t,X)‖2 = Op(ρN,µ), ‖ ˆ˜µk(t,X, S(t)) − µ˜0(t,X, S(t))‖2 =
Op(ρN,µ˜), ‖rˆk(t,X, S(t))− r0(t,X, S(t))‖2 = Op(ρN,r), and ‖µ˜0(t,X, S(t))− µ˜∗(t,X, S(t))‖2, ‖µ0(t,X)− µ∗(t,X)‖2
are almost surely bounded, according to Lemma D.6.
Bounding Eˆn,kRk,1 and Eˆn,kRk,2. Note that
EIk
{ T
eˆk(X)
(
R
rˆk(1, X, S(1))
− R
r0(1, X, S(1))
)(Y (1)− µ˜0(1, X, S))
}
≤ (1− )
2
3
EIk
{
(rˆk(1, X, S(1))− r0(1, X, S(1)))(Y (1)− µ˜∗(1, X, S(1)))
}
+
(1− )2
3
EIk
{
(rˆk(1, X, S(1))− r0(1, X, S(1)))(µ˜∗(1, X, S(1))− µ˜0(1, X, S(1)))
}
≤ (1− )
2
3
‖rˆk(1, X, S(1))− r0(1, X, S(1))‖2
(‖Var{Y | X,S, T}‖∞
+ ‖µ˜0(1, X, S(1))− µ˜∗(1, X, S(1))‖2
)
= Op(ρN,r).
where the second inequality uses Cauchy-Schwartz inequality. Plus,
EIk
{ T
eˆk(X)
(
R
rˆk(1, X, S(1))
− R
r0(1, X, S(1))
)(Y − µ˜∗(1, X, S))}2
≤ (1− )
2
6
(
E[(rˆk(1, X, S(1))− r0(1, X, S(1)))2(Y (1)− µ˜∗(1, X, S))2]
)
+
(1− )2
6
(
E[(rˆk(1, X, S(1))− r0(1, X, S(1)))2(µ˜0(1, X, S)− µ˜∗(1, X, S))2]
)
=
(1− )2
6
E
{
(rˆk(1, X, S(1))− r0(1, X, S(1)))2 [Var[Y (1) | X,S, T = 1] + C]
}
= O(ρ2N,r).
Then by Markov inequality, Eˆn,kRk,1 = Op(ρN,r) +Op(ρN,r/
√
n) = Op(ρN,r) +Op(ρN,r/
√
N) = op(1).
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Bounding Eˆn,kRk,3 ∼ Eˆn,kRk,6. Note that
EIk
{ T
eˆk(X)
(
R
rˆk(1, X, S(1))
− R
r0(1, X, S(1))
)(µ˜0(1, X, S(1))− ˆ˜µ(1, X, S(1)))
}
≤ (1− )
2
3
(‖rˆk(1, X, S(1))− r0(1, X, S(1))‖2‖ ˆ˜µ(1, X, S(1))− µ˜0(1, X, S(1))‖2) = O(ρN,rρN,µ˜) (33)
EIk
{ T
eˆk(X)
(
R
rˆk(1, X, S(1))
− R
r0(1, X, S(1))
)(µ˜0(1, X, S(1))− ˆ˜µ(1, X, S(1)))
}2
(34)
≤ (1− )
2
6
‖ ˆ˜µ(1, X, S(1))− µ˜0(1, X, S(1))‖22 = O(ρ2N,µ˜)
Thus Eˆn,kRk,3 = Op(ρN,rρN,µ˜ + ρN,µ˜/N1/2) = op(1), and similarly Eˆn,kRk,4 ∼ Eˆn,kRk,6 are all op(1).
Bounding Eˆn,kRk,7, Eˆn,kRk,8. Note that
EIk
{
(1− T
e0(X)
)(ˆ˜µ(1, X)− µ˜0(1, X))
}
= 0
EIk
{
(1− T
e0(X)
)(ˆ˜µ(1, X)− µ˜0(1, X))
}2 ≤ 1− 2
2
‖ ˆ˜µ(1, X)− µ˜0(1, X)‖22 = O(ρ2N,µ˜).
So Eˆn,kRk,7 = Op(ρN,µ˜/N1/2) = op(1), and similarly Eˆn,kRk,8 = op(1).
Bounding Eˆn,kRk,9. Note that
EIk
{
(
T
eˆk(X)
− T
e0(X)
)(µ˜0(1, X, S(1))− µ0(1, X))
}
= EIk
{
(
T
eˆk(X)
− T
e0(X)
)(µ˜0(1, X, S(1))− µ˜∗(1, X, S(1)))
}
+ EIk
{
(
T
eˆk(X)
− T
e0(X)
)(µ˜∗(1, X, S(1))− µ∗(1, X))}
+ EIk
{
(
T
eˆk(X)
− T
e0(X)
)(µ∗(1, X)− µ0(1, X))
}
≤ 1− 
2
‖eˆk(X)− e0(X)‖2‖µ˜0(1, X, S(1))− µ˜∗(1, X, S(1))‖2
+ 0 +
1− 
2
‖eˆk(X)− e0(X)‖2‖µ∗(1, X)− µ0(1, X)‖2
= Op(ρN,e),
where the second inequality holds because of Cauchy-Schwarz inequality and
EIk
{
(
T
eˆk(X)
− T
e0(X)
)(µ˜∗(1, X, S(1))− µ∗(1, X))}
=EIk
{
(
e∗(X)
eˆk(X)
− e
∗(X)
e0(X)
)E[µ˜∗(1, X, S(1))− µ∗(1, X) | X]}
=EIk
{(e∗(X)
eˆk(X)
− e
∗(X)
e0(X)
)
E
[
E[Y | X,S(1), T = 1, R = 1]− E[Y | X,T = 1, R = 1] | X,T = 1, R = 1]} = 0.
Moreover,
EIk
{
(
T
eˆk(X)
− T
e0(X)
)(µ˜0(1, X, S)− µ0(1, X))
}2
≤ 1− 
4
E
{
(eˆk(X)− e0(X))2
[
[µ˜0(1, X, S(1))− µ˜∗(1, X, S(1))]2 + Var{µ˜∗(T,X, S) | T,X}+ [µ∗(1, X)− µ0(1, X)]2
]}
≤ 3(1− )C
4
.
Thus Eˆn,kRk,9 = Op(ρN,e +N−1/2) = op(1).
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Double Robustness Analysis. The bounds above imply that
ξˆ1 − ξ∗1 =
1
N
N∑
i=1
{
Yi(1)− ξ∗1 +
T (R− r0(1, X, S))
e0(X)r0(1, X, S)
(Y (1)− µ˜0(1, X, S)) + T − e0(X)
e0(X)
(Y (1)− µ0(1, X))
}
+ op(1)
Note that
Var
{
Y (1)− ξ∗1 +
T (R− r0(X))
e0(X)r0(1, X, S)
(Y (1)− µ˜0(1, X, S)) + T − e0(X)
e0(X)
(Y (1)− µ0(1, X))
}
≤ 2 Var{Y (1)}+ 2
4
Var{Y (1)− µ˜0(1, X, S(1))}+ 2
2
Var{Y (1)− µ0(1, X)}
≤ 2 Var{Y (1)}+ 4
4
{
E[Var{Y (1) | X,S(1)}] + Var{µ˜∗(1, X, S(1))− µ˜0(1, X, S(1))}
}
+
4
2
{
E[Var{Y (1) | X}] + Var{µ˜∗(1, X)− µ˜0(1, X)}
}
≤ 2‖Y (1)‖22 +
4
4
(‖Var{Y (1) | X,S(1)}‖∞ + ‖µ˜∗(1, X, S(1))− µ˜0(1, X, S(1))}‖22)
+
4
2
(‖Var{Y (1) | X}‖∞ + ‖µ˜∗(1, X)− µ˜0(1, X)}‖22) ≤ (2 +
8
4
+
8
2
)C.
Then Markov inequality again implies that
ξˆ1 − ξ∗1
= E
{
Y (1)− ξ∗1 +
T (R− r0(1, X, S(1)))
e0(X)r0(1, X, S(1))
(Y (1)− µ˜0(1, X, S(1))) + T − e0(X)
e0(X)
(Y (1)− µ0(1, X))
}
+ op(1)
= E
{
e∗(X)(r∗(1, X, S(1))− r0(1, X, S(1)))
e0(X)r0(1, X, S(1))
(µ˜∗(1, X, S(1))− µ˜0(1, X, S(1)))
+
e∗(X)− e0(X)
e0(X)
(µ∗(1, X)− µ0(1, X))
}
+ op(1) = op(1)
Similarly, we can prove that ξˆ0 − ξ∗0 = op(1). Thus δˆ − δ∗ = op(1).
Proof for theorem 3.2. Here, if we can prove that Eˆn,kRk,j for j = 1, . . . , 9 in eq. (32) are all op(N−1/2), then eq. (32)
implies that
√
N(ξˆ1 − ξ∗1) =
1√
N
N∑
i=1
ψ1(W ; ξ
∗
1 , η
∗) + op(1).
By the same token,
√
N(ξˆ0 − ξ∗0) =
1√
N
N∑
i=1
ψ0(W ; ξ
∗
1 , η
∗) + op(1).
As a result,
√
N(δˆ − δ∗) = 1√
N
N∑
i=1
ψ(W ; ξ∗1 , η
∗) + op(1).
Then central limit theorem implies the asserted conclusion.
Now we prove that Eˆn,kRk,j for j = 1, . . . , 9 in eq. (32) are all op(N−1/2).
Since all nuisance estimators are correctly specified, by following the proof of Theorem 3.1, we can show that
EIk [Rk,1] = EIk [Rk,2] = EIk [Rk,7] = EIk [Rk,8] = EIk [Rk,9] = 0 and EIk [Rk,3] = O(ρN,rρN,µ˜), EIk [Rk,4] =
O(ρN,eρN,µ˜), EIk [Rk,5] = O(ρN,eρN,µ˜), EIk [Rk,6] = O(ρN,eρN,µ). Moreover, we can analogously bound EIk [R2k,j ]
respectively:
EIk [R2k,1] = O(ρ2N,r), EIk [R2k,2] = O(ρ2N,e), EIk [R2k,3] = O(ρ2N,µ˜),
EIk [R2k,4] = O(ρ2N,µ˜), EIk [R2k,5] = O(ρ2N,µ˜), EIk [R2k,6] = O(ρ2N,µ),
EIk [R2k,7] = O(ρ2N,µ), EIk [R2k,8] = O(ρ2N,µ˜), EIk [R2k,9] = O(ρ2N,e).
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Then by Markov inequality and Lemma 6.1 in Chernozhukov et al. [2018],
{Rj}9j=1 = Op
(
ρN,rρN,µ˜ + ρN,eρN,µ˜ + ρN,eρN,µ + n
−1/2(ρN,r + ρN,e + ρN,µ + ρN,µ˜)
)
= op(n
−1/2) = op(N−1/2).
Proof for theorem 3.3. Again, we prove the result for ξˆ1 that estimates ξ
∗
1 we introduced in the proof of Theorem 3.1.
Then the conclusion for δˆ that estimates δ∗ can be proved analogously.
Since
|Vˆ − V ∗| = |Vˆ − E[ψ2(W ; δ∗, η∗)]| = 1
K
K∑
k=1
|Eˆn,k[ψ2(W ; δˆ, ηˆk)]− E[ψ2(W ; δ∗, η∗)]|,
We only need to prove that |Eˆn,k[ψ2(W ; δˆ, ηˆk)]− E[ψ2(W ; δ∗, η∗)]| = op(1). Consider the following decomposition:
|Eˆn,k[ψ2(W ; δˆ, ηˆk)]− E[ψ2(W ; δ∗, η∗)]| ≤ |Eˆn,k[ψ2(W ; δˆ, ηˆk)]− Eˆn,k[ψ2(W ; δ∗, η∗)]|
+ |Eˆn,k[ψ2(W ; δ∗, η∗)]− E[ψ2(W ; δ∗, η∗)]|
= R10 +R11.
Thus we only need to prove that both R10 and R11 are op(1).
Bounding R11. According to Lemma D.6,
‖ψ(W ; δ∗, η∗)‖q ≤ 1
2
(‖Y (1)‖q + ‖Y (0)‖q) + 1 + 
2
(‖µ˜∗(1, X, S(1))‖q + ‖µ˜∗(0, X, S(0))‖q)
+
1 + 

(‖µ∗(1, X)‖q + ‖µ∗(0, X)‖q) ≤
[
2
2
+
2(1 + )
2
+
2(1 + )

]
C.
If q in assumption 5 satisfies that q ≥ 4, then
E[R211] =
1
n
Var{ψ2(W ; δ∗, η∗)} ≤ 1
n
Var{ψ4(W ; δ∗, η∗)}.
By Markov inequality, R11 = Op(N−1/2).
If 2 < q < 4, then we apply the von Bahr-Esseen inequality with p = q/2 ∈ (1, 2):
E[Rq/211 ] ≤ 2n−q/2+1E[ψq(W ; δ∗, η∗)] = 2n−q/2+1‖ψ(W ; δ∗, η∗)‖qq.
Thus E[Rq/211 ] = O(2N−q/2+1), which implies that R11 = Op(N−1+2/q) according to Markov inequality.
Therefore
R11 = Op(N−[(1−2/q)∨1/2]) = op(1).
Bounding R10. Simple algebra shows that for any a, δa,
(a+ δa)2 − a2 = δa(2a+ δa).
Now take a+ δa = ψ(W ; δˆ, ηˆk) and a = ψ(W ; δ
∗, η∗), then
|Eˆn,k[ψ2(W ; δˆ, ηˆk)]− Eˆn,k[ψ2(W ; δ∗, η∗)]|
=
∣∣∣∣Eˆn,k(ψ(W ; δˆ, ηˆk)− ψ(W ; δ∗, η∗))(2ψ(W ; δ∗, η∗) + ψ(W ; δˆ, ηˆk)− ψ(W ; δ∗, η∗))∣∣∣∣
≤
(
Eˆn,k
[
ψ(W ; δˆ, ηˆk)− ψ(W ; δ∗, η∗)
]2)1/2(Eˆn,k[2ψ(W ; δ∗, η∗) + ψ(W ; δˆ, ηˆk)− ψ(W ; δ∗, η∗)]2)1/2
≤R1/212 × (R1/212 + 2(Eˆn,k[ψ2(W ; δ∗, η∗)])1/2).
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where R12 = Eˆn,k
[
ψ(W ; δˆ, ηˆk)− ψ(W ; δ∗, η∗)
]2
.
Since E[ψ2(W ; δ∗, η∗)] = O(1), Markov inequality implies that Eˆn,k[ψ2(W ; δ∗, η∗)] = Op(1).
Moreover,
R12 ≤ 2Eˆn,k(δˆ − δ∗)2 + 2Eˆn,k
[
ψ(W ; δ∗, ηˆk)− ψ(W ; δ∗, η∗)
]2
.
Since δˆ− δ∗ = op(1) according to theorem 3.1, thus we only need to prove Eˆn,k
[
ψ(W ; δ∗, ηˆk)−ψ(W ; δ∗, η∗)
]2
= op(1)
as well. According to the decomposition in eq. (32), this means that we need to prove that Eˆn,kR2k,j = op(1) for
j = 1, . . . , 9 and a generic k ∈ {1, . . . ,K}. This can be analogously shown to be true by following the proof of
theorem 3.1 and bounding each term respectively.
Therefore, Vˆ = V ∗ + op(1), and by Slutsky’s theorem,√
N(δˆ − δ∗)√
Vˆ
d→ N (0, 1),
so that P(δ∗ ∈ CI)→ 1− α.
D.4 Proofs for section 4
Proof for theorem 4.1. We prove a more general conclusion without assuming R ⊥ T | X. The asserted conclusion
in this theorem then follows straightforwardly. Note that here we only observe the labelled data, so all distributions
of the observed data are conditional distributions given R = 1. These conditional distributions, as we assumed, are
not dependent on the sample size N . Also the ATE is defined in terms of P that does not depend on sample size N
as well. Thus throughout the proof, all observed data are i.i.d samples from a fixed distribution that does not vary
with sample size N . This means that we can directly apply standard semiparametric efficiency theory, and do not
need to customize the efficiency theory to N -dependent data generating process [e.g., Jankova et al., 2018].
Note that we assume the distribution of (X,T, S) is known. According to Assumption 3 that R ⊥ S(t) | T,X, the
distribution of S given T,X and R = 1 is also known: for any s ∈ S and x ∈ X ,
P(S ≤ s | X = x, T = t, R = 1) = P(S(t) ≤ s | X = x, T = t, R = 1)
= P(S(t) ≤ s | X = x, T = t)
= P(S ≤ s | X = x, T = t).
We introduce the following notations: we use f∗S|X,T,R=1(s, x, t) to denote the density function of the distribution of
S given T,X and R = 1. Moreover, we denote e∗(1, x) := P(T = 1 | R = 1, X = x), e∗(1, x, s) := P(T = 1 | R =
1, X = x, S(1) = s) for any x ∈ X and s ∈ S.
Since we only observe the labelled data, we consider the following model for the distribution of the observed data
M˜np =
{
fX,T,S,Y |R=1(X,T, S, Y | R = 1) = fX|R=1(X | R = 1)
[
e(1, X)T (1− e(1, X))1−T ]f∗S|X,T,R=1(S | X,T,R = 1)
× fY |S,T,X,R=1(Y, S, T,X | R = 1) : ∀e(1, X) ∈ [, 1− ],
fX|R=1, and fY |S,T,X,R=1are arbitrary density functions
}
First, note that under Assumptions 1 and 3,
ξ∗1 = E[Y (1)] =
∫
f∗X(x)E[Y (1) | X = x]dx
=
∫
f∗X(x)E[Y (1) | X = x, T = 1, R = 1]dx
=
∫∫
f∗X(x)f
∗
S|X,T=1,R=1(s | x, T = 1, R = 1)E[Y | X = x, S = s, T = 1, R = 1]dsdx
=
∫∫∫
yf∗X(x)f
∗
S|X,T=1,R=1(s | x, T = 1, R = 1)f∗Y |X,S,T=1,R=1(y | s, x, T = 1, R = 1)dydsdx.
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Here both f∗X and f
∗
S|X,T=1,R=1 are known according to our assumption that we know the distribution of (X,T, S).
So the only unknown part that requires modeling and contributes to the definition of ξ∗1 is the distribution of Y given
S, T,X,R.
Therefore, the efficiency lower bound of estimating ξ∗1 under model Mnp is the same as that under the following
model Mfix that fixes all components but the distribution of Y given S, T,X,R = 1 at truth:
Mfix =
{
fX,T,S,Y |R=1(X,T, S, Y | R = 1) = f∗X|R=1(X | R = 1)
[
e∗(1, X)T (1− e∗(1, X))1−T ]
× f∗S|X,T,R=1(S | X,T,R = 1)fY |S,T,X,R=1(Y, S, T,X | R = 1) : fY |S,T,X,R=1is an arbitrary density function
}
It is easy to verify that the tangent space of Mfix and its orthogonal complement are
Λfix = {SY |X,T,S,R=1(Y,X, T, S) ∈ L2(P ) : E[SY |X,T,S,R=1(Y,X, T, S) | X,T, S,R = 1] = 0},
Λ⊥fix = {SX,T,S|R=1(X,T, S) ∈ L2(P ) : E[SX,T,S|R=1(X,T, S) | R = 1] = 0}.
Again we consider smooth and regular parametric submodels indexed by γ when analyzing path-differentiability of
ξ∗1 . In the following part, we suppress the subscripts in the density functions f
∗, and the meaning of the density
functions should be self-evident from the arguments. For example, f∗(x) is the density for X.
∂
∂γ
Eγ [Y (1)]|γ=γ∗ =
∫
f∗(x)f∗(s | X = x, T = 1, R = 1) ∂
∂γ
Eγ [Y | X = x, S = s, T = 1, R = 1]|γ=γ∗dxds
=
∫
f∗(x)f∗(s | X = x, T = 1, R = 1)
× E[Y SY |X,S,T=1,R=1(Y,X, S(1), T = 1, R = 1; γ∗) | X = x, S(1) = s, T = 1, R = 1]dxds
=
∫
f∗(x)f∗(s | X = x, T = 1, R = 1)
× E[ T
e∗(1, X, S(1))
(Y − µ∗(T,X, S(1)))SY |X,S,T,R=1(Y,X, S(1), T,R = 1; γ∗) | X = x, S(1) = s,R = 1]dxds
=
∫
f∗(x)f∗S(1)|X,R=1(s | X = x,R = 1)
× E[ T
e∗(1, X)
(Y − µ∗(T,X, S(1)))SY |X,S,T,R=1(Y,X, S(1), T,R = 1; γ∗) | X = x, S(1) = s,R = 1]dxds
=
∫
f∗(x)E[
T
e∗(1, X)
(Y − µ∗(T,X, S))SY |X,S,T,R=1(Y,X, S, T,R = 1; γ∗) | X = x,R = 1]dx
= E[
f∗(X)
f∗(X | R = 1)
T
e∗(1, X)
(Y − µ∗(T,X, S))SY |X,S,T,R=1(Y,X, S, T,R = 1; γ∗) | R = 1].
Here the fourth equality holds because under Assumption 3 and Assumption 1 condition (2),
e∗(1, X, S(1)) = P(T = 1 | R = 1, X, S(1)) = P(R = 1 | T = 1, X, S(1))P(T = 1 | X,S(1))∑
t=0,1 P(R = 1 | T = t,X, S(1))P(T = t | X,S(1))
=
P(R = 1 | T = 1, X)P(T = 1 | X)∑
t=0,1 P(R = 1 | T = t,X)P(T = t | X)
= e∗(1, X)
and
f∗S|X,T=1,R=1(s | X = x, T = 1, R = 1) = f∗S(1)|X(s | X = x) = f∗S(1)|X,R=1(s | X = x,R = 1).
It is easy to verify that f
∗(X)
f∗(X|R=1)
T
e∗(1,X) (Y − µ∗(T,X, S)) is orthogonal to Λ⊥fix, thus it is exactly the efficient
influence function for ξ∗1 . Similarly we can prove that the efficient influence function for ξ
∗
0 is
f∗(X)
f∗(X|R=1)
1−T
1−e∗(1,X) (Y −
µ∗(T,X, S)), and the efficient influence function for δ∗ is the difference between the efficient influence functions for
ξ∗1 and ξ
∗
0 .
When R ⊥ T | X indeed holds, we know that e∗(1, X) = e∗(0, X) = e∗(X), which implies the asserted conclusion.
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Proof for theorem 4.2. We prove the result for estimator ξ˜1 that estimates ξ
∗
1 = E[Y (1)]. We can analogously prove
the result for ξ˜∗0 and δ˜. Note that we allow the data generating process to depend on N and the observations form
a triangular array {Wi,N = (Xi,N , Ti,N , Si,N , Ri,N , Yi,N ) : i = 1, . . . , N}. We denote the expectation and variance
under distribution PN as EN and VarN respectively. Note that once conditional on Ri,N = 1, they are the same as
expectation and variance under the distribution of P given R = 1.
According to eq. (13), the estimator λ˜1 corresponding to δ˜ is
ξ˜1 =
1
K
K∑
k=1
Eˆn,k
{
µˆk(1, X) +
T
eˆk(X)
(ˆ˜µk(1, X, S)− µˆk(1, X)) + λˆk(X)R
rˆN
T
eˆk(X)
(Y − ˆ˜µk(1, X, S))
}
.
Following the decomposition in eq. (32), we can similarly decompose ξˆ1 − ξ∗1 in the following way:
ξˆ1 − ξ∗1 =
1
N
N∑
i=1
{
µ˜(1, Xi,N ) +
Ti
e∗(Xi,N )
(µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N )) + λ
∗(Xi,N )Ri,N
rˆN
Ti,N
e∗(Xi,N )
(Yi,N − µ˜∗(1, Xi,N , Si,N ))
}
+
1
K
K∑
k=1
{
Eˆn,k
[
R
rˆN
T
eˆk(X)
(λˆk(X)− λ∗(X))(Y − µ˜∗(1, X, S))
]
︸ ︷︷ ︸
Rk,12
+Eˆn,k
[
Rλ∗(X)
rˆN
(
T
eˆk(X)
− T
e∗(X)
)(Y − µ˜∗(1, X, S))
]
︸ ︷︷ ︸
Rk,13
+ Eˆn,k
[
(
T
eˆk(X)
− T
e∗(X)
)(ˆ˜µk(1, X, S)− µ˜∗(1, X, S))
]
︸ ︷︷ ︸
Rk,14
+Eˆn,k
[
R
rˆN
T
eˆk(X)
(λˆk(X)− λ∗(X))(µ˜∗(1, X, S)− ˆ˜µk(1, X, S))
]
︸ ︷︷ ︸
Rk,15
+ Eˆn,k
[
Rλ∗(X)
rˆN
(
T
eˆk(X)
− T
e∗(X)
)(µ˜∗(1, X, S)− ˆ˜µk(1, X, S))
]
︸ ︷︷ ︸
Rk,16
+ Eˆn,k
[
(
T
eˆk(X)
− T
e∗(X)
)(µ∗(1, X)− µˆk(1, X))
]
︸ ︷︷ ︸
Rk,17
+Eˆn,k
[
(1− T
e∗(X)
)(µˆk(1, X)− µ∗(1, X))
]
︸ ︷︷ ︸
Rk,18
+ Eˆn,k
[
(
T
eˆk(X)
− T
e∗(X)
)(µ˜∗(1, X, S)− µ∗(1, X))
]
︸ ︷︷ ︸
Rk,19
+Eˆn,k
[
T
e∗(X)
(1− R
rˆN
λ∗(X))(ˆ˜µk(1, X, S)− µ˜0(1, X, S))
]
︸ ︷︷ ︸
Rk,20
}
(35)
We can follow the proof in theorem 3.2 to show that
|Eˆn,kRk,14| = Op(ρN,eρN l,µ˜) + op(ρN l,µ˜N−1/2), |Eˆn,kRk,17| = Op(ρN,eρN l,µ) + op(ρN l,µN−1/2),
|Eˆn,kRk,18| = Op(ρN l,µN−1/2), |Eˆn,kRk,19| = Op(ρN,eN−1/2).
We need extra care to bound Eˆn,kRk,j for j = 12, 13, 15, 16, 20 since they involve rˆN that is a random variable
depending on all data. We take |Eˆn,kRk,12| as an example.
Eˆn,kRk,12 = 1
N/K
∑
i∈Ik
{
Ri,N
rˆN
Ti,N
eˆk(Xi,N )
(λˆk(Xi,N )− λ∗(Xi,N ))(Yi,N − µ˜∗(1, Xi,N , Si,N ))
}
=
1
N/K
∑
i∈Ik
{
Ri,N
rN
Ti,N
eˆk(Xi,N )
(λˆk(Xi,N )− λ∗(Xi,N ))(Yi,N − µ˜∗(1, Xi,N , Si,N ))
}
+ rN
(
1
rˆN
− 1
rN
)
1
N/K
∑
i∈Ik
{
Ri,N
rN
Ti,N
eˆk(Xi,N )
(λˆk(Xi,N )− λ∗(Xi,N ))(Yi,N − µ˜∗(1, Xi,N , Si,N ))
}
.
According to Lemma D.5, rN
(
1
rˆN
− 1rN
)
= op(1), thus
Eˆn,kRk,12 = (1 + op(1)) 1
N/K
∑
i∈Ik
{
Ri,N
rN
Ti,N
eˆk(Xi,N )
(λˆk(Xi,N )− λ∗(Xi,N ))(Yi,N − µ˜∗(1, Xi,N , Si,N ))
}
.
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Note that
EIk
{
Ri,N
rN
Ti,N
eˆk(Xi,N )
(λˆk(Xi,N )− λ∗(Xi,N ))(Yi,N − µ˜∗(1, Xi,N , Si,N ))
}
=EIk [
Ti,N
eˆk(Xi,N )
(λˆk(Xi,N )− λ∗(Xi,N ))(Yi,N − µ˜∗(1, Xi,N , Si,N )) | Ri,N = 1]
=EIk [
Ti,N
eˆk(Xi,N )
(λˆk(Xi,N )− λ∗(Xi,N ))(E[Yi,N | Ri,N = 1, Ti,N , Xi,N , Si,N ]− µ˜∗(Ti,N , Xi,N , Si,N )) | Ri,N = 1] = 0.
and
VarIk
{
(N l)
1/2
N/K
∑
i∈Ik
[
Ri,N
rN
Ti,N
eˆk(Xi,N )
(λˆk(Xi,N )− λ∗(Xi,N ))(Yi,N − µ˜∗(1, Xi,N , Si,N ))
]}
= KrNEIk
[
Ri,N
r2N
Ti,N
eˆk(Xi,N )
(λˆk(Xi,N )− λ∗(Xi,N ))2(Yi,N − µ˜∗(1, Xi,N , Si,N ))2
]
= KEIk
[
Ti,N
eˆk(Xi,N )
(λˆk(Xi,N )− λ∗(Xi,N ))2(Yi,N − µ˜∗(1, Xi,N , Si,N ))2 | Ri,N = 1
]
≤ K

EIk
[
(λˆk(Xi,N )− λ∗(Xi,N ))2 Var (Yi,N | 1, Xi,N , Si,N ) | Ri,N = 1
]
≤ KC

EIk
[
(λˆk(Xi,N )− λ∗(Xi,N ))2 | Ri,N = 1
]
= Op(ρN l,λ).
By Markov inequality, we know that |Eˆn,kRk,12| = Op(ρN l,λN
−1/2
l ).
Analogously, we can get the following bounds:
|Eˆn,kRk,13| = Op(ρN,eN−1/2l ), |Eˆn,kRk,15| = Op(ρN l,λρN l,µ˜) +Op(ρN l,µ˜N
−1/2
l ),
|Eˆn,kRk,16| = Op(ρN,eρN l,µ˜) +Op(ρN l,µ˜N
−1/2
l ), |Eˆn,kRk,20| = Op(ρN,µ˜N−1/2).
Under the conditions that ρN l,λρN l,µ˜ = o(N
−/2
l ), ρN,eρN l,µ˜ = o(N
−/2
l ), ρN,eρN l,µ = o(N
−/2
l ), and ρN l,λ, ρN,e, ρN l,µ˜, ρN l, ˜˜µ
are all o(1), we can conclude that all remainder terms above are op(N
−1/2
l ). Therefore,
N
1/2
l (ξ˜1 − ξ∗1) =
N
1/2
l
N
N∑
i=1
{
Ri,N
rˆN
Ti,Nλ
∗(Xi,N )
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))
}
+
N
1/2
l
N
N∑
i=1
{
Ti,N
e∗(Xi,N )
(µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N ))
}
+
N
1/2
l
N
N∑
i=1
{
µ∗(1, Xi,N )− ξ∗1
}
+ op(1).
(36)
We handle each of these terms respectively. Note that
N
1/2
l
N
N∑
i=1
{
Ri,N
rˆN
Ti,Nλ
∗(Xi,N )
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))
}
=
r
1/2
N
N1/2
N∑
i=1
{
Ri,N
rˆN
Ti,Nλ
∗(Xi,N )
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))
}
=
r
1/2
N
N1/2
N∑
i=1
{
Ri,N
rN
Ti,Nλ
∗(Xi,N )
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))
}
+ rN
(
1
rˆN
− 1
rN
)
r
1/2
N
N1/2
N∑
i=1
{
Ri,N
rN
Ti,Nλ
∗(Xi,N )
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))
}
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Lemma D.5 implies that rN (
1
rˆN
− 1rN ) = rNrˆN − 1 = op(1). Thus
N
1/2
l
Nl
∑
i∈Il
{
λ∗(Xi,N )
Ti,N
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))
}
= (1 + op(1))
r
1/2
N
N1/2
N∑
i=1
{
Ri,N
rN
Ti,Nλ
∗(Xi,N )
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))
}
For the second and third terms in lemma D.5, we note that
EN
{
N
1/2
l
N
N∑
i=1
[
Ti,N
e∗(Xi,N )
(µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N ))
]}
= 0,
VarN
{
N
1/2
l
N
N∑
i=1
[
Ti,N
e∗(Xi,N )
(µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N ))
]}
=
N l
N
VarN
{
Ti,N
e∗(Xi,N )
(µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N ))
}
and
EN
{
N
1/2
l
N
N∑
i=1
[µ∗(1, Xi,N )− ξ∗1 ]
}
= 0
VarN
{
N
1/2
l
N
N∑
i=1
[µ∗(1, Xi,N )− ξ∗1 ]
}
=
N l
N
VarN {µ∗(1, Xi,N )− ξ∗1} .
If follows from Equation (36) that
N
1/2
l (ξ˜1 − ξ∗1) = (1 + op(1))
r
1/2
N
N1/2
N∑
i=1
{
Ri,N
rN
Ti,Nλ
∗(Xi,N )
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))
}
+
r
1/2
N
N1/2
N∑
i=1
{
Ti,N
e∗(Xi,N )
(µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N ))
}
+
r
1/2
N
N1/2
N∑
i=1
{
µ∗(1, Xi,N )− ξ∗1
}
+ op(1)
We denote SN =
∑N
i=1 Zi,N where
Zi,N =
r
1/2
N
N1/2
[
Ri,N
rN
Ti,Nλ
∗(Xi,N )
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N )) + Ti,N
e∗(Xi,N )
(µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N ))
+ µ∗(1, Xi,N )− ξ∗1
]
.
It is easy to verify that EN [SN ] = NEN [Zi,N ] = 0. Moreover,
VarN [SN ] = rNEN
[
Ri,N
rN
Ti,Nλ
∗(Xi,N )
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))
]2
+ rNEN
[
Ti,N
e∗(Xi,N )
(µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N ))
]2
+ rNEN
[
Ti,N
e∗(Xi,N )
(µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N ))
]2
→ E
{[
Tλ∗(X)
e∗(X)
(Y − µ˜∗(T,X, S))
]2
| R = 1
}
+ P(R = 1)E
[
T
e∗(X)
(µ˜∗(1, X, S)− µ∗(1, X))
]2
+ P(R = 1)E
[
T
e∗(X)
(µ˜∗(1, X, S)− µ∗(1, X))
]2
.
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To verify the Lyapunov condition, we note that for q > 2, {Var[SN ]}q = O(1), and
EN
[
N∑
i=1
|Zi,N |q
]
= NEN [|Zi,N |q] = N‖Zi,N‖qq
≤ r
q/2
N
N
q−2
2
[
‖Ri,N
rN
Ti,Nλ
∗(Xi,N )
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))‖q
+ ‖ Ti,N
e∗(Xi,N )
(µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N ))‖q + ‖µ∗(1, Xi,N )− ξ∗1‖q
]q
Note that
‖Ri,N
rN
Ti,Nλ
∗(Xi,N )
e∗(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))‖q = r−
q−1
q
N
{
EN
[
Ri,N
rN
T qi,Nλ
∗q(Xi,N )
e∗q(Xi,N )
(Yi,N − µ˜∗(Ti,N , Xi,N , Si,N ))q
]}1/q
= r
− q−1q
N
{
E
[
T qλ∗q(X)
e∗q(X)
(Y − µ˜∗(T,X, S))q | R = 1
]}1/q
≤ C
r
q−1
q
N 
{E [(Y − µ˜∗(T,X, S))q | R = 1]}1/q ≤ C
2
r
q−1
q
N 
,
‖ Ti,N
e∗(Xi,N )
(µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N ))‖q ≤ 1

‖µ˜∗(1, Xi,N , Si,N )− µ∗(1, Xi,N )‖q ≤ C

‖µ∗(1, Xi,N )− ξ∗1‖q ≤ C.
Therefore,
EN
[
N∑
i=1
|Zi,N |q
]
≤ 1
(NrN )
q−2
2
C2

+
r
q/2
N
N
q−2
2
C

+
r
q/2
N
N
q−2
2
C → 0.
By Lindberg-Feller Central Limit Theorem, we have
SN
d→ N
(
0, V˜1
)
,
where
V˜1 = E
{[
Tλ∗(X)
e∗(X)
(Y − µ˜∗(T,X, S))
]2
| R = 1
}
+ P(R = 1)E [µ∗(1, X)− ξ∗1 ]2 + P(R = 1)E
[
T
e∗(X)
(µ˜∗(1, X, S)− µ∗(1, X))
]2
.
Therefore,
N
1/2
l (ξ˜1 − ξ∗1) d→ N
(
0, V˜1
)
.
We can similarly prove that the asymptotic distribution for δ˜ is
N
1/2
l (δ˜ − δ∗) d→ N
(
0, V˜
)
,
where V˜ is given in eq. (15). Obviously when P(R = 1) = 0, V˜ equals V˜ ∗ in Theorem 4.1.
We can straightforwardly extend the proof of Theorem 3.2 to the current triangular array asymptotics and show the
same result, i.e., √
N(δˆ − δ∗) d→ N (0, V ∗),
where
V ∗ = E[ψ2(W ; δ∗, η∗)],
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with
E[ψ2(W ; δ∗, η∗)] = E [µ∗(1, X)− µ∗(0, X)− δ∗]2 + E
[
T
e∗(X)
(µ˜∗(1, X, S)− µ∗(1, X))− 1− T
1− e∗(X) (µ˜
∗(0, X, S)− µ∗(0, X))
]2
+ E
[
TR
e∗(X)r∗(X)
(Y − µ˜∗(1, X, S))− (1− T )R
(1− e∗(X))r∗(X) (Y − µ˜
∗(0, X, S))
]2
.
By Slutsky’s lemma and N l/N = rN → P(R = 1),
√
N l(δˆ − δ∗) =
√
N l
N
√
N(δˆ − δ∗) d→ N (0,P(R = 1)V ∗).
The conclusion then follows from the fact that
P(R = 1)E
[
TR
e∗(X)r∗(X)
(Y − µ˜∗(1, X, S))− (1− T )R
(1− e∗(X))r∗(X) (Y − µ˜
∗(0, X, S))
]2
=P2(R = 1)E
{[
T
e∗(X)r∗(X)
(Y − µ˜∗(1, X, S))− (1− T )
(1− e∗(X))r∗(X) (Y − µ˜
∗(0, X, S))
]2
| R = 1
}
=E
{
λ∗2(X)
[
T
e∗(X)
(Y − µ˜∗(1, X, S))− (1− T )
(1− e∗(X)) (Y − µ˜
∗(0, X, S))
]2
| R = 1
}
=E[ψ˜2(W ; δ∗, η˜∗) | R = 1]
where the second equality follows from the fact that λ∗(X) = P(R=1)r∗(X) .
E Proofs for Appendices A to C
E.1 Proofs for Appendix A
Proof for Proposition A.1. Since we consider the setting in Sections 2 and 3, we do not need the N -dependent
distribution PN . Instead, the target distribution P itself is enough for characterizing the distribution of observed
data. So in this proof, we do not consider the triangular array asymptotics in the proof of Theorem 4.2. Instead, we
use the ordinary central limit theorem for simple i.i.d samples.
We rewrite the two estimators as follows.
δˆour =
1
K
K∑
k=1
{
Eˆn,k [µˆk(1, X)− µˆk(0, X)] + Eˆn,k
[
R
rˆN
T
eˆk(X)
(Y − µˆk(1, X))− R
rˆN
1− T
(1− eˆk(X)) (Y − µˆk(0, X))
]}
,
δˆZB =
1
K
K∑
k=1
{
Eˆn,k
[
1−R
1− rˆN (µˆk(1, X)− µˆk(0, X))
]
+ Eˆn,k
[
R
rˆN
T
eˆk(X)
(Y − µˆk(1, X))− R
rˆN
1− T
(1− eˆk(X)) (Y − µˆk(0, X))
]}
.
where rˆN .
Following the proof in Theorem 4.2, we can show that
√
N(δˆour − δ∗) = 1√
N
N∑
i=1
[µ∗(1, Xi)− µ∗(0, Xi)− δ∗]
+ (1 + op(1))
1√
N
N∑
i=1
[
Ri
r
Ti
e∗(Xi)
(Yi − µ∗(1, Xi))− Ri
r
(1− Ti)
(1− e∗(Xi)) (Yi − µ
∗(0, Xi))
]
+ op(1).
where r = P(R = 1).
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Since
Var
[
1√
N
N∑
i=1
[µ∗(1, Xi)− µ∗(0, Xi)− δ∗]
]
= E [µ∗(1, Xi)− µ∗(0, Xi)− δ∗]2
Var
[
1√
N
N∑
i=1
[
Ri
r
Ti
e∗(Xi)
(Yi − µ∗(1, Xi))− Ri
r
(1− Ti)
(1− e∗(Xi)) (Yi − µ
∗(0, Xi))
]]
=
1
r
E
{[
Ti
e∗(Xi)
(Yi − µ∗(1, Xi))− (1− Ti)
(1− e∗(Xi)) (Yi − µ
∗(0, Xi))
]2
| Ri = 1
}
=
1
r
E
{[
Ti
e∗(Xi)
(Yi − µ∗(1, Xi))− (1− Ti)
(1− e∗(Xi)) (Yi − µ
∗(0, Xi))
]2}
where the last equality is implied by the assumption that Y is missing completely at random.
Thus by Central Limit Theorem,
√
N(δˆour − δ∗) d→ N (0, Vour)
where
Vour = Var [µ
∗(1, Xi)− µ∗(0, Xi)− δ∗] + 1P(Ri = 1)E
{[
Ti − e∗(Xi)
e∗(Xi)(1− e∗(Xi)) (Yi − µ
∗(Ti, Xi))
]2
| Ri = 1
}
.
Similarly, we can show that
√
N(δˆZB − δ∗) = (1 + op(1)) 1√
N
N∑
i=1
1−Ri
1− r [µ
∗(1, Xi)− µ∗(0, Xi)− δ∗]
+ (1 + op(1))
1√
N
N∑
i=1
[
Ri
r
Ti
e∗(Xi)
(Yi − µ∗(1, Xi))− Ri
r
(1− Ti)
(1− e∗(Xi)) (Yi − µ
∗(0, Xi))
]
+ op(1).
Note that
Var
{
1√
N
N∑
i=1
1−Ri
1− r [µ
∗(1, Xi)− µ∗(0, Xi)− δ∗]
}
=
1
1− rE
{
[µ∗(1, Xi)− µ∗(0, Xi)− δ∗]2 | Ri = 0
}
=
1
1− rE
{
[µ∗(1, Xi)− µ∗(0, Xi)− δ∗]2
}
.
Thus by Central Limit Theorem,
√
N(δˆZB − δ∗) d→ N (0, VZB)
where
VZB =
1
1− P(Ri = 1) Var [µ
∗(1, Xi)− µ∗(0, Xi)− δ∗] + 1P(Ri = 1)E
{[
Ti − e∗(Xi)
e∗(Xi)(1− e∗(Xi)) (Yi − µ
∗(Ti, Xi))
]2}
.
Then
VZB − Vour = P(Ri = 1)
1− P(Ri = 1)E [µ
∗(1, Xi)− µ∗(0, Xi)− δ∗]2 > 0
whenever P(Ri = 1) > 0.
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Proof for Theorem A.1. We derive the two conclusions respectively.
Efficiency bound without assuming the statistical surrogate condition while it is true. From Theorem 2.1,
we already know that the efficient influence function for δ∗ is given by the following:
ψ(W ; δ∗, η∗) = µ∗(1, X)− µ∗(0, X) + TR
e∗(X)r∗(1, X, S)
(Y − µ˜∗(1, X, S))− (1− T )R
(1− e∗(X))r∗(0, X, S) (Y − µ˜
∗(0, X, S))
+
T
e∗(X)
(µ˜∗(1, X, S)− µ∗(1, X))− 1− T
1− e∗(X) (µ˜
∗(0, X, S)− µ∗(0, X))− δ∗.
If indeed Y ⊥ T | X,S,R = 1, we know that for t = 0, 1,
µ˜∗(t,X, S) = E[Y | R = 1, T = t,X, S] = E[Y | R = 1, X, S] = µ˜∗(X,S).
Thus the efficient influence function becomes
ψ(W ; δ∗, η∗) = µ∗(1, X)− µ∗(0, X)− δ∗ + TR
e∗(X)r∗(1, X, S)
(Y − µ˜∗(X,S))− (1− T )R
(1− e∗(X))r∗(0, X, S) (Y − µ˜
∗(X,S))
+
T
e∗(X)
(µ˜∗(X,S)− µ∗(1, X))− 1− T
1− e∗(X) (µ˜
∗(X,S)− µ∗(0, X)).
Efficiency bound when explicitly assuming the statistical surrogate condition. If we indeed incorporate
the condition Y ⊥ T | X,S,R = 1 into our model, then we should consider the following model:
M′fix =
{
fX,T,S,R,Y (X,T, S,R, Y ) = fX(X)
[
e∗(X)T (1− e∗(X))1−T ]fS|X,T (S | X,T )[r∗(T,X, S)R(1− r∗(T,X, S))1−R]
× fRY |R=1,S,T,X(Y, S, T,X) : fX , fS|X,T are arbitrary density functions,
and fY |R=1,S,T,X is any valid density function obeying fY |R=1,S,T=1,X = fY |R=1,S,T=0,X
}
.
Note that this model is a submodel of model Mfix in the proof of Theorem 2.1, and ψ(W ; δ∗, η∗) is an influence
function of δ∗ with respect to the tangent space of Mfix. Thus ψ(W ; δ∗, η∗) is also an influence function of δ∗ with
respect to the tangent space of M′fix. Therefore, we only need to verify that ψ(W ; δ∗, η∗) belongs to the tangent
space of M′fix in order to prove that ψ(W ; δ∗, η∗) is the efficient influence function of δ∗ under model M′fix.
In the rest of the proof, we will prove that the tangent space of M′fix is
Λ′ = ΛX ⊕ ΛS|X,T ⊕ Λ′Y |R=1,S,T,X (37)
where
ΛX = {SX(X) ∈ H : E[SX(X)] = 0}
ΛS|X,T = {SS|X,T (S,X, T ) ∈ H : E[SS|X,T (S,X, T ) | X,T ] = 0}
Λ′Y |R=1,S,X,T = {SY |R=1,S,X,T (Y,R, S,X) ∈ H : E[SY |R=1,S,X(Y,R, S,X) | R = 1, S,X, T ] = 0}.
Note that here ΛX and ΛS|X,T are exactly the same as those in the proof for Theorem 2.1. The only difference
now lies in Λ′Y |R=1,S,X,T . Compared to score vectors in ΛY |R,S,X,T in Step I of the proof for Theorem 2.1, score
vectors corresponding to the distribution of Y given R = 1, S, T,X in Λ′Y |R=1,S,X,T are not functions of T , yet their
conditional expectations given T,R = 1 besides other observed variables are again restricted to be 0.
We note that
µ∗(1, X)− µ∗(0, X)− δ∗ ∈ Λ′X
T
e∗(X)
(µ˜∗(X,S)− µ∗(1, X))− 1− T
1− e∗(X) (µ˜
∗(X,S)− µ∗(0, X)) ∈ Λ′S|X,T
TR
e∗(X)r∗(1, X, S)
(Y − µ˜∗(X,S))− (1− T )R
(1− e∗(X))r∗(0, X, S) (Y − µ˜
∗(X,S)) ∈ Λ′Y |R=1,S,X,T .
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Thus eq. (37) implies that ψ(W ; δ∗, η∗) is also the efficient influence function for δ∗ if we explicitly assume the
statistical surrogate condition Y ⊥ T | X,S,R = 1 in our model.
Now we prove that eq. (37) is indeed true by verifying the structure of Λ′Y |R=1,S,X,T .
The log-likelihood corresponding to the distribution of Y given R = 1, S,X, T in a parametric submodel indexed by
γ is given by
RT log fY |R=1,T=1,S,X(Y, S,X; γ) +R(1− T ) log fY |R=1,T=0,S,X(Y, S,X; γ).
According to the statistical surrogate condition Y ⊥ T | S,X,R = 1,
fY |R=1,T=1,S,X(Y, S,X; γ) = fY |R=1,T=0,S,X(Y, S,X; γ),
so we denote their common value as g(Y, S,X; γ).
Therefore, the log-likelihood corresponding to the distribution of Y given R = 1, S,X, T in a parametric submodel
indexed by γ is given by
R log g(Y, S,X; γ).
The corresponding score vector is
SY |R=1,S,X,T (Y, S,X; γ∗) = R
∂ log g(Y, S,X; γ∗)
∂γ
= R
∂g(Y, S,X; γ∗)/∂γ
g(Y, S,X; γ∗)
Since g( ·, ·, ·; γ∗) is a valid density function for the distribution of Y given R = 1, S,X and T = t for t = 0, 1,
E
[
∂g(Y, S,X; γ∗)/∂γ
g(Y, S,X; γ∗)
| R = 1, T = 1, S,X
]
= E
[
∂g(Y, S,X; γ∗)/∂γ
g(Y, S,X; γ∗)
| R = 1, T = 0, S,X
]
= 0.
This means that the score vector corresponding to the distribution of Y given R = 1, S,X, T in any smooth and
regular parametric submodel belongs to Λ′Y |R=1,S,X,T .
In turn, for any mean 0, bounded, and square integrable element h(Y, 1, S,X) in Λ′Y |R=1,S,X,T , we can consider the
parametric submodel
fY |R=1,S,X,T (Y, S,X; γ) = f∗Y |R=1,S,X,T (Y, S,X)[1 + γh(Y, 1, S,X)]
where f∗Y |R=1,S,X,T is the true density function of the distribution of Y given R = 1, S,X, T , γ is sufficiently small
so that 1 + γh(Y, 1, S,X) ≥ 0, and γ∗ = 0. Then fY |R=1,S,X,T (·, ·, ·; γ) is a valid density function for the distribution
of Y given R = 1, S,X, T , since∫∫∫
fY |R=1,S,X,T (y, s, x; γ)dy
=
∫∫∫
f∗Y |R=1,S,X,T (y, s, x; γ)dy + γ
∫∫∫
f∗Y |R=1,S,X,T (y, s, x; γ)h(y, 1, S,X)dy = 1.
The last equality holds because E[h(Y,R, S,X) | R = 1, S,X] = 0 according to the definition of Λ′Y |R=1,S,X,T .
We can verify that the score vector for this parameteric submodel satisfies that
SY |R=1,S,X,T (Y, S,X; γ∗) = R
∂fY |R=1,S,X,T (Y, S,X; γ∗)/∂γ
fY |R=1,S,X,T (Y, S,X; γ∗)
= Rh(Y, 1, S,X) = h(Y,R, S,X).
Thus we prove that the tangent space corresponding to the distribution of Y given R = 1, S,X, T contains all
bounded and mean-0 elements in Λ′Y |R=1,S,X,T . Since any element in the Hilbert space can be approximated by a
sequence of bounded mean-0 elemenets, the tangent space corresponding to the distribution of Y given R = 1, S,X, T
is therefore indeed Λ′Y |R=1,S,X,T .
55
E.2 Proofs for Appendix B
Proof for Proposition B.1. In order to prove that T ⊥ Y | X,S, we need to verify that for any x ∈ X , s ∈ S, and
y ∈ Y,
P(Y ≤ y | T = 1, X = x, S = s) = P(Y ≤ y | T = 0, X = x, S = s),
or equivalently,
P(Y (1, s) ≤ y | T = 1, X = x, S(1) = s) = P(Y (0, s) ≤ y | T = 0, X = x, S(0) = s). (38)
We note that condition (iii) in Proposition B.1 implies that
P(Y (0, s) ≤ y | T = 0, X = x, S(0) = s) = P(Y (0, s) ≤ y | T = 0, X = x),
P(Y (1, s) ≤ y | T = 1, X = x, S(1) = s) = P(Y (1, s) ≤ y | T = 1, X = x).
Then the condition (i) in Proposition B.1 implies that
P(Y (0, s) ≤ y | T = 0, X = x) = P(Y (1, s) ≤ y | T = 0, X = x).
Moreover, the condition (ii) in Proposition B.1 implies that
P(Y (1, s) ≤ y | T = 0, X = x) = P(Y (1, s) ≤ y | T = 1, X = x).
These equations together ensure eq. (38).
E.3 Proofs for Appendix C
Proof for Theorem C.1. Note that under Assumption 1, Assumption 2 condition (4), Assumption 3, and R ⊥ T | X,
ξ∗1 = E[Y (1)] = E [E[Y (1) | X]] = E [E[Y | X,T = 1, R = 1]]
=
∫∫
yf∗X(x)f
∗
Y |X,T=1,R=1(y | x, T = 1, R = 1)dxdy.
According to the assumption, we know the distribution of (T,X), thus we know e∗(X) = P(T = 1 | X) and
f∗(X). The only unknown component that also contributes to the definition of ξ∗1 is the distribution of Y given
X,T = 1, R = 1. Therefore, we can equivalently consider the efficiency lower bound for ξ∗1 under the following model
that fix all other components but the distribution of Y given X,T = 1, R = 1 at the truth.
Mfix =
{
fX,T,Y |R=1(X,T, Y ) = f∗X|R=1(X)
[
e∗(1, X)T (1− e∗(1, X))1−T ]fY |R=1,T,X(Y, T,X) :
fY |R=1,T,X is an arbitrary density functions
}
It is easy to verify that the orthogonal complement to the tangent space of Mfix is Λ⊥fix = {SX,T,S ∈ L2(P ) :
E[SX,T,S | R = 1] = 0}.
Again we consider parametric submodels indexed by γ in path-differentiability analysis for ξ∗1 . In the following
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analysis, we suppress the subscripts in the density functions to ease the notations.
∂
∂γ
Eγ [Y (1)]|γ=γ∗
=
∫
f∗(x)
∂
∂γ
Eγ [Y | X = x, T = 1, R = 1]|γ=γ∗dxds
=
∫
f∗(x)E[Y SY |X,S,T=1,R=1(Y,X, T = 1, R = 1; γ∗) | X = x, T = 1, R = 1]dx
=
∫
f∗(x)E[
T
e∗(X)
Y SY |X,S,T=1,R=1(Y,X, T = 1, R = 1; γ∗) | X = x,R = 1]dx
=
∫
f∗(x)E[
T
e∗(X)
(Y − µ∗(T,X))SY |X,S,T=1,R=1(Y,X, T = 1, R = 1; γ∗) | X = x,R = 1]dx
=
∫
f∗(x | R = 1) f
∗(x)
f∗(x | R = 1)E[
T
e∗(X)
(Y − µ∗(T,X))SY |X,S,T=1,R=1(Y,X, T = 1, R = 1; γ∗) | X = x,R = 1]dx
= E[
f∗(X)
f∗(X | R = 1)
T
e∗(X)
(Y − µ∗(T,X))SY |X,S,T=1,R=1(Y,X, T = 1, R = 1; γ∗) | R = 1]
This means that ψ˜I,1(W ; δ
∗, η˜∗) = f
∗(X)
f∗(X|R=1)
T
e∗(X) (Y − µ∗(T,X)) is an influence function for ξ∗1 . Moreover, we can
easily verify that ψ˜I,1(W ; δ
∗, η˜∗) is orthogonal to Λ⊥fix. Therefore, ψ˜I,1(W ; δ
∗, η˜∗) is the efficient influence function
for ξ∗1 . Analogously, we can prove that the efficient influence function for δ
∗ is ψ˜I(W ; δ∗, η˜∗) in setting I.
Moreover, following the proof of Theorem 2.2, we can analogously prove that the efficient influence function for δ∗
in setting II is the same, i.e., ψ˜II(W ; δ
∗, η˜∗) = ψ˜I(W ; δ∗, η˜∗).
Therefore, the efficiency lower bounds for these two settings are
V˜ ∗I = V˜
∗
II = E
[
ψ˜2I (W ; δ
∗, η˜∗) | R = 1
]
= E
[[
Tλ∗(X)
e∗(X)
(Y − µ∗(1, X))− (1− T )λ
∗(X)
1− e∗(X) (Y − µ
∗(0, X))
]2
| R = 1
]
= E
[
λ∗2(X)
e∗(X)
(Y 2(1)− µ∗2(1, X)) + λ
∗2(X)
1− e∗(X) (Y
2(0)− µ∗2(0, X)) | R = 1
]
.
Note that the efficiency lower bound in Theorem 4.1 is
V˜ ∗ = E
[
ψ˜2(W ; δ∗, η˜∗) | R = 1
]
= E
[[
Tλ∗(X)
e∗(X)
(Y − µ˜∗(1, X, S))− (1− T )λ
∗(X)
1− e∗(X) (Y − µ˜
∗(0, X, S))
]2
| R = 1
]
= E
[
λ∗2(X)
e∗(X)
(Y 2(1)− µ˜∗2(1, X, S)) + λ
∗2(X)
1− e∗(X) (Y
2(0)− µ˜∗2(0, X, S)) | R = 1
]
.
Therefore, the efficiency improvement from surrogates is
V˜ ∗I − V˜ ∗ = V˜ ∗II − V˜ ∗ = E
[
λ∗2(X)
e∗(X)
(µ˜∗2(1, X, S)− µ∗2(1, X)) + λ
∗2(X)
1− e∗(X) (µ˜
∗2(0, X, S)− µ˜∗2(0, X)) | R = 1
]
= E
[
λ∗2(X)
e∗(X)
Var{µ˜∗(1, X, S(1)) | X}+ λ
∗2(X)
1− e∗(X) Var{µ˜
∗(0, X, S(0)) | X} | R = 1
]
.
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Proof for Theorem C.2. According to the proof of Theorem 4.1,
ξ∗1 = E[Y (1)] =
∫
f∗X(x)E[Y (1) | X = x]dx
=
∫
f∗X(x)f
∗
S|X,T=1(s | x, T = 1)E[Y (1) | X = x, S = s, T = 1]dx
=
∫
f∗X(x)E[Y (1) | X = x, T = 1, R = 1]dx
=
∫∫∫
yf∗X(x)f
∗
S|X,T=1(s | x, T = 1)f∗Y |X,S,T=1,R=1(y | s, x, T = 1, R = 1)dydsdx.
Again here both f∗X and f
∗
S|X,T=1 are known according to our assumption that we know the distribution of (X,T, S).
So the only unknown part that requires models and contributes to the definition of ξ∗1 is the distribution of Y given
S, T,X,R.
Therefore, we can again focus on efficiency lower bound in the following model Mfix that fixes all components but
the distribution of Y given S, T,X,R at truth:
Mfix =
{
fX,T,S,Y |R=1(X,T, S, Y ) = f∗X|R=1(X | R = 1)
[
e∗(1, X)T (1− e∗(1, X))1−T ]
× f∗S|X,T,R=1(S | X,T,R = 1)fY |S,T,X,R=1(Y, S, T,X | R = 1) : and fY |S,T,X,R=1is arbitrary density function
}
The orthogonal complement to the tangent space ofMfix is again Λ⊥fix = {SX,T,S ∈ L2(P ) : E[SX,T,S | R = 1] = 0}.
Again we consider parametric submodels indexed by γ in path-differentiability analysis for ξ∗1 . In the following
analysis, we suppress the subscripts in the density functions to ease the notations.
∂
∂γ
Eγ [Y (1)]|γ=γ∗
=
∫
f∗(x)f∗(s | X = x, T = 1) ∂
∂γ
Eγ [Y | X = x, S = s, T = 1, R = 1]|γ=γ∗dxds
=
∫
f∗(x)f∗(s | X = x, T = 1)E[Y SY |X,S,T=1,R=1(Y,X, S, T = 1, R = 1; γ∗) | X = x, S = s, T = 1, R = 1]dxds
=
∫
f∗(x)f∗(s | X = x, T = 1, R = 1)
× E[ f
∗(S | X = x, T = 1)
f∗(S | X = x, T = 1, R = 1)Y SY |X,S,T,R=1(Y,X, S, T,R = 1) | X = x, S = s,R = 1, T = 1]dxds
=
∫
f∗(x)E[
f∗(S | X = x, T = 1)
f∗(S | X = x, T = 1, R = 1)Y SY |X,S,T,R=1(Y,X, S, T,R = 1) | X = x,R = 1, T = 1]dx
=
∫
f∗(x)E[
f∗(S | X = x, T = 1)
f∗(S | X = x, T = 1, R = 1)
T
e∗(1, X)
Y SY |X,S,T,R=1(Y,X, S, T,R = 1) | X = x,R = 1]dx
= E[
f∗(X)
f∗(X | R = 1)
f∗(S | X,T = 1)
f∗(S | X,T = 1, R = 1)
T
e∗(1, X)
Y SY |X,S,T,R=1(Y,X, S, T,R = 1) | R = 1]
= E
[
f∗(X)
f∗(X | R = 1)
f∗(S | X,T = 1)
f∗(S | X,T = 1, R = 1)
T
e∗(1, X)
[Y − µ˜∗(T,X, S)]SY |X,S,T,R=1(Y,X, S, T,R = 1) | R = 1
]
Moreover, it is easy to verify that ψ˜′1(W ; δ
∗, η˜
′∗) = f
∗(X)
f∗(X|R=1)
f∗(S|X,T=1)
f∗(S|X,T=1,R=1)
T
e∗(1,X) [Y − µ˜∗(T,X, S)] is orthogonal
to Λ⊥fix thus it is the efficient influence function for ξ
∗
1 .
Similarly, we can prove that the efficient influence function for ξ∗0 is
ψ˜′0(W ; δ
∗, η˜
′∗) =
f∗(X)
f∗(X | R = 1)
f∗(S | X,T = 0)
f∗(S | X,T = 0, R = 1)
1− T
1− e∗(1, X) [Y − µ˜
∗(T,X, S)] .
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As a result, the efficient influence function for δ∗ is
ψ˜′(W ; δ∗, η˜
′∗) =
f∗(X)
f∗(X | R = 1)
f∗(S | X,T = 1)
f∗(S | X,T = 1, R = 1)
T
e∗(1, X)
[Y − µ˜∗(T,X, S)]
− f
∗(X)
f∗(X | R = 1)
f∗(S | X,T = 0)
f∗(S | X,T = 0, R = 1)
1− T
1− e∗(1, X) [Y − µ˜
∗(T,X, S)] .
Proof for Proposition C.1. The efficiency bound V ∗i directly follows from the efficiency bound V
∗
IV in Theorem 2.2.
The efficiency bound V ∗ii directly follows from the efficiency bound V
∗
III in Theorem 2.2 and the reformulation in
Theorem 4.2 eq. (15). The efficiency lower bound V ∗iii directly follows from the efficiency bound V˜
∗ in Theorem 4.1.
The formula for efficiency gaps V ∗i − V ∗ii and V ∗ii − V ∗iii follow from the algebraic facts below:
V ∗i = E
[
1
e∗(X)
(
Y 2(1)− µ∗2(1, X)
)
+
1
1− e∗(X)
(
Y 2(0)− µ∗2(0, X)
)]2
+ E [µ∗(1, X)− µ∗(0, X)− δ∗]2 ,
V ∗ii = E
[
1
e∗(X)
(
Y 2(1)− µ˜∗2(1, X, S(1)))+ 1
1− e∗(X)
(
Y 2(0)− µ˜∗2(0, X, S(0)))]2
+ P(R = 1)E
[
1
e∗(X)
(
µ˜∗2(1, X, S(1))− µ∗2(1, X)
)
+
1
1− e∗(X)
(
µ˜∗2(0, X, S(0))− µ∗2(0, X)
)]2
+ P(R = 1)E [µ∗(1, X)− µ∗(0, X)− δ∗]2 ,
V ∗iii = E
[
1
e∗(X)
(
Y 2(1)− µ˜∗2(1, X, S(1)))+ 1
1− e∗(X)
(
Y 2(0)− µ˜∗2(0, X, S(0)))]2 .
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